UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

The registrant meets the conditions set forth in General Instructions I (1)(a) and (b) of Form 10-K and is therefore filing this form with the reduced disclosure format.

 

[X]          ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2013

 

OR

 

[  ]           TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

Commission file number 0-31248

 

ALLSTATE LIFE INSURANCE COMPANY

(Exact name of registrant as specified in its charter)

 

Illinois

36-2554642

(State or Other Jurisdiction of

(I.R.S. Employer

Incorporation or Organization)

Identification No.)

 

3100 Sanders Road, Northbrook, Illinois 60062

(Address of principal executive offices)      (Zip Code)

 

Registrant’s telephone number, including area code:  (847) 402-5000

 

Securities registered pursuant to Section 12(b) of the Act:  None

 

Securities registered pursuant to Section 12(g) of the Act:  Common Stock, par value $227.00 per share

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes                          No   X  

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.

Yes                          No   X  

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes   X                    No      

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

 

Yes   X                    No      

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.     X  

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ____

 

 

Accelerated filer

____

 

 

 

 

Non-accelerated filer     X     (Do not check if a smaller reporting company)

Smaller reporting company ____

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes                        No   X  

 

None of the common equity of the registrant is held by non-affiliates.  Therefore, the aggregate market value of the common equity held by non-affiliates of the registrant is zero.

 

As of March 5, 2014, the registrant had 23,800 common shares, $227 par value, outstanding, all of which are held by Allstate Insurance Company.

 



 

TABLE OF CONTENTS

 

 

 

 

 

Page

PART I

 

 

 

Item 1.

Business

 

1

Item 1A.

Risk Factors

 

3

Item 1B.

Unresolved Staff Comments

 

10

Item 2.

Properties

 

11

Item 3.

Legal Proceedings

 

11

Item 4.

Mine Safety Disclosures

 

11

 

 

 

 

PART II

 

 

 

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

11

Item 6.

Selected Financial Data

 

11

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

12

Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

 

44

Item 8.

Financial Statements and Supplementary Data

 

45

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

102

Item 9A.

Controls and Procedures

 

102

Item 9B.

Other Information

 

102

 

 

 

 

PART III

 

 

 

Item 10.

Directors, Executive Officers and Corporate Governance *

 

N/A

Item 11.

Executive Compensation *

 

N/A

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters *

 

N/A

Item 13.

Certain Relationships and Related Transactions, and Director Independence *

 

N/A

Item 14.

Principal Accounting Fees and Services

 

103

 

 

 

 

PART IV

 

 

 

Item 15.

Exhibits and Financial Statement Schedules

 

104

Signatures

 

 

108

Financial Statement Schedules

 

S-1

 

 

 

 

 

* Omitted pursuant to General Instruction I(2) of Form 10-K

 

 

 



 

Part I

Item 1.  Business

 

Allstate Life Insurance Company was organized in 1957 as a stock life insurance company under the laws of the State of Illinois.  Allstate Life Insurance Company, together with its subsidiaries, provides life insurance and voluntary accident and health insurance.  It conducts substantially all of its operations directly or through wholly owned United States subsidiaries.  In this document, we refer to Allstate Life Insurance Company as “Allstate Life” or “ALIC” and to Allstate Life and its wholly owned subsidiaries as the “Allstate Life Group” or the “Company”.

 

Allstate Life is a wholly owned subsidiary of Allstate Insurance Company, a stock property-liability insurance company organized under the laws of the State of Illinois.  All of the outstanding stock of Allstate Insurance Company is owned by Allstate Insurance Holdings, LLC, which is wholly owned by The Allstate Corporation, a publicly owned holding company incorporated under the laws of the State of Delaware.  In this document, we refer to Allstate Insurance Company as “AIC” and to The Allstate Corporation and its consolidated subsidiaries as “Allstate”, the “Parent Group” or the “Corporation”.  The Allstate Corporation is the largest publicly held personal lines insurer in the United States.  Widely known through the “You’re In Good Hands With Allstate®” slogan, Allstate’s strategy is to reinvent protection and retirement to help individuals in approximately 16 million households protect what they have today and better prepare for tomorrow.  Customers can access Allstate products and services such as auto and homeowners insurance through approximately 11,600 exclusive Allstate agencies and financial representatives in the United States and Canada, as well as through independent agencies, contact centers and the internet.  Allstate is the 2nd largest personal property and casualty insurer in the United States on the basis of 2012 statutory direct premiums earned according to A.M. Best.  In addition, according to A.M. Best, it is the nation’s 17th largest issuer of life insurance business on the basis of 2012 ordinary life insurance in force and 24th largest on the basis of 2012 statutory admitted assets.

 

The Parent Group has four business segments, one of which is Allstate Financial.  Allstate Financial, which is not a separate legal entity, is comprised of the Allstate Life Group together with the majority of American Heritage Life Insurance Company.  This document describes the Allstate Life Group.  It does not describe the entire group of companies that form the Allstate Financial segment of the Parent Group.

 

In this annual report on Form 10-K, we occasionally refer to statutory financial information.  All domestic United States insurance companies are required to prepare statutory-basis financial statements.  As a result, industry data is available that enables comparisons between insurance companies, including competitors that are not subject to the requirement to prepare financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”).  We frequently use industry publications containing statutory financial information to assess our competitive position.

 

Products and Distribution

 

The Allstate Life Group provides life insurance and voluntary accident and health insurance.  Our principal products are interest-sensitive, traditional and variable life insurance.  We sell products through Allstate exclusive agencies and exclusive financial specialists, and workplace enrolling independent agents in New York.  The table below lists our current distribution channels with the associated products and target customers.

 

 

Distribution Channels

 

 

Proprietary Products

 

 

Target Customers

 

Allstate exclusive agencies and exclusive financial specialists

Term life insurance
Whole life insurance
Interest-sensitive life insurance
Variable life insurance

 

Middle market (1) and mass affluent consumers (2) with retirement and family financial protection needs

Workplace enrolling independent agents

Workplace life and voluntary accident and health insurance:

Interest-sensitive and term life insurance

Disability income insurance

Cancer, accident and critical illness insurance

Middle market consumers in New York with family financial protection needs employed by small, medium, and large size firms

 

(1) Consumers with $35,000-$75,000 in household income.

(2) Consumers with greater than $75,000 in household income.

 

1



 

Competition

 

We compete on a wide variety of factors, including product offerings, brand recognition, financial strength and ratings, prices, distribution and the level of customer service.  The market for life insurance continues to be highly fragmented and competitive.  As of December 31, 2012, there were approximately 420 groups of life insurance companies in the United States, most of which offered one or more similar products.  According to A.M. Best, as of December 31, 2012, the Allstate Life Group is the nation’s 17th largest issuer of life insurance and related business on the basis of 2012 ordinary life insurance in force and 24th largest on the basis of 2012 statutory admitted assets.

 

Geographic Markets

 

We sell life insurance throughout the United States and voluntary accident and health insurance in New York.  The Allstate Life Group is authorized to sell various types of these products in all 50 states, the District of Columbia, Puerto Rico, the U.S. Virgin Islands and Guam.

 

The following table reflects, in percentages, the principal geographic distribution of statutory premiums and annuity considerations for the Allstate Life Group for 2013, based on information contained in statements filed with state insurance departments.  No other jurisdiction accounted for more than 5 percent of the statutory premiums and annuity considerations.

 

California

 

13.8

  %

Texas

 

8.0

 

Florida

 

7.1

 

New York

 

6.3

 

 

REGULATION

 

The Allstate Life Group is subject to extensive regulation, primarily at the state level.  The method, extent, and substance of such regulation varies by state but generally has its source in statutes that establish standards and requirements for conducting the business of insurance and that delegate regulatory authority to a state agency.  These rules have a substantial effect on our business and relate to a wide variety of matters, including insurer solvency, reserve adequacy, insurance company licensing and examination, agent licensing, policy forms, rate setting, the nature and amount of investments, claims practices, participation in guaranty funds, transactions with affiliates, the payment of dividends, underwriting standards, statutory accounting methods, trade practices, and corporate governance.  Some of these matters are discussed in more detail below.  For a discussion of statutory financial information, see Note 15 of the consolidated financial statements.  For a discussion of regulatory contingencies, see Note 12 of the consolidated financial statements.  Notes 12 and 15 are incorporated in this Part I, Item 1 by reference.

 

In recent years, the state insurance regulatory framework has come under increased federal scrutiny.  As part of an effort to strengthen the regulation of the financial services market, the Dodd-Frank Wall Street Reform and Consumer Protection Act (“Dodd-Frank”) was enacted in 2010.  Many regulations required pursuant to this law must still be finalized, and we cannot predict what the final regulations will require but do not expect a material impact on the Allstate Life Group’s operations.  Dodd-Frank also created the Federal Insurance Office (“FIO”) within the Treasury Department.  The FIO monitors the insurance industry, provides advice to the Financial Stability Oversight Council (“FSOC”), represents the U.S. on international insurance matters, and studies the current regulatory system.  FIO submitted a report to Congress in December 2013 addressing how to improve and modernize the system of insurance regulation.  In addition, state legislators and insurance regulators continue to examine the appropriate nature and scope of state insurance regulation.  We cannot predict whether any specific state or federal measures will be adopted to change the nature or scope of the regulation of insurance or what effect any such measures would have on the Allstate Life Group.

 

Agent and Broker Compensation.  In recent years, several states considered new legislation or regulations regarding the compensation of agents and brokers by insurance companies.  The proposals ranged in nature from new disclosure requirements to new duties on insurance agents and brokers in dealing with customers.  Agents and brokers in New York are required to disclose certain information concerning compensation.

 

Limitations on Dividends By Insurance Subsidiaries.  Allstate Life may receive dividends from time to time from its subsidiaries.  When received, these dividends represent a source of cash from which Allstate Life may meet some of its obligations.  If a subsidiary is an insurance company, its ability to pay dividends may be restricted by state laws regulating insurance companies.  For additional information regarding those restrictions, see Note 15 of

 

2



 

the consolidated financial statements.

 

Guaranty Funds.  Under state insurance guaranty fund laws, insurers doing business in a state can be assessed, up to prescribed limits, in order to cover certain obligations of insolvent insurance companies.

 

Investment Regulation.  Our insurance subsidiaries are subject to regulations that require investment portfolio diversification and that limit the amount of investment in certain categories.  Failure to comply with these rules leads to the treatment of non-conforming investments as non-admitted assets for purposes of measuring statutory surplus.  Further, in some instances, these rules require divestiture of non-conforming investments.

 

Variable Life Insurance and Registered Fixed Annuities.  The sale and administration of variable life insurance and registered fixed annuities with market value adjustment features are subject to extensive regulatory oversight at the federal and state level, including regulation and supervision by the Securities and Exchange Commission (“SEC”) and the Financial Industry Regulatory Authority (“FINRA”).

 

Broker-Dealers, Investment Advisors, and Investment Companies.  The Allstate Life Group entities that operate as broker-dealers, registered investment advisors, and investment companies are subject to regulation and supervision by the SEC, FINRA and/or, in some cases, state securities administrators.

 

Privacy Regulation.  Federal law and the laws of many states require financial institutions to protect the security and confidentiality of customer information and to notify customers about their policies and practices relating to collection and disclosure of customer information and their policies relating to protecting the security and confidentiality of that information.  Federal law and the laws of many states also regulate disclosures and disposal of customer information.  Congress, state legislatures, and regulatory authorities are expected to consider additional regulation relating to privacy and other aspects of customer information.

 

EMPLOYEES AND OTHER SHARED SERVICES

 

The Allstate Life Group has no employees.  Instead, we primarily use the services of employees of AIC, our direct parent.  We also make use of other services and facilities provided by AIC and other members of the Parent Group.  These services and facilities include space rental, utilities, building maintenance, human resources, investment management, finance, information technology and legal services.  We reimburse our affiliates for these services and facilities under a variety of agreements.

 

OTHER INFORMATION

 

“Allstate” is one of the most recognized brand names in the United States.  We use the names “Allstate” and “Lincoln Benefit Life®” extensively in our business, along with related service marks, logos, and slogans, such as “Good Hands®.”  Our rights in the United States to these names, service marks, logos, and slogans continue so long as we continue to use them in commerce.  These service marks and many others used by Allstate are the subject of renewable U.S. and/or foreign service mark registrations.  We believe that these service marks are important to our business and we intend to maintain our rights to them through continued use.

 

Item 1A.  Risk Factors

 

This document contains “forward-looking statements” that anticipate results based on our estimates, assumptions and plans that are subject to uncertainty.  These statements are made subject to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995.  We assume no obligation to update any forward-looking statements as a result of new information or future events or developments.

 

These forward-looking statements do not relate strictly to historical or current facts and may be identified by their use of words like “plans,” “seeks,” “expects,” “will,” “should,” “anticipates,” “estimates,” “intends,” “believes,” “likely,” “targets” and other words with similar meanings.  These statements may address, among other things, our strategy for growth, product development, investment results, regulatory approvals, market position, expenses, financial results, litigation and reserves.  We believe that these statements are based on reasonable estimates, assumptions and plans.  However, if the estimates, assumptions or plans underlying the forward-looking statements prove inaccurate or if other risks or uncertainties arise, actual results could differ materially from those communicated in these forward-looking statements.

 

In addition to the normal risks of business, we are subject to significant risks and uncertainties, including those listed below, which apply to us as an insurer and a provider of other products and financial services.  These risks constitute our cautionary statements under the Private Securities Litigation Reform Act of 1995 and readers should

 

3



 

carefully review such cautionary statements as they identify certain important factors that could cause actual results to differ materially from those in the forward-looking statements and historical trends.  These cautionary statements are not exclusive and are in addition to other factors discussed elsewhere in this document, in our filings with the SEC or in materials incorporated therein by reference.

 

Changes in underwriting and actual experience could materially affect profitability and financial condition

 

Our product pricing includes long-term assumptions regarding investment returns, mortality, morbidity, persistency and operating costs and expenses of the business.  We establish target returns for each product based upon these factors and the average amount of capital that we must hold to support in-force contracts taking into account rating agencies and regulatory requirements.  We monitor and manage our pricing and overall sales mix to achieve target new business returns on a portfolio basis, which could result in the discontinuation or de-emphasis of products and a decline in sales.  Profitability from new business emerges over a period of years depending on the nature and life of the product and is subject to variability as actual results may differ from pricing assumptions.  Additionally, many of our products have fixed or guaranteed terms that limit our ability to increase revenues or reduce benefits, including credited interest, once the product has been issued.

 

Our profitability depends on the sufficiency of premiums and contract charges to cover mortality and morbidity benefits, the persistency of policies to ensure recovery of acquisition expenses, the adequacy of investment spreads, the management of market and credit risks associated with investments, and the management of operating costs and expenses within anticipated pricing allowances.  Legislation and regulation of the insurance marketplace and products could also affect our profitability and financial condition.

 

Changes in reserve estimates may adversely affect our operating results

 

The reserve for life-contingent contract benefits is computed on the basis of long-term actuarial assumptions of future investment yields, mortality, morbidity, persistency and expenses.  We periodically review the adequacy of these reserves on an aggregate basis and if future experience differs significantly from assumptions, adjustments to reserves and amortization of deferred policy acquisition costs (“DAC”) may be required that could have a material effect on our operating results.

 

Changes in market interest rates may lead to a significant decrease in the profitability of spread-based products

 

Our ability to manage our in-force spread-based products, such as fixed annuities, is dependent upon maintaining profitable spreads between investment yields and interest crediting rates.  When market interest rates decrease or remain at relatively low levels, proceeds from investments that have matured or have been prepaid or sold may be reinvested at lower yields, reducing investment spread.  Lowering interest crediting rates on some products in such an environment can partially offset decreases in investment yield.  However, these changes could be limited by regulatory minimum rates or contractual minimum rate guarantees on many contracts and may not match the timing or magnitude of changes in investment yields.  Increases in market interest rates can have negative effects, for example by increasing the attractiveness of other investments to our customers, which can lead to increased surrenders at a time when our fixed income investment asset values are lower as a result of the increase in interest rates.  This could lead to the sale of fixed income securities at a loss.  In addition, changes in market interest rates impact the valuation of derivatives embedded in equity-indexed annuity contracts that are not hedged, which could lead to volatility in net income.

 

Changes in estimates of profitability on interest-sensitive life products may adversely affect our profitability and financial condition through the amortization of DAC

 

DAC related to interest-sensitive life contracts is amortized in proportion to actual historical gross profits and estimated future gross profits (“EGP”) over the estimated lives of the contracts.  The principal assumptions for determining the amount of EGP are mortality, persistency, expenses, investment returns, including capital gains and losses on assets supporting contract liabilities, interest crediting rates to contractholders, and the effects of any hedges.  Updates to these assumptions (commonly referred to as “DAC unlocking”) could result in accelerated amortization of DAC and thereby adversely affect our profitability and financial condition.

 

4



 

Reducing our concentration in spread-based business and exiting certain distribution channels may adversely affect reported results

 

We have been reducing our concentration in spread-based business and will no longer offer fixed annuities effective January 1, 2014.  We also exited the independent master brokerage agencies and structured settlement annuity brokers distribution channels in 2013.  The reduction in sales of these products could negatively impact investment portfolio levels, complicate settlement of contract benefits including forced sales of assets with unrealized capital losses, and affect insurance reserves deficiency testing.

 

Changes in tax laws may decrease sales and profitability of products and adversely affect our financial condition

 

Under current federal and state income tax law, certain products we offer, primarily life insurance, receive favorable tax treatment.  This favorable treatment may give certain of our products a competitive advantage over noninsurance products.  Congress and various state legislatures from time to time consider legislation that would reduce or eliminate the favorable policyholder tax treatment currently applicable to life insurance.  Congress and various state legislatures also consider proposals to reduce the taxation of certain products or investments that may compete with life insurance.  Legislation that increases the taxation on insurance products or reduces the taxation on competing products could lessen the advantage or create a disadvantage for certain of our products making them less competitive.  Such proposals, if adopted, could have a material effect on our profitability and financial condition or ability to sell such products and could result in the surrender of some existing contracts and policies.  In addition, changes in the federal estate tax laws could negatively affect the demand for the types of life insurance used in estate planning.

 

We may not be able to mitigate the capital impact associated with statutory reserving requirements, potentially resulting in a need to increase prices, reduce sales of term or universal life products, and/or a return on equity below original levels assumed in pricing

 

To support statutory reserves for certain term and universal life insurance products with secondary guarantees, we currently utilize reinsurance and capital markets solutions for financing a portion of our statutory reserve requirements deemed to be non-economic.  As we continue to underwrite term and universal life business, we expect to have additional financing needs to mitigate the impact of these reserve requirements.  If we do not obtain additional financing as a result of market conditions or otherwise, this could require us to increase prices, reduce our sales of term or universal life products, and/or result in a return on equity below original levels assumed in pricing.

 

Risks Relating to Investments

 

We are subject to market risk and declines in credit quality which may adversely affect investment income and cause realized and unrealized losses

 

Although we continually reevaluate our investment management strategies, we remain subject to the risk that we will incur losses due to adverse changes in interest rates, credit spreads, equity prices or currency exchange rates.  Adverse changes in these rates, spreads and prices may occur due to changes in monetary policy and the economic climate, the liquidity of a market or market segment, investor return expectations and/or risk tolerance, insolvency or financial distress of key market makers or participants, or changes in market perceptions of credit worthiness.  We are also subject to market risk related to investments in real estate, loans and securities collateralized by real estate.  Some of our investment strategies target individual investments with unique risks that are not highly correlated with broad market risks.  Although we expect these investments to increase total portfolio returns over time, their performance may vary from and under-perform relative to the market in some periods.

 

We are subject to risks associated with potential declines in credit quality related to specific issuers or specific industries and a general weakening in the economy, which are typically reflected through credit spreads.  Credit spread is the additional yield on fixed income securities and loans above the risk-free rate (typically referenced as the yield on U.S. Treasury securities) that market participants require to compensate them for assuming credit, liquidity and/or prepayment risks.  Credit spreads vary (i.e. increase or decrease) in response to the market’s perception of risk and liquidity in a specific issuer or specific sector and are influenced by the credit ratings, and the reliability of those ratings, published by external rating agencies.  Although we have the ability to use derivative financial instruments to manage these risks, the effectiveness of such instruments is subject to the same risks.  Adverse economic conditions or other factors could cause declines in the quality and valuation of our investment portfolio that could result in realized and unrealized losses.

 

5



 

A decline in market interest rates or credit spreads could have an adverse effect on our investment income as we invest cash in new investments that may earn less than the portfolio’s average yield.  In a declining interest rate environment, borrowers may prepay or redeem securities more quickly than expected as they seek to refinance at lower rates.  A decline could also lead us to purchase longer-term or riskier assets in order to obtain adequate investment yields resulting in a duration gap when compared to the duration of liabilities.  Alternatively, longer-term assets may be sold and reinvested in shorter-term assets in anticipation of rising interest rates.  An increase in market interest rates or credit spreads could have an adverse effect on the value of our investment portfolio by decreasing the fair values of the fixed income securities that comprise a substantial majority of our investment portfolio.

 

Deteriorating financial performance impacting securities collateralized by residential and commercial mortgage loans, collateralized corporate loans, and commercial mortgage loans may lead to write-downs and impact our results of operations and financial condition

 

Adverse changes in residential or commercial mortgage delinquencies, loss severities or recovery rates, declining residential or commercial real estate prices, corporate loan delinquencies or recovery rates, borrower ability to obtain alternative sources of financing, changes in credit or bond insurer strength ratings and the quality of service provided by service providers on securities in our portfolio could lead us to determine that write-downs are necessary in the future.

 

Concentration of our investment portfolio in any particular segment of the economy may have adverse effects on our operating results and financial condition

 

The concentration of our investment portfolio in any particular industry, collateral type, group of related industries, geographic sector or risk type could have an adverse effect on our investment portfolio and consequently on our results of operations and financial condition.  Events or developments that have a negative impact on any particular industry, group of related industries or geographic region may have a greater adverse effect on the investment portfolio to the extent that the portfolio is concentrated rather than diversified.

 

The determination of the amount of realized capital losses recorded for impairments of our investments is subjective and could materially impact our operating results and financial condition

 

The determination of the amount of realized capital losses recorded for impairments vary by investment type and is based upon our ongoing evaluation and assessment of known and inherent risks associated with the respective asset class.  Such evaluations and assessments are revised as conditions change and new information becomes available.  We update our evaluations regularly and reflect changes in other-than-temporary impairments in our results of operations.  The assessment of whether other-than-temporary impairments have occurred is based on our case-by-case evaluation of the underlying reasons for the decline in fair value.  Our conclusions on such assessments are judgmental and include assumptions and projections of future cash flows which may ultimately prove to be incorrect as assumptions, facts and circumstances change.  Furthermore, historical trends may not be indicative of future impairments and additional impairments may need to be recorded in the future.

 

The determination of the fair value of our fixed income and equity securities is subjective and could materially impact our operating results and financial condition

 

In determining fair values we principally use the market approach which utilizes market transaction data for the same or similar instruments.  The degree of management judgment involved in determining fair values is inversely related to the availability of market observable information.  The fair value of assets may differ from the actual amount received upon sale of an asset in an orderly transaction between market participants at the measurement date.  Moreover, the use of different valuation assumptions may have a material effect on the assets’ fair values.  The difference between amortized cost or cost and fair value, net of deferred income taxes, certain DAC, certain deferred sales inducement costs, and certain reserves for life-contingent contract benefits, is reflected as a component of accumulated other comprehensive income in shareholder’s equity.  Changing market conditions could materially affect the determination of the fair value of securities and unrealized net capital gains and losses could vary significantly.

 

6



 

Risks Relating to the Insurance Industry

 

Our future growth and profitability are dependent in part on our ability to successfully operate in an insurance industry that is highly competitive

 

The insurance industry is highly competitive.  Many of our primary insurance competitors have well-established national reputations and market similar products.

 

Because of the competitive nature of the insurance industry, there can be no assurance that we will continue to effectively compete with our industry rivals, or that competitive pressures will not have a material effect on our business, operating results or financial condition.  This includes competition for producers such as exclusive agents and their licensed sales professionals.  In the event we are unable to attract and retain these producers or they are unable to attract customers for our products, growth could be materially affected.  Furthermore, certain competitors operate using a mutual insurance company structure and therefore may have dissimilar profitability and return targets.  Our ability to successfully operate may also be impaired if we are not effective in developing the talent and skills of our human resources, attracting and assimilating new executive talent into our organization, or deploying human resource talent consistently with our business goals.

 

Difficult conditions in the global economy and capital markets generally could adversely affect our business and operating results and these conditions may not improve in the near future

 

As with most businesses, we believe difficult conditions in the global economy and capital markets, such as significant negative macroeconomic trends, including relatively high and sustained unemployment, reduced consumer spending, lower residential and commercial real estate prices, substantial increases in delinquencies on consumer debt, including defaults on home mortgages, and the relatively low availability of credit could have an adverse effect on our business and operating results.

 

Stressed conditions, volatility and disruptions in global capital markets, particular markets or financial asset classes could adversely affect our investment portfolio.  Disruptions in one market or asset class can also spread to other markets or asset classes.  Although the disruption in the global financial markets has moderated, not all global financial markets are functioning normally, and the rate of recovery from the U.S. recession has been below historic averages.  Several governments around the world have announced austerity actions to address their budget deficits that may lead to a decline in economic activity.  While European policy makers have developed mechanisms to address funding concerns, risks to the European economy and financial markets remain.

 

General economic conditions could adversely affect us in the form of consumer behavior and pressure investment results.  Consumer behavior changes could include decreased demand for our products.  In addition, holders of some of our interest-sensitive life insurance and annuity products may engage in an elevated level of discretionary withdrawals of contractholder funds.  Our investment results could be adversely affected as deteriorating financial and business conditions affect the issuers of the securities in our investment portfolio.

 

There can be no assurance that we can accurately predict the timing and impact of changes in the Federal Reserve’s monetary policy

 

The Federal Reserve has indicated that it may change its highly accommodative monetary policy as the U.S. economic recovery strengthens and unemployment declines.  There can be no assurance as to the long-term impact such actions will have on the financial markets or on economic conditions, including potential inflationary effects.  Continued volatility and rising interest rates could materially and adversely affect our business, financial condition and results of operations.

 

Losses from legal and regulatory actions may be material to our operating results, cash flows and financial condition

 

As is typical for a large company, from time to time we are involved in various legal actions, including class action litigation challenging a range of company practices and coverage provided by our insurance products, some of which involve claims for substantial or indeterminate amounts.  We are also involved in various regulatory actions and inquiries, including market conduct exams by state insurance regulatory agencies.  In the event of an unfavorable outcome in one or more of these matters, the ultimate liability may be in excess of amounts currently accrued and may be material to our operating results or cash flows for a particular quarter or annual period and to our financial condition.

 

7



 

We are subject to extensive regulation and potential further restrictive regulation may increase our operating costs and limit our growth

 

As insurance companies, broker-dealers, investment advisers and/or investment companies, many of our subsidiaries are subject to extensive laws and regulations.  These laws and regulations are complex and subject to change.  Changes may sometimes lead to additional expenses, increased legal exposure, and additional limits on our ability to grow or to achieve targeted profitability.  Moreover, laws and regulations are administered and enforced by a number of different governmental authorities, each of which exercises a degree of interpretive latitude, including state insurance regulators; state securities administrators; state attorneys general and federal agencies including the SEC, the FINRA and the U.S. Department of Justice.  Consequently, we are subject to the risk that compliance with any particular regulator’s or enforcement authority’s interpretation of a legal issue may not result in compliance with another’s interpretation of the same issue, particularly when compliance is judged in hindsight.  In addition, there is risk that any particular regulator’s or enforcement authority’s interpretation of a legal issue may change over time to our detriment, or that changes in the overall legal environment may, even absent any particular regulator’s or enforcement authority’s interpretation of a legal issue changing, cause us to change our views regarding the actions we need to take from a legal risk management perspective, thus necessitating changes to our practices that may, in some cases, limit our ability to grow or to improve the profitability of our business.  Furthermore, in some cases, these laws and regulations are designed to protect or benefit the interests of a specific constituency rather than a range of constituencies.  For example, state insurance laws and regulations are generally intended to protect or benefit purchasers or users of insurance products.  In many respects, these laws and regulations limit our ability to grow or to improve the profitability of our business.

 

Regulatory reforms, and the more stringent application of existing regulations, may make it more expensive for us to conduct our business

 

The federal government has enacted comprehensive regulatory reforms for financial services entities.  As part of a larger effort to strengthen the regulation of the financial services market, certain reforms are applicable to the insurance industry, including the FIO established within the Treasury Department.

 

In recent years, the state insurance regulatory framework has come under public scrutiny, members of Congress have discussed proposals to provide for federal chartering of insurance companies, and the FIO and FSOC were established.  We can make no assurances regarding the potential impact of state or federal measures that may change the nature or scope of insurance and financial regulation.

 

These regulatory reforms and any additional legislative change or regulatory requirements imposed upon us in connection with the federal government’s regulatory reform of the financial services industry, and any more stringent enforcement of existing regulations by federal authorities, may make it more expensive for us to conduct our business, or limit our ability to grow or to achieve profitability.

 

Reinsurance may be unavailable at current levels and prices, which may limit our ability to write new business

 

Market conditions beyond our control impact the availability and cost of the reinsurance we purchase.  No assurances can be made that reinsurance will remain continuously available to us to the same extent and on the same terms and rates as is currently available.  If we were unable to maintain our current level of reinsurance or purchase new reinsurance protection in amounts that we consider sufficient and at prices that we consider acceptable, we would have to either accept an increase in our risk exposure, reduce our insurance writings, or develop or seek other alternatives.

 

Reinsurance subjects us to the credit risk of our reinsurers and may not be adequate to protect us against losses arising from ceded insurance, which could have a material effect on our operating results and financial condition

 

The collectability of reinsurance recoverables is subject to uncertainty arising from a number of factors, including changes in market conditions, whether insured losses meet the qualifying conditions of the reinsurance contract and whether reinsurers, or their affiliates, have the financial capacity and willingness to make payments under the terms of a reinsurance treaty or contract.  Our inability to collect a material recovery from a reinsurer could have a material effect on our operating results and financial condition.

 

8



 

A large scale pandemic, the continued threat of terrorism or military actions may have an adverse effect on the level of claim losses we incur, the value of our investment portfolio, our competitive position, marketability of product offerings, liquidity and operating results

 

A large scale pandemic, the continued threat of terrorism, within the United States and abroad, or military and other actions, and heightened security measures in response to these types of threats, may cause significant volatility and losses in our investment portfolio from declines in the equity markets and from interest rate changes in the United States, Europe and elsewhere, and result in loss of life, property damage, disruptions to commerce and reduced economic activity.  Some of the assets in our investment portfolio may be adversely affected by declines in the equity markets and reduced economic activity caused by a large scale pandemic or the continued threat of terrorism.  Additionally, a large scale pandemic or terrorist act could have a material effect on the sales, profitability, competitiveness, marketability of product offerings, liquidity, and operating results.

 

A downgrade in our financial strength ratings may have an adverse effect on our competitive position, the marketability of our product offerings, our liquidity, operating results and financial condition

 

Financial strength ratings are important factors in establishing the competitive position of insurance companies and generally have an effect on an insurance company’s business.  On an ongoing basis, rating agencies review our financial performance and condition and could downgrade or change the outlook on our ratings due to, for example, a change in one of our insurance company’s statutory capital; a change in a rating agency’s determination of the amount of risk-adjusted capital required to maintain a particular rating; an increase in the perceived risk of our investment portfolio; a reduced confidence in management or our business strategy; as well as a number of other considerations that may or may not be under our control.  Our insurance financial strength ratings from A.M. Best, Standard & Poor’s and Moody’s are subject to continuous review, and the retention of current ratings cannot be assured.  A downgrade in any of these ratings could have a material effect on our sales, our competitiveness, the marketability of our product offerings, our liquidity, operating results and financial condition.

 

Adverse capital and credit market conditions may significantly affect our ability to meet liquidity needs or our ability to obtain credit on acceptable terms

 

In periods of extreme volatility and disruption in the capital and credit markets, liquidity and credit capacity may be severely restricted.  In such circumstances, our ability to obtain capital to fund operating expenses, financing costs, capital expenditures or acquisitions may be limited, and the cost of any such capital may be significant.  Our access to additional financing will depend on a variety of factors such as market conditions, the general availability of credit, the overall availability of credit to our industry, our credit ratings and credit capacity, as well as lenders’ perception of our long- or short-term financial prospects.  Similarly, our access to funds may be impaired if regulatory authorities or rating agencies take negative actions against us.  If a combination of these factors were to occur, our internal sources of liquidity may prove to be insufficient and in such case, we may not be able to successfully obtain additional financing on favorable terms.

 

Changes in accounting standards issued by the Financial Accounting Standards Board or other standard-setting bodies may adversely affect our results of operations and financial condition

 

Our financial statements are subject to the application of generally accepted accounting principles, which are periodically revised, interpreted and/or expanded.  Accordingly, we are required to adopt new guidance or interpretations, or could be subject to existing guidance as we enter into new transactions, which may have a material effect on our results of operations and financial condition that is either unexpected or has a greater impact than expected.  For a description of changes in accounting standards that are currently pending and, if known, our estimates of their expected impact, see Note 2 of the consolidated financial statements.

 

The change in our unrecognized tax benefit during the next 12 months is subject to uncertainty

 

We have disclosed our estimate of unrecognized tax benefits and the reasonably possible increase or decrease in its balance during the next 12 months in Note 13 of the consolidated financial statements.  However, actual results may differ from our estimate for reasons such as changes in our position on specific issues, developments with respect to the governments’ interpretations of income tax laws or changes in judgment resulting from new information obtained in audits or the appeals process.

 

9



 

The failure in cyber or other information security systems, as well as the occurrence of events unanticipated in our disaster recovery systems and management continuity planning could result in a loss or disclosure of confidential information, damage to our reputation, additional costs and impairment of our ability to conduct business effectively

 

We depend heavily upon computer systems to perform necessary business functions.  Despite our implementation of a variety of security measures, our computer systems could be subject to cyber attacks and unauthorized access, such as physical and electronic break-ins or unauthorized tampering.  Like other global companies, we have experienced threats to our data and systems, including malware and computer virus attacks, unauthorized access, system failures and disruptions.  Events such as these could jeopardize the confidential, proprietary and other information (including personal information of our customers or employees) processed and stored in, and transmitted through, our computer systems and networks, or otherwise cause interruptions or malfunctions in our operations, which could result in damage to our reputation, financial losses, litigation, increased costs, regulatory penalties and/or customer dissatisfaction or loss.  These risks may increase in the future as we continue to expand our internet and mobile strategies and develop additional remote connectivity solutions to serve our customers.

 

In the event of a disaster such as a natural catastrophe, industrial accident, terrorist attack, war, cyber attack or computer virus, unanticipated problems with our disaster recovery systems, or a support failure from external providers, could have an adverse effect on our ability to conduct business and on our results of operations and financial condition, particularly if those events affect our computer-based data processing, transmission, storage, and retrieval systems or destroy data.  If a significant number of our managers were unavailable in the event of a disaster, our ability to effectively conduct our business could be severely compromised.

 

Third parties to whom we outsource certain of our functions are also subject to the risks outlined above, any one of which may result in our incurring substantial costs and other negative consequences, including a material adverse effect on our business, financial condition, results of operations and liquidity.

 

Loss of key vendor relationships or failure of a vendor to protect personal information of our customers or employees could affect our operations

 

We rely on services and products provided by many vendors in the United States and abroad.  These include, for example, vendors of computer hardware and software.  In the event that one or more of our vendors suffers a bankruptcy or otherwise becomes unable to continue to provide products or services, or fails to protect personal information of our customers or employees, we may suffer operational impairments and financial losses.

 

We may not be able to protect our intellectual property and may be subject to infringement claims

 

We rely on a combination of contractual rights and copyright, trademark, patent and trade secret laws to establish and protect our intellectual property.  Although we use a broad range of measures to protect our intellectual property rights, third parties may infringe or misappropriate our intellectual property.  We may have to litigate to enforce and protect our intellectual property and to determine its scope, validity or enforceability, which could divert significant resources and prove unsuccessful.  An inability to protect our intellectual property could have a material effect on our business.

 

We may be subject to claims by third parties for patent, trademark or copyright infringement or breach of usage rights.  Any such claims and any resulting litigation could result in significant expense and liability.  If our third party providers or we are found to have infringed a third-party intellectual property right, either of us could be enjoined from providing certain products or services or from utilizing and benefiting from certain methods, processes, copyrights, trademarks, trade secrets or licenses.  Alternatively, we could be required to enter into costly licensing arrangements with third parties or implement a costly work around.  Any of these scenarios could have a material effect on our business and results of operations.

 

Item 1B.  Unresolved Staff Comments

 

None.

 

10



 

Item 2.  Properties

 

Our home office is part of the Parent Group’s home office complex in Northbrook, Illinois.  As of December 31, 2013, the Home Office complex consists of several buildings totaling 2.3 million square feet of office space on a 278-acre site.  In addition, the Parent Group operates various administrative, data processing, claims handling and other support facilities.

 

All of the facilities from which we operate are owned or leased by our direct parent, AIC, except for office space in Lincoln, Nebraska that is leased by Lincoln Benefit Life Company, a wholly owned subsidiary of ALIC, for general operations, file storage and information technology.  Expenses associated with facilities owned or leased by AIC are allocated to us on both a direct and an indirect basis, depending on the nature and use of each particular facility.  We believe that these facilities are suitable and adequate for our current operations.

 

The locations out of which the Allstate exclusive agencies operate in the U.S. are normally leased by the agencies as lessees.

 

Item 3.  Legal Proceedings

 

Information required for Item 3 is incorporated by reference to the discussion under the heading “Regulation and Compliance” in Note 12 of the consolidated financial statements.

 

Item 4.  Mine Safety Disclosures

 

Not applicable.

 

Part II

 

Item 5.  Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

No established public trading market exists for Allstate Life’s common stock.  All of its outstanding common stock is owned by its parent, Allstate Insurance Company (“AIC”).  All of the outstanding common stock of AIC is owned by Allstate Insurance Holdings, LLC, which is wholly owned by The Allstate Corporation.

 

The Company paid a return of capital of $500 million to AIC in 2013.  The Company did not pay dividends or a return of capital in 2012.  For additional information on dividends, including restrictions on the payment of dividends by Allstate Life and its subsidiaries, see the Limitations on Dividends by Insurance Subsidiaries subsection of the “Regulation” section of Item 1. Business of this Form 10-K and the discussion under the heading “Dividend Limitations” in Note 15 of our consolidated financial statements, which are incorporated herein by reference.

 

Item 6.  Selected Financial Data

 

5-YEAR SUMMARY OF SELECTED FINANCIAL DATA

($ in millions)

 

2013

 

 

2012

 

 

2011

 

 

2010

 

 

2009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Operating Results

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Premiums

$

613

 

 

$

593

 

 

$

624

 

 

$

592

 

 

$

581

 

Contract charges

 

1,054

 

 

 

1,029

 

 

 

1,008

 

 

 

991

 

 

 

952

 

Net investment income

 

2,485

 

 

 

2,597

 

 

 

2,637

 

 

 

2,760

 

 

 

2,974

 

Realized capital gains and losses

 

76

 

 

 

(16

)

 

 

390

 

 

 

(513

)

 

 

(420)

 

Total revenues

 

4,228

 

 

 

4,203

 

 

 

4,659

 

 

 

3,830

 

 

 

4,087

 

Net (loss) income

 

(38

)

 

 

426

 

 

 

469

 

 

 

(40

)

 

 

(514)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Financial Position

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments (1)

$

37,944

 

 

$

55,866

 

 

$

56,277

 

 

$

59,442

 

 

$

60,217

 

Total assets

 

63,368

 

 

 

70,111

 

 

 

71,119

 

 

 

75,981

 

 

 

78,459

 

Reserve for life-contingent contract benefits and contractholder funds (1)

 

35,193

 

 

 

52,751

 

 

 

55,335

 

 

 

59,178

 

 

 

63,106

 

Notes due to related parties

 

282

 

 

 

496

 

 

 

700

 

 

 

677

 

 

 

675

 

Shareholder’s equity

 

6,070

 

 

 

7,313

 

 

 

6,067

 

 

 

5,319

 

 

 

3,960

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) As of December 31, 2013, $11.98 billion of investments and $12.84 billion of reserves for life-contingent contract benefits and contractholder funds are classified as held for sale relating to the pending sale of Lincoln Benefit Life Company (see Note 3 of the consolidated financial statements).

 

11



 

Item 7.  Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

Page

 

 

Overview

12

 

 

Application of Critical Accounting Estimates

13

 

 

2013 Highlights

18

 

 

Impact of Low Interest Rate Environment

18

 

 

Operations

20

 

 

Investments 2013 Highlights

28

 

 

Investments

28

 

 

Market Risk

36

 

 

Capital Resources and Liquidity

39

 

 

Regulation and Legal Proceedings

44

 

 

Pending Accounting Standards

44

 

OVERVIEW

 

The following discussion highlights significant factors influencing the consolidated financial position and results of operations of Allstate Life Insurance Company (referred to in this document as “we,” “our,” “us,” the “Company” or “ALIC”).  It should be read in conjunction with the 5-year summary of selected financial data, consolidated financial statements and related notes found under Part II. Item 6. and Item 8. contained herein.  We operate as a single segment entity based on the manner in which we use financial information to evaluate business performance and to determine the allocation of resources.

 

The most important factors we monitor to evaluate the financial condition and performance of our company include:

 

·                  For operations:  benefit and investment spread, asset-liability matching, amortization of deferred policy acquisition costs (“DAC”), expenses, operating income, net income, new business sales, invested assets, and premiums and contract charges.

·                  For investments:  exposure to market risk, credit quality/experience, total return, net investment income, cash flows, realized capital gains and losses, unrealized capital gains and losses, stability of long-term returns, and asset and liability duration.

·                  For financial condition:  liquidity, financial strength ratings, operating leverage, capital position, and return on equity.

 

Summary of Results:

 

·                  Net loss was $38 million in 2013 compared to net income of $426 million in 2012 and $469 million in 2011.  The change in 2013 compared to 2012 was primarily due to the estimated loss on disposition related to the pending Lincoln Benefit Life Company sale.  The decrease in 2012 compared to 2011 was primarily due to net realized capital losses in 2012 compared to net realized capital gains in 2011, partially offset by decreased interest credited to contractholder funds and lower amortization of DAC.

·                  Capital management actions during 2013 included a $500 million return of capital to Allstate Insurance Company (“AIC”) and the $200 million repayment of surplus notes to AIC.  Consolidated shareholder’s equity decreased to $6.07 billion as of December 31, 2013 from $7.31 billion as of December 31, 2012.

 

12



 

APPLICATION OF CRITICAL ACCOUNTING ESTIMATES

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in the consolidated financial statements.  The most critical estimates include those used in determining:

 

·                  Fair value of financial assets

·                  Impairment of fixed income and equity securities

·                  Deferred policy acquisition costs amortization

·                  Reserve for life-contingent contract benefits estimation

 

In making these determinations, management makes subjective and complex judgments that frequently require estimates about matters that are inherently uncertain.  Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to our business and operations.  It is reasonably likely that changes in these estimates could occur from period to period and result in a material impact on our consolidated financial statements.

 

A brief summary of each of these critical accounting estimates follows.  For a more detailed discussion of the effect of these estimates on our consolidated financial statements, and the judgments and assumptions related to these estimates, see the referenced sections of this document.  For a complete summary of our significant accounting policies, see the notes to the consolidated financial statements.

 

Fair value of financial assets  Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  We are responsible for the determination of fair value of financial assets and the supporting assumptions and methodologies.  We use independent third-party valuation service providers, broker quotes and internal pricing methods to determine fair values.  We obtain or calculate only one single quote or price for each financial instrument.

 

Valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of proprietary models, produce valuation information in the form of a single fair value for individual fixed income and other securities for which a fair value has been requested under the terms of our agreements.  The inputs used by the valuation service providers include, but are not limited to, market prices from recently completed transactions and transactions of comparable securities, interest rate yield curves, credit spreads, liquidity spreads, currency rates, and other information, as applicable.  Credit and liquidity spreads are typically implied from completed transactions and transactions of comparable securities.  Valuation service providers also use proprietary discounted cash flow models that are widely accepted in the financial services industry and similar to those used by other market participants to value the same financial instruments.  The valuation models take into account, among other things, market observable information as of the measurement date, as described above, as well as the specific attributes of the security being valued including its term, interest rate, credit rating, industry sector, and where applicable, collateral quality and other issue or issuer specific information.  Executing valuation models effectively requires seasoned professional judgment and experience.  For certain equity securities, valuation service providers provide market quotations for completed transactions on the measurement date.  In cases where market transactions or other market observable data is limited, the extent to which judgment is applied varies inversely with the availability of market observable information.

 

For certain of our financial assets measured at fair value, where our valuation service providers cannot provide fair value determinations, we obtain a single non-binding price quote from a broker familiar with the security who, similar to our valuation service providers, may consider transactions or activity in similar securities among other information.  The brokers providing price quotes are generally from the brokerage divisions of leading financial institutions with market making, underwriting and distribution expertise regarding the security subject to valuation.

 

The fair value of certain financial assets, including privately placed corporate fixed income securities, auction rate securities (“ARS”) backed by student loans, equity-indexed notes, and certain free-standing derivatives, for which our valuation service providers or brokers do not provide fair value determinations, is determined using valuation methods and models widely accepted in the financial services industry.  Our internal pricing methods are primarily based on models using discounted cash flow methodologies that develop a single best estimate of fair value.  Our models generally incorporate inputs that we believe are representative of inputs other market participants would use to determine fair value of the same instruments, including yield curves, quoted market prices of

 

13



 

comparable securities, published credit spreads, and other applicable market data as well as instrument-specific characteristics that include, but are not limited to, coupon rates, expected cash flows, sector of the issuer, and call provisions.  Judgment is required in developing these fair values.  As a result, the fair value of these financial assets may differ from the amount actually received to sell an asset in an orderly transaction between market participants at the measurement date.  Moreover, the use of different valuation assumptions may have a material effect on the financial assets’ fair values.

 

For most of our financial assets measured at fair value, all significant inputs are based on or corroborated by market observable data and significant management judgment does not affect the periodic determination of fair value.  The determination of fair value using discounted cash flow models involves management judgment when significant model inputs are not based on or corroborated by market observable data.  However, where market observable data is available, it takes precedence, and as a result, no range of reasonably likely inputs exists from which the basis of a sensitivity analysis could be constructed.

 

We gain assurance that our financial assets are appropriately valued through the execution of various processes and controls designed to ensure the overall reasonableness and consistent application of valuation methodologies, including inputs and assumptions, and compliance with accounting standards.  For fair values received from third parties or internally estimated, our processes and controls are designed to ensure that the valuation methodologies are appropriate and consistently applied, the inputs and assumptions are reasonable and consistent with the objective of determining fair value, and the fair values are accurately recorded.  For example, on a continuing basis, we assess the reasonableness of individual fair values that have stale security prices or that exceed certain thresholds as compared to previous fair values received from valuation service providers or brokers or derived from internal models.  We perform procedures to understand and assess the methodologies, processes and controls of valuation service providers.  In addition, we may validate the reasonableness of fair values by comparing information obtained from valuation service providers or brokers to other third party valuation sources for selected securities.  We perform ongoing price validation procedures such as back-testing of actual sales, which corroborate the various inputs used in internal models to market observable data.  When fair value determinations are expected to be more variable, we validate them through reviews by members of management who have relevant expertise and who are independent of those charged with executing investment transactions.

 

We also perform an analysis to determine whether there has been a significant decrease in the volume and level of activity for the asset when compared to normal market activity, and if so, whether transactions may not be orderly.  Among the indicators we consider in determining whether a significant decrease in the volume and level of market activity for a specific asset has occurred include the level of new issuances in the primary market, trading volume in the secondary market, level of credit spreads over historical levels, bid-ask spread, and price consensuses among market participants and sources.  If evidence indicates that prices are based on transactions that are not orderly, we place little, if any, weight on the transaction price and will estimate fair value using an internal model.  As of December 31, 2013 and 2012, we did not alter fair values provided by our valuation service providers or brokers or substitute them with an internal model for such securities.

 

The following table identifies fixed income and equity securities and short-term investments, including those classified as held for sale, as of December 31, 2013 by source of fair value determination.

 

($ in millions)

 

Fair

value

 

Percent

to total

 

Fair value based on internal sources

$

4,709

 

11.7

%

Fair value based on external sources (1)

 

35,614

 

88.3

 

Total

$

 

40,323

 

100.0

%

 

 

 

 

(1) Includes $2.34 billion that are valued using broker quotes.

 

 

 

For additional detail on fair value measurements, see Note 7 of the consolidated financial statements.

 

Impairment of fixed income and equity securities  For investments classified as available for sale, the difference between fair value and amortized cost for fixed income securities and cost for equity securities, net of certain other items and deferred income taxes (as disclosed in Note 6), is reported as a component of accumulated other comprehensive income on the Consolidated Statements of Financial Position and is not reflected in the operating results of any period until reclassified to net income upon the consummation of a transaction with an unrelated third party or when a write-down is recorded due to an other-than-temporary decline in fair value.  We

 

14



 

have a comprehensive portfolio monitoring process to identify and evaluate each fixed income and equity security whose carrying value may be other-than-temporarily impaired.

 

For each fixed income security in an unrealized loss position, we assess whether management with the appropriate authority has made the decision to sell or whether it is more likely than not we will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes.  If a security meets either of these criteria, the security’s decline in fair value is considered other than temporary and is recorded in earnings.

 

If we have not made the decision to sell the fixed income security and it is not more likely than not we will be required to sell the fixed income security before recovery of its amortized cost basis, we evaluate whether we expect to receive cash flows sufficient to recover the entire amortized cost basis of the security.  We use our best estimate of future cash flows expected to be collected from the fixed income security, discounted at the security’s original or current effective rate, as appropriate, to calculate a recovery value and determine whether a credit loss exists.  The determination of cash flow estimates is inherently subjective and methodologies may vary depending on facts and circumstances specific to the security.  All reasonably available information relevant to the collectability of the security, including past events, current conditions, and reasonable and supportable assumptions and forecasts, are considered when developing the estimate of cash flows expected to be collected.  That information generally includes, but is not limited to, the remaining payment terms of the security, prepayment speeds, foreign exchange rates, the financial condition and future earnings potential of the issue or issuer, expected defaults, expected recoveries, the value of underlying collateral, vintage, geographic concentration, available reserves or escrows, current subordination levels, third party guarantees and other credit enhancements.  Other information, such as industry analyst reports and forecasts, sector credit ratings, financial condition of the bond insurer for insured fixed income securities, and other market data relevant to the realizability of contractual cash flows, may also be considered.  The estimated fair value of collateral will be used to estimate recovery value if we determine that the security is dependent on the liquidation of collateral for ultimate settlement.  If the estimated recovery value is less than the amortized cost of the security, a credit loss exists and an other-than-temporary impairment for the difference between the estimated recovery value and amortized cost is recorded in earnings.  The portion of the unrealized loss related to factors other than credit remains classified in accumulated other comprehensive income.  If we determine that the fixed income security does not have sufficient cash flow or other information to estimate a recovery value for the security, we may conclude that the entire decline in fair value is deemed to be credit related and the loss is recorded in earnings.

 

There are a number of assumptions and estimates inherent in evaluating impairments of equity securities and determining if they are other than temporary, including: 1) our ability and intent to hold the investment for a period of time sufficient to allow for an anticipated recovery in value; 2) the length of time and extent to which the fair value has been less than cost; 3) the financial condition, near-term and long-term prospects of the issue or issuer, including relevant industry specific market conditions and trends, geographic location and implications of rating agency actions and offering prices; and 4) the specific reasons that a security is in an unrealized loss position, including overall market conditions which could affect liquidity.

 

Once assumptions and estimates are made, any number of changes in facts and circumstances could cause us to subsequently determine that a fixed income or equity security is other-than-temporarily impaired, including: 1) general economic conditions that are worse than previously forecasted or that have a greater adverse effect on a particular issuer or industry sector than originally estimated; 2) changes in the facts and circumstances related to a particular issue or issuer’s ability to meet all of its contractual obligations; and 3) changes in facts and circumstances that result in changes to management’s intent to sell or result in our assessment that it is more likely than not we will be required to sell before recovery of the amortized cost basis of a fixed income security or causes a change in our ability or intent to hold an equity security until it recovers in value.  Changes in assumptions, facts and circumstances could result in additional charges to earnings in future periods to the extent that losses are realized.  The charge to earnings, while potentially significant to net income, would not have a significant effect on shareholder’s equity, since our securities are designated as available for sale and carried at fair value and as a result, any related unrealized loss, net of deferred income taxes and related DAC, deferred sales inducement costs and reserves for life-contingent contract benefits, would already be reflected as a component of accumulated other comprehensive income in shareholder’s equity.

 

The determination of the amount of other-than-temporary impairment is an inherently subjective process based on periodic evaluations of the factors described above.  Such evaluations and assessments are revised as conditions

 

15



 

change and new information becomes available.  We update our evaluations regularly and reflect changes in other-than-temporary impairments in results of operations as such evaluations are revised.  The use of different methodologies and assumptions in the determination of the amount of other-than-temporary impairments may have a material effect on the amounts presented within the consolidated financial statements.

 

For additional detail on investment impairments, see Note 6 of the consolidated financial statements.

 

Deferred policy acquisition costs amortization  We incur significant costs in connection with acquiring insurance policies and investment contracts.  In accordance with GAAP, costs that are related directly to the successful acquisition of new or renewal insurance policies and investment contracts are deferred and recorded as an asset on the Consolidated Statements of Financial Position.

 

DAC related to traditional life insurance is amortized over the premium paying period of the related policies in proportion to the estimated revenues on such business.  Significant assumptions relating to estimated premiums, investment returns, as well as mortality, persistency and expenses to administer the business are established at the time the policy is issued and are generally not revised during the life of the policy.  The assumptions for determining the timing and amount of DAC amortization are consistent with the assumptions used to calculate the reserve for life-contingent contract benefits.  Any deviations from projected business in force resulting from actual policy terminations differing from expected levels and any estimated premium deficiencies may result in a change to the rate of amortization in the period such events occur.  Generally, the amortization periods for these policies approximates the estimated lives of the policies.  The recovery of DAC is dependent upon the future profitability of the business.  We periodically review the adequacy of reserves and recoverability of DAC for these policies on an aggregate basis using actual experience.  We aggregate all traditional life insurance products and immediate annuities with life contingencies in the analysis.  In the event actual experience is significantly adverse compared to the original assumptions and a premium deficiency is determined to exist, any remaining unamortized DAC balance must be expensed to the extent not recoverable and a premium deficiency reserve may be required if the remaining DAC balance is insufficient to absorb the deficiency.  In 2013, 2012 and 2011, our reviews concluded that no premium deficiency adjustments were necessary, primarily due to projected profit from traditional life insurance more than offsetting the projected losses in immediate annuities with life contingencies.

 

DAC related to interest-sensitive life, fixed annuities and other investment contracts is amortized in proportion to the incidence of the total present value of gross profits, which includes both actual historical gross profits (“AGP”) and estimated future gross profits (“EGP”) expected to be earned over the estimated lives of the contracts.  The amortization is net of interest on the prior period DAC balance using rates established at the inception of the contracts.  Actual amortization periods generally range from 15-30 years; however, incorporating estimates of the rate of customer surrenders, partial withdrawals and deaths generally results in the majority of the DAC being amortized during the surrender charge period, which is typically 10-20 years for interest-sensitive life and 5-10 years for fixed annuities.  The cumulative DAC amortization is reestimated and adjusted by a cumulative charge or credit to income when there is a difference between the incidence of actual versus expected gross profits in a reporting period or when there is a change in total EGP.

 

AGP and EGP primarily consist of the following components: contract charges for the cost of insurance less mortality costs and other benefits (benefit margin);  investment income and realized capital gains and losses less interest credited (investment margin); and surrender and other contract charges less maintenance expenses (expense margin).  The principal assumptions for determining the amount of EGP are persistency, mortality, expenses, investment returns, including capital gains and losses on assets supporting contract liabilities, interest crediting rates to contractholders, and the effects of any hedges, and these assumptions are reasonably likely to have the greatest impact on the amount of DAC amortization.  Changes in these assumptions can be offsetting and we are unable to reasonably predict their future movements or offsetting impacts over time.

 

Each reporting period, DAC amortization is recognized in proportion to AGP for that period adjusted for interest on the prior period DAC balance.  This amortization process includes an assessment of AGP compared to EGP, the actual amount of business remaining in force and realized capital gains and losses on investments supporting the product liability.  The impact of realized capital gains and losses on amortization of DAC depends upon which product liability is supported by the assets that give rise to the gain or loss.  If the AGP is greater than EGP in the period, but the total EGP is unchanged, the amount of DAC amortization will generally increase, resulting in a current period decrease to earnings.  The opposite result generally occurs when the AGP is less than the EGP in the period, but the total EGP is unchanged.  However, when DAC amortization or a component of gross profits for a quarterly period is potentially negative (which would result in an increase of the DAC balance) as a

 

16



 

result of negative AGP, the specific facts and circumstances surrounding the potential negative amortization are considered to determine whether it is appropriate for recognition in the consolidated financial statements.  Negative amortization is only recorded when the increased DAC balance is determined to be recoverable based on facts and circumstances.  Negative amortization was not recorded for certain fixed annuities during 2012 and 2011 periods in which capital losses were realized on their related investment portfolio.  For products whose supporting investments are exposed to capital losses in excess of our expectations which may cause periodic AGP to become temporarily negative, EGP and AGP utilized in DAC amortization may be modified to exclude the excess capital losses.

 

Annually, we review and update all assumptions underlying the projections of EGP, including persistency, mortality, expenses, investment returns, comprising investment income and realized capital gains and losses, interest crediting rates and the effect of any hedges.  At each reporting period, we assess whether any revisions to assumptions used to determine DAC amortization are required.  These reviews and updates may result in amortization acceleration or deceleration, which are commonly referred to as “DAC unlocking”.  If the update of assumptions causes total EGP to increase, the rate of DAC amortization will generally decrease, resulting in a current period increase to earnings.  A decrease to earnings generally occurs when the assumption update causes the total EGP to decrease.

 

The following table provides the effect on DAC amortization of changes in assumptions relating to the gross profit components of investment margin, benefit margin and expense margin during the years ended December 31.

 

($ in millions)

 

2013

 

2012

 

2011

Investment margin

$

(22)

$

$

(3)

Benefit margin

 

13 

 

33 

 

(6)

Expense margin

 

27 

 

(2)

 

18 

Net acceleration

$

18 

$

34 

$

 

In 2013, DAC amortization deceleration for changes in the investment margin component of EGP primarily related to fixed annuities and interest-sensitive life insurance and was due to increased projected investment margins.  The acceleration related to benefit margin was primarily due to interest-sensitive life insurance and was due to an increase in projected mortality.  The acceleration related to expense margin related to interest-sensitive life insurance and was due to an increase in projected expenses.  In 2012, DAC amortization acceleration for changes in the investment margin component of EGP primarily related to fixed annuities and was due to lower projected investment returns.  The acceleration related to benefit margin was primarily due to increased projected mortality on variable life insurance, partially offset by increased projected persistency on interest-sensitive life insurance.  The deceleration related to expense margin related to interest-sensitive life insurance and fixed annuities and was due to a decrease in projected expenses.  In 2011, DAC amortization deceleration related to changes in the investment margin component of EGP primarily related to equity-indexed annuities and was due to an increase in projected investment margins.  The deceleration related to benefit margin was primarily due to increased projected persistency on interest-sensitive life insurance.  The acceleration related to expense margin primarily related to interest-sensitive life insurance and was due to an increase in projected expenses.

 

The following table displays the sensitivity of reasonably likely changes in assumptions included in the gross profit components of investment margin or benefit margin to amortization of the DAC balance as of December 31, 2013.

 

($ in millions)

 

Increase/(reduction) in DAC

Increase in future investment margins of 25 basis points

 

$

77

 

Decrease in future investment margins of 25 basis points

 

$

(86)

 

 

 

 

 

 

Decrease in future life mortality by 1%

 

$

17

 

Increase in future life mortality by 1%

 

$

(18)

 

 

Any potential changes in assumptions discussed above are measured without consideration of correlation among assumptions.  Therefore, it would be inappropriate to add them together in an attempt to estimate overall variability in amortization.

 

For additional detail related to DAC, see the Operations section of this document.

 

17



 

Reserve for life-contingent contract benefits estimation  Due to the long term nature of traditional life insurance, life-contingent immediate annuities and voluntary accident and health insurance products, benefits are payable over many years; accordingly, the reserves are calculated as the present value of future expected benefits to be paid, reduced by the present value of future expected net premiums.  Long-term actuarial assumptions of future investment yields, mortality, morbidity, policy terminations and expenses are used when establishing the reserve for life-contingent contract benefits payable under these insurance policies.  These assumptions, which for traditional life insurance are applied using the net level premium method, include provisions for adverse deviation and generally vary by characteristics such as type of coverage, year of issue and policy duration.  Future investment yield assumptions are determined based upon prevailing investment yields as well as estimated reinvestment yields.  Mortality, morbidity and policy termination assumptions are based on our experience and industry experience.  Expense assumptions include the estimated effects of inflation and expenses to be incurred beyond the premium-paying period.  These assumptions are established at the time the policy is issued, are consistent with assumptions for determining DAC amortization for these policies, and are generally not changed during the policy coverage period.  However, if actual experience emerges in a manner that is significantly adverse relative to the original assumptions, adjustments to DAC or reserves may be required resulting in a charge to earnings which could have a material effect on our operating results and financial condition.  We periodically review the adequacy of reserves and recoverability of DAC for these policies on an aggregate basis using actual experience.  In the event actual experience is significantly adverse compared to the original assumptions and a premium deficiency is determined to exist, any remaining unamortized DAC balance must be expensed to the extent not recoverable and the establishment of a premium deficiency reserve may be required.  In 2013, 2012 and 2011, our reviews concluded that no premium deficiency adjustments were necessary, primarily due to projected profit from traditional life insurance more than offsetting the projected losses in immediate annuities with life contingencies.  We will continue to monitor the experience of our traditional life insurance and immediate annuities.  We anticipate that mortality, investment and reinvestment yields, and policy terminations are the factors that would be most likely to require premium deficiency adjustments to these reserves or related DAC.

 

For further detail on the reserve for life-contingent contract benefits, see Note 9 of the consolidated financial statements.

 

2013 HIGHLIGHTS

 

·

Net loss was $38 million in 2013 compared to net income of $426 million in 2012.

·

Premiums and contract charges on underwritten products, including traditional life, interest-sensitive life and accident and health insurance, totaled $1.61 billion in 2013, an increase of 3.4% from $1.56 billion in 2012.

·

Investments totaled $37.94 billion as of December 31, 2013, reflecting a decrease of $17.92 billion from $55.87 billion as of December 31, 2012. Investments classified as held for sale totaled $11.98 billion as of December 31, 2013. Net investment income decreased 4.3% to $2.49 billion in 2013 from $2.60 billion in 2012.

·

Net realized capital gains totaled $76 million in 2013 compared to net realized capital losses of $16 million in 2012.

·

During 2013, loss on disposition of $521 million, after-tax, was recorded relating to the pending sale of Lincoln Benefit Life Company.

·

Contractholder funds totaled $23.60 billion as of December 31, 2013, reflecting a decrease of $15.03 billion from $38.63 billion as of December 31, 2012. Contractholder funds classified as held for sale totaled $10.95 billion as of December 31, 2013.

 

IMPACT OF LOW INTEREST RATE ENVIRONMENT

 

Despite the increase in interest rates during 2013, our current reinvestment yields are generally lower than the overall portfolio income yield, primarily for our investments in fixed income securities and commercial mortgage loans.  At the December 2013 meeting, the Federal Reserve Board announced its decision to reduce the amount of its purchases of both longer-term Treasury and agency mortgage-backed securities in the open market.  The Federal Open Market Committee also reaffirmed its view that a highly accommodative stance of monetary policy will remain appropriate for a considerable time after the asset purchase program ends and the economic recovery strengthens and stated that it now anticipates that it likely will be appropriate to maintain the current target range for the federal funds rate well past the time that the unemployment rate declines below 6.5 percent, especially if projected inflation continues to run below the Committee’s 2 percent longer-run goal.  We anticipate that interest

 

18



 

rates will continue to increase but remain below historic averages and the portfolio income yield for some period.  We also expect capital markets to remain volatile.

 

Deferred annuity contracts with fixed and guaranteed crediting rates, or floors that limit crediting rate reductions, are adversely impacted by a prolonged low interest rate environment since we may not be able to reduce crediting rates sufficiently to maintain investment spreads.  Financial results of long duration products that do not have stated crediting rate guarantees but for which underlying assets may have to be reinvested at interest rates that are lower than portfolio rates, such as structured settlements and term life insurance, may also be adversely impacted.

 

The following table summarizes the weighted average guaranteed crediting rates and weighted average current crediting rates as of December 31, 2013 for certain fixed annuities and interest-sensitive life contracts where management has the ability to change the crediting rate, subject to a contractual minimum.  Other products, including equity-indexed, variable and immediate annuities, equity-indexed and variable life, and institutional products totaling $6.39 billion of contractholder funds, have been excluded from the analysis because management does not have the ability to change the crediting rate or the minimum crediting rate is not considered meaningful in this context.

 

($ in millions)

 

Weighted

average
guaranteed
crediting rates

 

Weighted average
current
crediting
rates

 

Contractholder
funds

 

 

 

 

 

 

 

Annuities with annual crediting rate resets

 

2.89 %

 

2.89 %

 

$       6,628

Annuities with multi-year rate guarantees (1):

 

 

 

 

 

 

      Resettable in next 12 months

 

1.01

 

4.18

 

1,227

      Resettable after 12 months

 

1.26

 

3.46

 

2,479

Interest-sensitive life insurance

 

3.99

 

4.14

 

6,884

 

 

 

(1)  These contracts include interest rate guarantee periods which are typically 5 or 6 years.

 

 

Investing activity will continue to decrease our portfolio yield as long as market yields remain below the current portfolio yield.  The portfolio yield has been less impacted by reinvestment in the current low interest rate environment, as much of the investment cash flows have been used to fund the managed reduction in spread-based liabilities.  The declines in both invested assets and portfolio yield are expected to result in lower net investment income in future periods.

 

We expect approximately 4.4% of the amortized cost of fixed income securities not subject to prepayment and approximately 7.8% of commercial mortgage loans to mature in 2014.  We have $24.94 billion of such fixed income securities and $4.17 billion of such commercial mortgage loans as of December 31, 2013.  Additionally, for asset-backed securities (“ABS”), residential mortgage-backed securities (“RMBS”) and commercial mortgage-backed securities (“CMBS”) that have the potential for prepayment and are therefore not categorized by contractual maturity, we received periodic principal payments of $1.40 billion in 2013.  To the extent portfolio cash flows are reinvested, the average pre-tax investment yield of 5.6% is expected to decline due to lower market yields.  These amounts exclude assets classified as held for sale.

 

In order to mitigate the unfavorable impact that the current interest rate environment has on investment results, we are:

 

·     Shifting the portfolio mix to have less reliance on investments whose returns come primarily from interest payments to investments in which we have ownership interests and a greater proportion of return is derived from idiosyncratic operating or market performance including equities and real estate.

·                  Investing to the specific needs and characteristics of our business.

 

These topics are discussed in more detail in the respective sections of the MD&A.

 

19



 

OPERATIONS

 

Overview and strategy  We sell life insurance and voluntary employee benefits products.  We serve our customers through Allstate exclusive agencies and exclusive financial specialists, and workplace distribution.  We bring value to our ultimate parent, the Corporation in three principal ways: through profitable growth, by bringing new customers to Allstate, and by improving the economics of the Corporation through increased customer loyalty and stronger customer relationships based on cross selling our products to existing customers.  Our strategy is focused on expanding Allstate customer relationships, growing the number of products delivered to customers through Allstate exclusive agencies, improving returns on our in-force annuity products, and emphasizing capital efficiency and shareholder returns.

 

On July 17, 2013, we announced our plans to exit the independent master brokerage agencies distribution channel.  In connection with this announcement, we entered into a definitive agreement with Resolution Life Holdings, Inc. to sell Lincoln Benefit Life Company, LBL’s life insurance business generated through independent master brokerage agencies, and all of LBL’s deferred fixed annuity and long-term care insurance business for $600 million subject to certain adjustments as of the closing date.  The transaction is subject to regulatory approvals and other customary closing conditions.  We expect the closing to occur in April 2014.  The estimated loss on disposition of $521 million, after-tax, was recorded in 2013.  The business being sold had $341 million of premiums and contract charges in 2013.  Effective July 18, 2013, we no longer offer any products through the independent master brokerage agency distribution channel.

 

The principal products we currently offer include interest-sensitive, traditional and variable life insurance.  These products are sold through Allstate exclusive agencies and exclusive financial specialists.  We also offer voluntary accident and health insurance through workplace enrolling independent agents in New York.  Effective January 1, 2014, we no longer offer fixed annuities such as deferred and immediate annuities.  We are planning to outsource the administration of our annuity business to a third party administration company by the end of 2014.  Institutional products consisting of funding agreements sold to unaffiliated trusts that use them to back medium-term notes were previously offered and $85 million remain outstanding as of December 31, 2013.

 

Based upon Allstate’s strong financial position and brand, we have a unique opportunity to cross-sell our products to meet the needs of more Allstate customers.  We will enhance trusted customer relationships established through Allstate exclusive agencies to serve those who are looking for assistance in meeting their protection and retirement needs by providing them with information, products and services.  To further strengthen our value proposition to Allstate exclusive agencies and drive further engagement in selling our products, the agent compensation structure incorporates sales of our products.

 

Our in-force deferred and immediate annuity business has been adversely impacted by the credit cycle and historically low interest rate environment.  Our immediate annuity business has also been impacted by medical advancements that have resulted in annuitants living longer than anticipated when many of these contracts were originated.  We have reduced the level of legacy deferred annuities in force and proactively manage annuity crediting rates to improve the profitability of the business.  The pending LBL sale will further reduce the level of deferred annuities in force.  We are managing the investment portfolio supporting our immediate annuities to ensure the assets match the characteristics of the liabilities and provide the long-term returns needed to support this business.  We are increasing investments in which we have ownership interests and a greater proportion of return is derived from idiosyncratic operating or market performance including equities and real estate to more appropriately match investment duration with these long-term liabilities.

 

Outlook

 

·                  Our growth initiatives continue to focus on increasing the number of customers served through the Allstate agency channel.

·                  We continue to focus on improving returns on our in-force deferred and immediate annuity products.

·                  We plan to accelerate growth of premiums and contract charges by offering a broad range of products to meet our customers’ needs.  The solutions we offer to meet customer life and retirement needs will include underwritten insurance products as well as third-party solutions where we choose not to offer certain products.

·                We expect lower investment spread due to reduced contractholder funds, the continuing low interest rate environment and changes in asset allocations.  The amount by which the low interest rate environment will reduce our investment spread is contingent on our ability to maintain the portfolio yield and lower interest crediting rates on spread-based products, which could be limited by market conditions, regulatory minimum

 

20



 

rates or contractual minimum rate guarantees, and may not match the timing or magnitude of changes in asset yields.  We also anticipate changing our asset allocation for long-term immediate annuities to have less reliance on investments whose returns come primarily from interest payments to investments in which we have ownership interests and a greater proportion of return is derived from idiosyncratic operating or market performance including equities and real estate.  This shift could result in lower and more volatile investment income; however, we anticipate that this strategy will lead to higher total returns on shareholder’s equity.

·                  Shareholder’s equity may increase as there may be limitations on the amount of dividends we can pay without prior approval by our insurance department.

·                  We continue to review our strategic options to reduce our exposure and improve returns of the spread-based businesses.  As a result, we may take additional operational and financial actions that offer return improvement and risk reduction opportunities.

 

Summary analysis   Summarized financial data for the years ended December 31 is presented in the following table.

 

($ in millions)

 

2013

 

2012

 

2011

Revenues

 

 

 

 

 

 

Premiums

613 

593 

$

624 

Contract charges

 

1,054 

 

1,029 

 

1,008 

Net investment income

 

2,485 

 

2,597 

 

2,637 

Realized capital gains and losses

 

76 

 

(16)

 

390 

Total revenues

 

4,228 

 

4,203 

 

4,659 

 

 

 

 

 

 

 

Costs and expenses

 

 

 

 

 

 

Contract benefits

 

(1,606)

 

(1,521)

 

(1,502)

Interest credited to contractholder funds

 

(1,251)

 

(1,289)

 

(1,608)

Amortization of DAC

 

(240)

 

(324)

 

(430)

Operating costs and expenses

 

(434)

 

(437)

 

(394)

Restructuring and related charges

 

(6)

 

-- 

 

(1)

Interest expense

 

(23)

 

(45)

 

(45)

Total costs and expenses

 

(3,560)

 

(3,616)

 

(3,980)

 

 

 

 

 

 

 

(Loss) gain on disposition of operations

 

(687)

 

18 

 

15 

Income tax expense

 

(19)

 

(179)

 

(225)

Net (loss) income

 

(38)

426 

$

469 

 

Net loss was $38 million in 2013 compared to net income of $426 million in 2012.  The change was primarily due to the estimated loss on disposition related to the pending LBL sale, lower net investment income and higher contract benefits, partially offset by net realized capital gains in 2013 compared to net realized capital losses in 2012 and decreased amortization of DAC.

 

Net income in 2012 was $426 million compared to $469 million in 2011.  The decrease was primarily due to net realized capital losses in 2012 compared to net realized capital gains in 2011, partially offset by decreased interest credited to contractholder funds and lower amortization of DAC.

 

Analysis of revenues   Total revenues increased 0.6% or $25 million in 2013 compared to 2012, primarily due to net realized capital gains in 2013 compared to net realized capital losses in 2012 and higher premiums and contract charges, partially offset by lower net investment income.  Total revenues decreased 9.8% or $456 million in 2012 compared to 2011 due to net realized capital losses in 2012 compared to net realized capital gains in 2011 and lower net investment income.

 

Premiums represent revenues generated from traditional life insurance, immediate annuities with life contingencies, and accident and health insurance products that have significant mortality or morbidity risk.

 

Contract charges are revenues generated from interest-sensitive and variable life insurance and fixed annuities for which deposits are classified as contractholder funds or separate account liabilities.  Contract charges are assessed against the contractholder account values for maintenance, administration, cost of insurance and surrender prior to contractually specified dates.

 

21



 

The following table summarizes premiums and contract charges by product for the years ended December 31.

 

($ in millions)

 

2013

 

2012

 

2011

Underwritten products

 

 

 

 

 

 

Traditional life insurance premiums

471

449

420

Accident and health insurance premiums

 

105

 

99

 

98

Interest-sensitive life insurance contract charges

 

1,036

 

1,011

 

975

   Subtotal

 

1,612

 

1,559

 

1,493

 

 

 

 

 

 

 

Annuities

 

 

 

 

 

 

Immediate annuities with life contingencies premiums

 

37

 

45

 

106

Other fixed annuity contract charges

 

18

 

18

 

33

   Subtotal

 

55

 

63

 

139

 

 

 

 

 

 

 

Premiums and contract charges (1)

1,667

1,622

1,632

 

 

 

(1)  Contract charges related to the cost of insurance totaled $714 million, $685 million and $648 million in 2013, 2012 and 2011, respectively.

 

Total premiums and contract charges increased 2.8% in 2013 compared to 2012, primarily due to higher contract charges on interest-sensitive life insurance products primarily resulting from the aging of our policyholders and growth of insurance in force, and increased traditional life insurance premiums due to lower reinsurance premiums ceded and higher sales and renewals through Allstate agencies, partially offset by lower sales of immediate annuities with life contingencies.  Effective March 22, 2013, we no longer offer structured settlement annuities.  We continue to service the in-force structured settlement contracts.

 

Total premiums and contract charges decreased 0.6% in 2012 compared to 2011, primarily due to lower sales of immediate annuities with life contingencies, partially offset by higher contract charges on interest-sensitive life insurance products primarily resulting from the aging of our policyholders and lower reinsurance ceded, and increased traditional life insurance premiums due to lower reinsurance ceded and higher sales through Allstate agencies.

 

22



 

Contractholder funds represent interest-bearing liabilities arising from the sale of products such as interest-sensitive life insurance, fixed annuities and funding agreements.  The balance of contractholder funds is equal to the cumulative deposits received and interest credited to the contractholder less cumulative contract benefits, surrenders, withdrawals, maturities and contract charges for mortality or administrative expenses.  The following table shows the changes in contractholder funds for the years ended December 31.

 

($ in millions)

 

2013

 

2012

 

2011

Contractholder funds, beginning balance

38,634 

41,669 

46,458 

 

 

 

 

 

 

 

Deposits

 

 

 

 

 

 

Fixed annuities

 

1,062 

 

927 

 

666 

Interest-sensitive life insurance

 

1,276 

 

1,253 

 

1,203 

Total deposits

 

2,338 

 

2,180 

 

1,869 

 

 

 

 

 

 

 

Interest credited

 

1,268 

 

1,296 

 

1,592 

 

 

 

 

 

 

 

Benefits, withdrawals, maturities and other adjustments

 

 

 

 

 

 

Benefits

 

(1,521)

 

(1,454)

 

(1,454)

Surrenders and partial withdrawals

 

(3,279)

 

(3,969)

 

(4,908)

Maturities of and interest payments on institutional products

 

(1,799)

 

(138)

 

(867)

Contract charges

 

(1,032)

 

(995)

 

(962)

Net transfers from separate accounts

 

12 

 

11 

 

12 

Fair value hedge adjustments for institutional products

 

-- 

 

-- 

 

(34)

Other adjustments (1)

 

(72)

 

34 

 

(37)

Total benefits, withdrawals, maturities and other adjustments

 

(7,691)

 

(6,511)

 

(8,250)

 

 

 

 

 

 

 

Contractholder funds classified as held for sale

 

(10,945)

 

--

 

--

 

 

 

 

 

 

 

Contractholder funds, ending balance

23,604 

38,634 

41,669 

 

 

 

(1)    The table above illustrates the changes in contractholder funds, which are presented gross of reinsurance recoverables on the Consolidated Statements of Financial Position.  The table above is intended to supplement our discussion and analysis of revenues, which are presented net of reinsurance on the Consolidated Statements of Operations and Comprehensive Income.  As a result, the net change in contractholder funds associated with products reinsured to third parties is reflected as a component of the other adjustments line.

 

Contractholder funds decreased 38.9%, 7.3% and 10.3% in 2013, 2012 and 2011, respectively.  The decrease in 2013 reflects the reclassification of contractholder funds held for sale relating to the pending LBL sale.  Contractholder funds including those classified as held for sale decreased 10.6% in 2013, reflecting a large institutional product maturity in 2013 and our continuing strategy to reduce our concentration in spread-based products.  Average contractholder funds decreased 22.5% in 2013 compared to 2012 and 8.9% in 2012 compared to 2011.

 

Contractholder deposits increased 7.2% in 2013 compared to 2012, primarily due to increased fixed annuity deposits driven by the new equity-indexed annuity products and higher deposits on immediate annuities, as well as higher deposits on interest-sensitive life insurance.  Contractholder deposits increased 16.6% in 2012 compared to 2011, primarily due to increased fixed annuity deposits driven by new equity-indexed annuity products launched in second quarter 2012.

 

Surrenders and partial withdrawals on deferred fixed annuities and interest-sensitive life insurance products decreased 17.4% to $3.28 billion in 2013 from $3.97 billion in 2012.  Surrenders and partial withdrawals on deferred fixed annuities and interest-sensitive life insurance products decreased 19.1% to $3.97 billion in 2012 from $4.91 billion in 2011.  2011 had elevated surrenders on fixed annuities resulting from crediting rate actions and a large number of contracts reaching the 30-45 day period (typically at their 5 or 6 year anniversary) during which there is no surrender charge.  The surrender and partial withdrawal rate on deferred fixed annuities and interest-sensitive life insurance products, based on the beginning of year contractholder funds, was 10.4% in 2013 compared to 11.5% in 2012 and 12.7% in 2011.

 

Maturities of and interest payments on institutional products in 2013 include a $1.75 billion maturity.  There are $85 million of institutional products outstanding as of December 31, 2013.  Maturities of and interest payments on

 

23



 

institutional products decreased to $138 million in 2012 from $867 million in 2011, reflecting differences in the timing and magnitude of maturities.

 

Analysis of costs and expenses   Total costs and expenses decreased 1.5% or $56 million in 2013 compared to 2012, primarily due to lower amortization of DAC and lower interest credited to contractholder funds, partially offset by higher contract benefits.  Total costs and expenses decreased 9.1% or $364 million in 2012 compared to 2011, primarily due to lower interest credited to contractholder funds and amortization of DAC.

 

Contract benefits increased 5.6% or $85 million in 2013 compared to 2012, primarily due to an increase in reserves for secondary guarantees on interest-sensitive life insurance and worse mortality experience on life insurance.  Our 2013 annual review of assumptions resulted in a $37 million increase in reserves primarily for secondary guarantees on interest-sensitive life insurance due to higher concentration of and increased projected exposure to secondary guarantees.

 

Contract benefits increased 1.3% or $19 million in 2012 compared to 2011, primarily due to worse mortality experience on life insurance, partially offset by lower sales of immediate annuities with life contingencies and the reduction in reserves for secondary guarantees on interest-sensitive life insurance.  Our 2012 annual review of assumptions resulted in a $13 million decrease in the reserves for secondary guarantees on interest-sensitive life insurance due to favorable projected mortality.

 

We analyze our mortality and morbidity results using the difference between premiums and contract charges earned for the cost of insurance and contract benefits excluding the portion related to the implied interest on immediate annuities with life contingencies (“benefit spread”).  This implied interest totaled $527 million, $538 million and $541 million in 2013, 2012 and 2011, respectively.

 

The benefit spread by product group for the years ended December 31 is disclosed in the following table.

 

($ in millions) 

 

2013

 

2012

 

2011

Life insurance

310 

334 

342 

Accident and health insurance

 

15 

 

27 

 

24 

Annuities

 

(77)

 

(66)

 

(55)

Total benefit spread

248 

295 

311 

 

Benefit spread decreased 15.9% or $47 million in 2013 compared to 2012, primarily due to the increase in reserves for secondary guarantees on interest-sensitive life insurance and worse mortality experience on life insurance and annuities, partially offset by higher cost of insurance contract charges on interest-sensitive life insurance.

 

Benefit spread decreased 5.1% or $16 million in 2012 compared to 2011, primarily due to worse mortality experience on life insurance and annuities, partially offset by lower reinsurance premiums ceded on life insurance, higher cost of insurance contract charges on interest-sensitive life insurance and the reduction in reserves for secondary guarantees on interest-sensitive life insurance.

 

Interest credited to contractholder funds decreased 2.9% or $38 million in 2013 compared to 2012, primarily due to lower average contractholder funds and lower interest crediting rates, partially offset by the valuation change on derivatives embedded in equity-indexed annuity contracts that reduced interest credited expense in 2012.  Interest credited to contractholder funds decreased 19.8% or $319 million in 2012 compared to 2011, primarily due to the valuation change on derivatives embedded in equity-indexed annuity contracts that reduced interest credited expense, lower average contractholder funds and lower interest crediting rates.  Valuation changes on derivatives embedded in equity-indexed annuity contracts that are not hedged increased interest credited to contractholder funds by $24 million in 2013 compared to a $126 million decrease in 2012 and an $18 million increase in 2011.  During third quarter 2012, we reviewed the significant valuation inputs for these embedded derivatives and reduced the projected option cost to reflect management’s current and anticipated crediting rate setting actions, which were informed by the existing and projected low interest rate environment and are consistent with our strategy to reduce exposure to spread-based business.  The reduction in projected interest rates resulted in a reduction of contractholder funds and interest credited expense by $169 million in 2012.

 

In order to analyze the impact of net investment income and interest credited to contractholders on net income, we monitor the difference between net investment income and the sum of interest credited to contractholder funds

 

24



 

and the implied interest on immediate annuities with life contingencies, which is included as a component of contract benefits on the Consolidated Statements of Operations and Comprehensive Income (“investment spread”).

 

The investment spread by product group for the years ended December 31 is shown in the following table.

 

($ in millions) 

 

2013

 

2012

 

2011

 

Annuities and institutional products

338 

290

188 

 

Life insurance

 

107 

 

86

 

59 

 

Accident and health insurance

 

14 

 

14

 

 

Net investment income on investments supporting capital

 

272 

 

254

 

251 

 

Investment spread before valuation changes on embedded derivatives that are not hedged

 

731 

 

644

 

506 

 

Valuation changes on derivatives embedded in equity-indexed annuity contracts that are not hedged

 

(24)

 

126

 

(18)

 

Total investment spread

707 

770

488 

 

 

Investment spread before valuation changes on embedded derivatives that are not hedged increased 13.5% or $87 million in 2013 compared to 2012, primarily due to lower crediting rates, higher prepayment fee income and litigation proceeds and higher limited partnership income, partially offset by the continued managed reduction in our spread-based business in force.  Investment spread before valuation changes on embedded derivatives that are not hedged increased 27.3% or $138 million in 2012 compared to 2011 due to income from limited partnerships and lower crediting rates, partially offset by lower yields on fixed income securities and the continued managed reduction in our spread-based business in force.

 

To further analyze investment spreads, the following table summarizes the weighted average investment yield on assets supporting product liabilities and capital, interest crediting rates and investment spreads.  For purposes of these calculations, investments, reserves and contractholder funds classified as held for sale are included.

 

 

 

Weighted average
investment yield

 

Weighted average
interest crediting rate

 

Weighted average
investment spreads

 

 

 

2013

 

2012

 

2011

 

2013

 

2012

 

2011

 

2013

 

2012

 

2011

 

Interest-sensitive life insurance

 

5.3

%

5.3

%

5.4

%

3.9

%

4.0

%

4.2

%

1.4

%

1.3

%

1.2

%

Deferred fixed annuities and institutional products

 

4.5

 

4.6

 

4.6

 

2.9

 

3.2

 

3.3

 

1.6

 

1.4

 

1.3

 

Immediate fixed annuities with and without life contingencies

 

6.9

 

6.9

 

6.3

 

6.0

 

6.1

 

6.2

 

0.9

 

0.8

 

0.1

 

Investments supporting capital, traditional life and other products

 

4.1

 

4.1

 

4.0

 

n/a

 

n/a

 

n/a

 

n/a

 

n/a

 

n/a

 

 

The following table summarizes our product liabilities as of December 31 and indicates the account value of those contracts and policies in which an investment spread is generated.

 

($ in millions)

 

2013

 

2012

 

2011

Immediate fixed annuities with life contingencies

8,924

8,885

8,827

Other life contingent contracts and other

 

2,665

 

5,232

 

4,839

   Reserve for life-contingent contract benefits

11,589

14,117

13,666

 

 

 

 

 

 

 

Interest-sensitive life insurance

7,104

10,356

10,195

Deferred fixed annuities

 

12,499

 

22,038

 

25,198

Immediate fixed annuities without life contingencies

 

3,673

 

3,813

 

3,819

Institutional products

 

85

 

1,851

 

1,891

Other

 

243

 

576

 

566

   Contractholder funds

23,604

38,634

41,669

 

 

 

 

 

 

 

Traditional life insurance

570

--

--

Accident and health insurance

 

1,324

 

--

 

--

Interest-sensitive life insurance

 

3,529

 

--

 

--

Deferred fixed annuities

 

7,416

 

--

 

--

   Liabilities held for sale

12,839

--

--

 

25



 

Amortization of DAC decreased 25.9% or $84 million in 2013 compared to 2012 and 24.7% or $106 million in 2012 compared to 2011.  The components of amortization of DAC for the years ended December 31 are summarized in the following table.

 

($ in millions)

 

2013

 

2012

 

2011

 

Amortization of DAC before amortization relating to realized capital gains and losses, valuation changes on embedded derivatives that are not hedged and changes in assumptions

$

215

$

233

$

265

 

Amortization relating to realized capital gains and losses (1) and valuation changes on embedded derivatives that are not hedged

 

7

 

57

 

156

 

Amortization acceleration for changes in assumptions (“DAC unlocking”)

 

18

 

34

 

9

 

Total amortization of DAC

$

240

$

324

$

430

 

 

 

 

 

 

 

 

 

 

 

(1)     The impact of realized capital gains and losses on amortization of DAC is dependent upon the relationship between the assets that give rise to the gain or loss and the product liability supported by the assets.  Fluctuations result from changes in the impact of realized capital gains and losses on actual and expected gross profits.

 

 

The decrease in DAC amortization in 2013 compared to 2012 was primarily due to the absence of amortization on a large fixed annuity block that became fully amortized in 2012, lower amortization relating to valuation changes on derivatives embedded in equity-indexed annuity contracts due to a large valuation change in 2012, lower amortization on interest-sensitive life insurance resulting from decreased benefit spread, and lower amortization acceleration for changes in assumptions.  Amortization relating to valuation changes on derivatives embedded in equity-indexed annuity contracts was $1 million in 2013 compared to $25 million in 2012.

 

The decrease in DAC amortization in 2012 compared to 2011 was primarily due to decreased amortization relating to realized capital gains and losses and decreased amortization on fixed annuity products due to the DAC balance for contracts issued prior to 2010 being fully amortized, partially offset by increased amortization acceleration for changes in assumptions and increased amortization relating to valuation changes on embedded derivatives that are not hedged.

 

Our annual comprehensive review of the profitability of our products to determine DAC balances for our interest-sensitive life, fixed annuities and other investment contracts covers assumptions for persistency, mortality, expenses, investment returns, including capital gains and losses, interest crediting rates to policyholders, and the effect of any hedges in all product lines.  In 2013, the review resulted in an acceleration of DAC amortization (charge to income) of $18 million.  Amortization acceleration of $33 million related to interest-sensitive life insurance and was primarily due to an increase in projected mortality and expenses, partially offset by increased projected investment margins.  Amortization deceleration of $12 million related to fixed annuities and was primarily due to an increase in projected investment margins.  Amortization deceleration of $3 million related to variable life insurance.

 

In 2012, the review resulted in an acceleration of DAC amortization of $34 million.  Amortization acceleration of $38 million related to variable life insurance and was primarily due to an increase in projected mortality.  Amortization acceleration of $4 million related to fixed annuities and was primarily due to lower projected investment returns.  Amortization deceleration of $8 million related to interest-sensitive life insurance and was primarily due to an increase in projected persistency.

 

In 2011, the review resulted in an acceleration of DAC amortization of $9 million.  Amortization acceleration of $15 million related to interest-sensitive life insurance and was primarily due to an increase in projected expenses.  Amortization deceleration of $6 million related to equity-indexed annuities and was primarily due to an increase in projected investment margins.

 

26



 

The changes in DAC for the years ended December 31 are detailed in the following table.

 

($ in millions)

 

Traditional life
and accident
and health

 

Interest-
sensitive life
insurance

 

Fixed
annuities

 

Total

 

 

 

2013

 

2012

 

2013

 

2012

 

2013

 

2012

 

2013

 

2012

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Beginning balance

$

410

$

384

$

1,399

$

1,572

$

25

$

209

$

1,834

$

2,165

 

Acquisition costs deferred

 

76

 

65

 

154

 

172

 

24

 

25

 

254

 

262

 

Amortization of DAC before amortization relating to realized capital gains and losses, valuation changes on embedded derivatives that are not hedged and changes in assumptions (1)

 

(44)

 

(39)

 

(158)

 

(169)

 

(13)

 

(25)

 

(215)

 

(233)

 

Amortization relating to realized capital gains and losses and valuation changes on embedded derivatives that are not hedged (1)

 

--

 

--

 

(6)

 

(18)

 

(1)

 

(39)

 

(7)

 

(57)

 

Amortization (acceleration) deceleration for changes in assumptions (“DAC unlocking”) (1)

 

--

 

--

 

(30)

 

(30)

 

12

 

(4)

 

(18)

 

(34)

 

Effect of unrealized capital gains and losses (2)

 

--

 

--

 

198

 

(128)

 

28

 

(141)

 

226

 

(269)

 

DAC classified as held for sale

 

(13)

 

--

 

(700)

 

--

 

(30)

 

--

 

(743)

 

--

 

Ending balance

$

429

$

410

$

857

$

1,399

$

45

$

25

$

1,331

$

1,834

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)     Included as a component of amortization of DAC on the Consolidated Statements of Operations and Comprehensive Income.

(2)   Represents the change in the DAC adjustment for unrealized capital gains and losses.  The DAC adjustment represents the amount by which the amortization of DAC would increase or decrease if the unrealized gains and losses in the respective product portfolios were realized

 

Operating costs and expenses decreased 0.7% or $3 million in 2013 compared to 2012 and increased 10.9% or $43 million in 2012 compared to 2011.  The following table summarizes operating costs and expenses for the years ended December 31.

 

($ in millions)

 

2013

 

2012

 

2011

 

Non-deferrable commissions

$

27

$

33

$

39

 

General and administrative expenses

 

363

 

370

 

313

 

Taxes and licenses

 

44

 

34

 

42

 

Total operating costs and expenses

$

434

$

437

$

394

 

 

 

 

 

 

 

 

 

Restructuring and related charges

$

6

$

--

$

1

 

 

General and administrative expenses decreased 1.9% or $7 million in 2013 compared to 2012, primarily due to lower employee related expenses and proceeds received from a litigation settlement.

 

General and administrative expenses increased 18.2% or $57 million in 2012 compared to 2011, primarily due to higher employee related expenses, lower reinsurance expense allowances and increased marketing costs, partially offset by a charge in 2011 related to the liquidation plan for Executive Life Insurance Company of New York.

 

Loss on disposition of $687 million in 2013 includes the estimated $698 million loss relating to the pending LBL sale.  Gain on disposition of $18 million in 2012 relates to the amortization of the deferred gain from the disposition through reinsurance of substantially all of our variable annuity business in 2006, and the sale of Surety Life Insurance Company, which was not used for new business, in third quarter 2012.

 

Reinsurance ceded               We enter into reinsurance agreements with unaffiliated reinsurers to limit our risk of mortality and morbidity losses.  In addition, we have used reinsurance to effect the acquisition or disposition of certain blocks of business.  We retain primary liability as a direct insurer for all risks ceded to reinsurers.  As of December 31, 2013 and 2012, 36% and 39%, respectively, of our face amount of life insurance in force was reinsured.  Additionally, we ceded substantially all of the risk associated with our variable annuity business.

 

27



 

Our reinsurance recoverables, summarized by reinsurer as of December 31, are shown in the following table.

 

($ in millions)

 

Standard & Poor’s
financial strength
rating 
(4)

 

Reinsurance
recoverable on paid
and unpaid benefits

 

 

 

 

 

2013

 

2012

 

Prudential Insurance Company of America

 

AA-

$

1,510

$

1,691

 

RGA Reinsurance Company

 

AA-

 

302

 

359

 

Swiss Re Life and Health America, Inc. (1)

 

AA-

 

185

 

216

 

Paul Revere Life Insurance Company

 

A

 

121

 

127

 

Munich American Reassurance

 

AA-

 

108

 

131

 

Scottish Re Group

 

N/A

 

104

 

131

 

Transamerica Life Group

 

AA-

 

88

 

447

 

Manulife Insurance Company

 

AA-

 

59

 

62

 

Triton Insurance Company

 

N/A

 

54

 

55

 

Security Life of Denver

 

A-

 

48

 

83

 

American Health & Life Insurance Co.

 

N/A

 

44

 

45

 

Lincoln National Life Insurance

 

AA-

 

39

 

60

 

SCOR Global Life

 

A+

 

21

 

19

 

Employers Reassurance Corporation

 

A+

 

15

 

1,059

 

Other (2)

 

 

 

56

 

85

 

Total (3)

 

 

$

2,754

$

4,570

 

 

 

 

(1)           The Company has extensive reinsurance contracts directly with Swiss Re and its affiliates and indirectly through Swiss Re’s acquisition of other companies with whom we had reinsurance or retrocession contracts.

(2)           As of December 31, 2013 and 2012, the other category includes $39 million and $68 million, respectively, of recoverables due from reinsurers with an investment grade credit rating from Standard & Poor’s (“S&P”).

(3)      Reinsurance recoverables classified as held for sale were $1.66 billion as of December 31, 2013.

(4)           N/A reflects no rating available.

 

We continuously monitor the creditworthiness of reinsurers in order to determine our risk of recoverability on an individual and aggregate basis, and a provision for uncollectible reinsurance is recorded if needed.  No amounts have been deemed unrecoverable in the three-years ended December 31, 2013.

 

INVESTMENTS 2013 HIGHLIGHTS

 

·     Investments totaled $37.94 billion as of December 31, 2013, decreasing from $55.87 billion as of December 31, 2012.  Investments classified as held for sale totaled $11.98 billion as of December 31, 2013.

·      Unrealized net capital gains totaled $1.59 billion as of December 31, 2013, decreasing from $3.70 billion as of December 31, 2012.

·      Net investment income was $2.49 billion in 2013, a decrease of 4.31% from $2.60 billion in 2012.

·      Net realized capital gains were $76 million in 2013 compared to net realized capital losses of $16 million in 2012.

 

INVESTMENTS

 

Overview and strategy The return on our investment portfolio is an important component of our financial results.  Our investment strategy focuses on the total return of assets needed to support the underlying liabilities, asset-liability management and achieving an appropriate return on capital.

 

We employ a strategic asset allocation approach which considers the nature of the liabilities and risk tolerances, as well as the risk and return parameters of the various asset classes in which we invest.  This asset allocation is informed by our global economic and market outlook, as well as other inputs and constraints, including diversification effects, duration, liquidity and capital considerations.  Within the ranges set by the strategic asset allocation, tactical investment decisions are made in consideration of prevailing market conditions.  We manage risks associated with interest rates, credit spreads, equity markets, real estate and currency exchange rates.  Our continuing focus is to manage risks and returns and to position our portfolio to take advantage of market opportunities while attempting to mitigate adverse effects.

 

28



 

Investments outlook

 

Although interest rates rose in 2013, we anticipate that they may remain below historic averages for an extended period of time and that financial markets will continue to have periods of high volatility.  Invested assets and income are expected to decline in line with reductions in contractholder funds, including $11.98 billion of investments classified as held for sale as of December 31, 2013 related to the pending sale of Lincoln Benefit Life.  Additionally, income will decline as we continue to invest and reinvest proceeds at market yields that are below the current portfolio yield.  We plan to focus on the following priorities:

 

·                  Shifting the portfolio mix to have less reliance on investments whose returns come primarily from interest payments to investments in which we have ownership interests and a greater proportion of return is derived from idiosyncratic operating or market performance including equities and real estate.

·                  Investing to the specific needs and characteristics of our business.

 

Portfolio composition   The composition of the investment portfolio as of December 31, 2013 is presented in the following table.

 

($ in millions)

 

 

 

Percent
to total

 

Fixed income securities (1)

$

28,756

 

75.8

%

Mortgage loans

 

4,173

 

11.0

 

Equity securities (2)

 

650

 

1.7

 

Limited partnership interests (3)

 

2,064

 

5.4

 

Short-term investments (4)

 

590

 

1.6

 

Policy loans

 

623

 

1.6

 

Other

 

1,088

 

2.9

 

Total

$

37,944

 

100.0

%

 

 

 

 

 

 

 

(1)     Fixed income securities are carried at fair value.  Amortized cost basis for these securities was $27.43 billion.

(2)     Equity securities are carried at fair value.  Cost basis for these securities was $565 million.

(3)     We have commitments to invest in additional limited partnership interests totaling $1.37 billion.

(4)     Short-term investments are carried at fair value.  Amortized cost basis for these investments was $590 million.

 

Total investments decreased to $37.94 billion as of December 31, 2013, from $55.87 billion as of December 31, 2012, primarily due to the reclassification of investments relating to LBL to assets held for sale.  Total investments including those classified as held for sale were $49.93 billion as of December 31, 2013, a decrease of $5.94 billion from December 31, 2012, reflecting net reductions in contractholder funds and lower fixed income valuations.  The decline in valuation of fixed income securities during 2013 was primarily due to increasing risk-free interest rates.

 

During 2013, strategic actions focused on optimizing portfolio yield, return and risk in the low interest rate environment.  We increased our investment in intermediate term corporate fixed income securities and reduced our investments in ARS through dispositions.  The carrying value of RMBS and CMBS declined due to the receipt of principal payments during the year.  We also increased our equity investments and limited partnership interests, consistent with our strategy to have a greater proportion of ownership of assets.

 

Fixed income securities by type are listed in the following table.

 

($ in millions)

 

Fair value as of
December 31, 2013

 

Percent to
total
investments

 

Fair value as of
December 31, 2012

 

Percent to
total
investments

 

U.S. government and agencies

$

766

 

2.0 %

$

2,379

 

4.3 %

 

Municipal

 

3,304

 

8.7

 

4,704

 

8.4

 

Corporate

 

21,316

 

56.2

 

31,531

 

56.5

 

Foreign government

 

792

 

2.1

 

1,180

 

2.1

 

ABS

 

1,007

 

2.7

 

1,865

 

3.3

 

RMBS

 

790

 

2.1

 

1,791

 

3.2

 

CMBS

 

764

 

2.0

 

1,408

 

2.5

 

Redeemable preferred stock

 

17

 

--

 

18

 

--

 

Total fixed income securities

$

28,756

 

75.8 %

$

44,876

 

80.3 %

 

 

29



 

As of December 31, 2013, 90.0% of the fixed income securities portfolio was rated investment grade, which is defined as a security having a rating of Aaa, Aa, A or Baa from Moody’s, a rating of AAA, AA, A or BBB from S&P, Fitch, Dominion, Kroll or Realpoint, a rating of aaa, aa, a or bbb from A.M. Best, or a comparable internal rating if an externally provided rating is not available.  All of our fixed income securities are rated by third party credit rating agencies, the National Association of Insurance Commissioners, and/or are internally rated.  Our initial investment decisions and ongoing monitoring procedures for fixed income securities are based on a thorough due diligence process which includes, but is not limited to, an assessment of the credit quality, sector, structure, and liquidity risks of each issue.

 

The following table summarizes the fair value and unrealized net capital gains and losses for fixed income securities by credit rating as of December 31, 2013.

 

($ in millions)

 

Aaa

 

Aa

 

A

 

 

 

Fair
value

 

Unrealized
gain/(loss)

 

Fair
value

 

Unrealized
gain/(loss)

 

Fair
value

 

Unrealized
gain/(loss)

 

U.S. government and agencies

$

766

$

88

$

--

$

--

$

--

$

--

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Municipal

 

195

 

5

 

1,916

 

133

 

941

 

53

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate

 

 

 

 

 

 

 

 

 

 

 

 

 

Public

 

358

 

8

 

1,012

 

43

 

5,293

 

255

 

Privately placed

 

268

 

3

 

588

 

42

 

2,124

 

158

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign government

 

389

 

61

 

111

 

2

 

103

 

6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ABS

 

 

 

 

 

 

 

 

 

 

 

 

 

Collateralized debt obligations (“CDO”)

 

93

 

2

 

294

 

(1)

 

183

 

(6)

 

Consumer and other asset-backed securities (“Consumer and other ABS”)

 

263

 

4

 

23

 

1

 

40

 

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RMBS

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government sponsored entities (“U.S. Agency”)

 

231

 

13

 

--

 

--

 

--

 

--

 

Prime residential mortgage-backed securities (“Prime”)

 

14

 

--

 

8

 

--

 

16

 

1

 

Alt-A residential mortgage-backed securities (“Alt-A”)

 

--

 

--

 

--

 

--

 

3

 

--

 

Subprime residential mortgage-backed securities (“Subprime”)

 

6

 

--

 

--

 

--

 

6

 

--

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CMBS

 

304

 

12

 

50

 

3

 

82

 

5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redeemable preferred stock

 

--

 

--

 

--

 

--

 

--

 

--

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total fixed income securities

$

2,887

$

196

$

4,002

$

223

$

8,791

$

474

 

 

 

 

Baa

 

Ba or lower

 

Total

 

 

 

Fair
value

 

Unrealized
gain/(loss)

 

Fair
value

 

Unrealized
gain/(loss)

 

Fair
value

 

Unrealized
gain/(loss)

 

U.S. government and agencies

$

--

$

--

$

--

$

--

$

766

$

88

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Municipal

 

207

 

(18)

 

45

 

(4)

 

3,304

 

169

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate

 

 

 

 

 

 

 

 

 

 

 

 

 

Public

 

6,286

 

229

 

1,410

 

29

 

14,359

 

564

 

Privately placed

 

3,316

 

143

 

661

 

9

 

6,957

 

355

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign government

 

189

 

8

 

--

 

--

 

792

 

77

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ABS

 

 

 

 

 

 

 

 

 

 

 

 

 

CDO

 

5

 

--

 

73

 

(7)

 

648

 

(12)

 

Consumer and other ABS

 

26

 

2

 

7

 

(1)

 

359

 

8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RMBS

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Agency

 

--

 

--

 

--

 

--

 

231

 

13

 

Prime

 

51

 

--

 

140

 

19

 

229

 

20

 

Alt-A

 

11

 

--

 

172

 

8

 

186

 

8

 

Subprime

 

--

 

--

 

132

 

(3)

 

144

 

(3)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CMBS

 

80

 

3

 

248

 

17

 

764

 

40

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redeemable preferred stock

 

16

 

2

 

1

 

--

 

17

 

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total fixed income securities

$

10,187

$

369

$

2,889

$

67

$

28,756

$

1,329

 

 

30



 

Municipal bonds totaled $3.30 billion as of December 31, 2013 with an unrealized net capital gain of $169 million.  The municipal bond portfolio includes general obligations of state and local issuers and revenue bonds (including pre-refunded bonds, which are bonds for which an irrevocable trust has been established to fund the remaining payments of principal and interest).

 

The following table summarizes by state the fair value, amortized cost and credit rating of our municipal bonds, excluding $56 million of pre-refunded bonds, as of December 31, 2013.

 

($ in millions)

 

State

 

State
general
obligation

 

Local general
obligation

 

Revenue (1)

 

Fair value

 

Amortized
cost

 

Average
credit
rating

 

California

$

71

$

171

$

276

$

518

$

507

 

A

 

Texas

 

--

 

271

 

168

 

439

 

413

 

Aa

 

Oregon

 

--

 

153

 

23

 

176

 

159

 

Aa

 

New Jersey

 

99

 

15

 

53

 

167

 

153

 

A

 

New York

 

10

 

--

 

156

 

166

 

161

 

Aa

 

Illinois

 

--

 

50

 

116

 

166

 

162

 

Aa

 

Michigan

 

78

 

--

 

68

 

146

 

134

 

Aa

 

Ohio

 

--

 

38

 

89

 

127

 

119

 

Aa

 

Florida

 

26

 

38

 

56

 

120

 

113

 

Aa

 

Washington

 

--

 

--

 

98

 

98

 

91

 

Aa

 

All others

 

183

 

187

 

755

 

1,125

 

1,071

 

A

 

Total

$

467

$

923

$

1,858

$

3,248

$

3,083

 

Aa

 

 

 

 

(1)      The nature of the activities supporting revenue bonds is highly diversified and includes transportation, health care, industrial development, housing, higher education, utilities, recreation/convention centers and other activities.

 

Our practice for acquiring and monitoring municipal bonds is predominantly based on the underlying credit quality of the primary obligor.  We currently rely on the primary obligor to pay all contractual cash flows and are not relying on bond insurers for payments.  As a result of downgrades in the insurers’ credit ratings, the ratings of the insured municipal bonds generally reflect the underlying ratings of the primary obligor.  As of December 31, 2013, 99.3% of our insured municipal bond portfolio is rated investment grade.

 

Corporate bonds, including publicly traded and privately placed, totaled $21.32 billion as of December 31, 2013, with an unrealized net capital gain of $919 million.  Privately placed securities primarily consist of corporate issued senior debt securities that are directly negotiated with the borrower or are in unregistered form.

 

Our $6.96 billion portfolio of privately placed securities is broadly diversified by issuer, industry sector and country.  The portfolio is made up of 395 issuers.  Privately placed corporate obligations contain structural security features such as financial covenants and call protections that provide investors greater protection against credit deterioration, reinvestment risk or fluctuations in interest rates than those typically found in publicly registered debt securities.  Additionally, investments in these securities are made after due diligence of the issuer, typically including direct discussions with senior management and on-site visits to company facilities.  Ongoing monitoring includes direct periodic dialog with senior management of the issuer and continuous monitoring of operating performance and financial position.  Every issue not rated by an independent rating agency is internally rated with a formal rating affirmation at least once a year.

 

Foreign government securities totaled $792 million as of December 31, 2013, with 100% rated investment grade and an unrealized net capital gain of $77 million.  Of these securities, 47.4% are backed by the U.S. government, 15.1% are in Canadian governmental and provincial securities, and the remaining 37.5% are highly diversified in other foreign governments.

 

ABS, RMBS and CMBS are structured securities that are primarily collateralized by consumer or corporate borrowings and residential and commercial real estate loans.  The cash flows from the underlying collateral paid to the securitization trust are generally applied in a pre-determined order and are designed so that each security issued by the trust, typically referred to as a “class”, qualifies for a specific original rating.  For example, the “senior” portion or “top” of the capital structure, or rating class, which would originally qualify for a rating of Aaa typically has priority in receiving principal repayments on the underlying collateral and retains this priority until the class is paid in full.  In a sequential structure, underlying collateral principal repayments are directed to the most senior rated Aaa class in the structure until paid in full, after which principal repayments are directed to the next most senior Aaa class in the structure until it is paid in full.  Senior Aaa classes generally share any losses from the underlying

 

31



 

collateral on a pro-rata basis after losses are absorbed by classes with lower original ratings.  The payment priority and class subordination included in these securities serves as credit enhancement for holders of the senior or top portions of the structures.  These securities continue to retain the payment priority features that existed at the origination of the securitization trust.  Other forms of credit enhancement may include structural features embedded in the securitization trust, such as overcollateralization, excess spread and bond insurance.  The underlying collateral can have fixed interest rates, variable interest rates (such as adjustable rate mortgages) or may contain features of both fixed and variable rate mortgages.

 

ABS, including CDO and Consumer and other ABS, totaled $1.01 billion as of December 31, 2013, with 92.1% rated investment grade and an unrealized net capital loss of $4 million.  Credit risk is managed by monitoring the performance of the underlying collateral.  Many of the securities in the ABS portfolio have credit enhancement with features such as overcollateralization, subordinated structures, reserve funds, guarantees and/or insurance.

 

CDO totaled $648 million as of December 31, 2013, with 88.7% rated investment grade and an unrealized net capital loss of $12 million.  CDO consist of obligations collateralized by cash flow CDO, which are structures collateralized primarily by below investment grade senior secured corporate loans.

 

Consumer and other ABS totaled $359 million as of December 31, 2013, with 98.1% rated investment grade.  Consumer and other ABS consists of $50 million of consumer auto and $309 million of other ABS with unrealized net capital gains of zero and $8 million, respectively.

 

RMBS totaled $790 million as of December 31, 2013, with 43.8% rated investment grade and an unrealized net capital gain of $38 million.  The RMBS portfolio is subject to interest rate risk, but unlike other fixed income securities, is additionally subject to significant prepayment risk from the underlying residential mortgage loans.  RMBS consists of a U.S. Agency portfolio having collateral issued or guaranteed by U.S. government agencies and a non-agency portfolio consisting of securities collateralized by Prime, Alt-A and Subprime loans.  The non-agency portfolio totaled $559 million as of December 31, 2013, with 20.6% rated investment grade and an unrealized net capital gain of $25 million.

 

CMBS totaled $764 million as of December 31, 2013, with 67.5% rated investment grade and an unrealized net capital gain of $40 million.  The CMBS portfolio is subject to credit risk and has a sequential paydown structure.  Of the CMBS investments, 99.4% are traditional conduit transactions collateralized by commercial mortgage loans, broadly diversified across property types and geographical area.  The remainder consists of non-traditional CMBS such as small balance transactions, large loan pools and single borrower transactions.

 

Mortgage loans Our mortgage loan portfolio totaled $4.17 billion as of December 31, 2013 and primarily comprises loans secured by first mortgages on developed commercial real estate.  Key considerations used to manage our exposure include property type and geographic diversification.  For further detail on our mortgage loan portfolio, see Note 6 of the consolidated financial statements.

 

Equity securities Equity securities primarily include common stocks, exchange traded and mutual funds, non-redeemable preferred stocks and real estate investment trust equity investments.  The equity securities portfolio was $650 million as of December 31, 2013 with an unrealized net capital gain of $85 million.

 

32



 

Limited partnership interests consist of investments in private equity/debt funds, real estate funds, tax credit funds and other funds.  The limited partnership interests portfolio is well diversified across a number of characteristics including fund managers, vintage years, strategies, geography (including international), and company/property types.  The following table presents information about our limited partnership interests as of December 31, 2013.

 

($ in millions)

 

Private
equity/debt
funds 
(1)

 

Real
estate
funds

 

Tax
credit
funds

 

Other
funds

 

Total

 

Cost method of accounting (“Cost”)

$

482

$

123

$

--

$

--

$

605

 

Equity method of accounting (“EMA”)

 

839

 

282

 

309

 

29

 

1,459

 

Total

$

1,321

$

405

$

309

$

29

$

2,064

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of managers

 

106

 

29

 

11

 

1

 

 

 

Number of individual funds

 

178

 

54

 

20

 

1

 

 

 

Largest exposure to single fund

$

64

$

35

$

26

$

29

 

 

 

 

 

(1)   Includes $273 million of infrastructure and real asset funds.

 

The following tables show the earnings from our limited partnership interests by fund type and accounting classification for the years ended December 31.

 

($ in millions)

 

2013

 

2012

 

 

 

Cost

 

EMA

 

Total
income

 

Impairment
write-downs 

 

Cost

 

EMA

 

Total
income

 

Impairment
write-downs

 

Private equity/debt funds

$

89

$

57

$

146

$

(8)

$

52

$

88

$

140

$

(1)

 

Real estate funds

 

13

 

29

 

42

 

(1)

 

3

 

31

 

34

 

(2)

 

Tax credit funds

 

--

 

(18)

 

(18)

 

--

 

--

 

(14)

 

(14)

 

--

 

Other funds

 

--

 

5

 

5

 

--

 

--

 

(1)

 

(1)

 

--

 

Total

$

102

$

73

$

175

$

(9)

$

55

$

104

$

159

$

(3)

 

 

Limited partnership interests produced income, excluding impairment write-downs, of $175 million in 2013 compared to $159 million in 2012.  Higher cost method limited partnership income resulted from an increase in earnings distributed by the partnerships.  Income on EMA limited partnerships is recognized on a delay due to the availability of the related financial statements.  The recognition of income on private equity/debt funds, real estate funds and tax credit funds are generally on a three month delay and the income recognition on other funds is primarily on a one month delay.  Income on cost method limited partnerships is recognized only upon receipt of amounts distributed by the partnerships.

 

Short-term investments Our short-term investment portfolio was $590 million as of December 31, 2013.

 

Policy loans Our policy loan balance was $623 million as of December 31, 2013.  Policy loans are carried at unpaid principal balances.

 

Other investments        Our other investments as of December 31, 2013 primarily comprise $341 million of agent loans, $160 million of bank loans, $275 million of notes due from related party and $266 million of certain derivatives.  For further detail on our use of derivatives, see Note 8 of the consolidated financial statements.

 

33



 

Unrealized net capital gains totaled $1.59 billion as of December 31, 2013 compared to $3.70 billion as of December 31, 2012.  The decline was primarily due to increasing risk-free interest rates.  The following table presents unrealized net capital gains and losses as of December 31.

 

($ in millions)

 

2013

 

2012

U.S. government and agencies

$

88

$

242

Municipal

 

169

 

551

Corporate

 

919

 

2,783

Foreign government

 

77

 

163

ABS

 

(4)

 

(56)

RMBS

 

38

 

13

CMBS

 

40

 

(17)

Redeemable preferred stock

 

2

 

3

Fixed income securities

 

1,329

 

3,682

Equity securities

 

85

 

35

Derivatives

 

(13)

 

(17)

EMA limited partnerships

 

(2)

 

1

Investments classified as held for sale

 

190

 

--

Unrealized net capital gains and losses, pre-tax

$

1,589

$

3,701

 

The unrealized net capital gain for the fixed income portfolio totaled $1.33 billion and comprised $1.75 billion of gross unrealized gains and $418 million of gross unrealized losses as of December 31, 2013.  This is compared to an unrealized net capital gain for the fixed income portfolio totaling $3.68 billion, comprised of $4.11 billion of gross unrealized gains and $426 million of gross unrealized losses as of December 31, 2012.

 

Gross unrealized gains and losses on fixed income securities by type and sector as of December 31, 2013 are provided in the following table.

 

($ in millions)

 

Amortized

 

Gross unrealized

 

Fair

 

 

 

cost

 

Gains

 

Losses

 

value

 

Corporate:

 

 

 

 

 

 

 

 

 

Utilities

$

4,810

$

387

$

(54)

$

5,143

 

Consumer goods (cyclical and non-cyclical)

 

3,862

 

195

 

(43)

 

4,014

 

Banking

 

1,105

 

46

 

(40)

 

1,111

 

Capital goods

 

2,301

 

134

 

(37)

 

2,398

 

Basic industry

 

1,332

 

51

 

(30)

 

1,353

 

Energy

 

1,793

 

107

 

(23)

 

1,877

 

Technology

 

976

 

32

 

(23)

 

985

 

Communications

 

1,424

 

78

 

(21)

 

1,481

 

Financial services

 

1,203

 

68

 

(11)

 

1,260

 

Transportation

 

1,055

 

74

 

(9)

 

1,120

 

Other

 

536

 

42

 

(4)

 

574

 

Total corporate fixed income portfolio

 

20,397

 

1,214

 

(295)

 

21,316

 

 

 

 

 

 

 

 

 

 

 

U.S. government and agencies

 

678

 

90

 

(2)

 

766

 

Municipal

 

3,135

 

231

 

(62)

 

3,304

 

Foreign government

 

715

 

83

 

(6)

 

792

 

ABS

 

1,011

 

30

 

(34)

 

1,007

 

RMBS

 

752

 

50

 

(12)

 

790

 

CMBS

 

724

 

47

 

(7)

 

764

 

Redeemable preferred stock

 

15

 

2

 

--

 

17

 

Total fixed income securities

$

27,427

$

1,747

$

(418)

$

28,756

 

 

The utilities, consumer goods and banking sectors had the highest concentration of gross unrealized losses in our corporate fixed income securities portfolio as of December 31, 2013.  In general, the gross unrealized losses are principally related to increasing risk-free interest rates or widening credit spreads since the time of initial purchase.

 

The unrealized net capital gain for the equity portfolio totaled $85 million and comprised $90 million of gross unrealized gains and $5 million of gross unrealized losses as of December 31, 2013.  This is compared to an unrealized net capital gain for the equity portfolio totaling $35 million, comprised of $36 million of gross unrealized gains and $1 million of gross unrealized losses as of December 31, 2012.

 

34



 

Net investment income  The following table presents net investment income for the years ended December 31.

 

($ in millions)

 

2013

 

2012

 

2011

 

Fixed income securities

$

1,947

$

2,084

$

2,264

 

Mortgage loans

 

345

 

345

 

345

 

Equity securities

 

12

 

9

 

7

 

Limited partnership interests (1)

 

175

 

159

 

49

 

Short-term investments

 

2

 

2

 

3

 

Policy loans

 

49

 

51

 

53

 

Other

 

63

 

61

 

18

 

Investment income, before expense

 

2,593

 

2,711

 

2,739

 

Investment expense

 

(108)

 

(114)

 

(102)

 

Net investment income

$

2,485

$

2,597

$

2,637

 

 

 

 

 

 

 

 

 

 

 

 

(1) Income from EMA limited partnerships is reported in net investment income in 2013 and 2012 and realized capital gains and losses in 2011.

 

 

Net investment income decreased 4.3% or $112 million in 2013 compared to 2012, after decreasing 1.5% or $40 million in 2012 compared to 2011.  The 2013 decrease was primarily due to lower average investment balances, partially offset by higher limited partnership income, as well as prepayment fee income and litigation proceeds which together increased 2013 income by a total of $48 million.  Higher cost method limited partnership income resulted from an increase in earnings distributed by the partnerships.  Net investment income in 2013 includes $264 million relating to investments classified as held for sale for the period from July 17, 2013 to December 31, 2013.  The 2012 decline was primarily due to lower average investment balances and lower fixed income yields, partially offset by income from limited partnerships.

 

Realized capital gains and losses  The following table presents the components of realized capital gains and losses and the related tax effect for the years ended December 31.

 

($ in millions)

 

2013

 

2012

 

2011

 

Impairment write-downs

$

(33)

$

(51)

$

(242)

 

Change in intent write-downs

 

(19)

 

(17)

 

(51)

 

Net other-than-temporary impairment losses recognized in earnings

 

(52)

 

(68)

 

(293)

 

Sales

 

114

 

17

 

823

 

Valuation of derivative instruments

 

(3)

 

(16)

 

(224)

 

Settlements of derivative instruments

 

17

 

51

 

22

 

EMA limited partnership income (1)

 

--

 

--

 

62

 

Realized capital gains and losses, pre-tax

 

76

 

(16)

 

390

 

Income tax (expense) benefit

 

(29)

 

6

 

(139)

 

Realized capital gains and losses, after-tax

$

47

$

(10)

$

251

 

 

 

 

 

 

(1) Income from EMA limited partnerships is reported in net investment income in 2013 and 2012 and realized capital gains and losses in 2011.

 

 

Impairment write-downs, which includes changes in the mortgage loan valuation allowance, for the years ended December 31 are presented in the following table.

 

($ in millions)

 

2013

 

2012

 

2011

 

 

 

 

 

 

 

 

 

Fixed income securities

$

(32)

$

(53)

$

(190)

 

Mortgage loans

 

11

 

5

 

(33)

 

Equity securities

 

--

 

--

 

(5)

 

Limited partnership interests

 

(9)

 

(3)

 

(3)

 

Other investments

 

(3)

 

--

 

(11)

 

Impairment write-downs

$

(33)

$

(51)

$

(242)

 

 

Impairment write-downs on fixed income securities in 2013 were primarily driven by CMBS that experienced deterioration in expected cash flows and limited partnership write-downs primarily related to cost method limited partnerships that experienced declines in portfolio valuations deemed to be other than temporary.  The valuation

 

35



 

allowance on mortgage loans as of December 31, 2013 decreased compared to December 31, 2012 primarily due to reversals related to loans no longer deemed impaired.

 

Impairment write-downs on fixed income securities in 2012 were primarily driven by RMBS and CMBS that experienced deterioration in expected cash flows and corporate fixed income securities impacted by issuer specific circumstances.

 

Impairment write-downs in 2011 were primarily driven by RMBS, which experienced deterioration in expected cash flows; investments with commercial real estate exposure, including CMBS, mortgage loans and municipal bonds, which were impacted by lower real estate valuations or experienced deterioration in expected cash flows; and corporate fixed income securities impacted by issuer specific circumstances.

 

Change in intent write-downs were $19 million, $17 million and $51 million in 2013, 2012 and 2011, respectively.  The change in intent write-downs in 2013 were primarily a result of plans to reduce holdings of ARS backed by student loans, plans to sell certain CMBS securities, and ongoing portfolio management of our equity securities.  The change in intent write-downs in 2012 were primarily a result of ongoing comprehensive reviews of our portfolio resulting in write-downs of individually identified investments, primarily RMBS and corporate fixed income securities.  The change in intent write-downs in 2011 were primarily a result of ongoing comprehensive reviews of our portfolio resulting in write-downs of individually identified investments, primarily lower yielding, floating rate RMBS and municipal bonds.

 

Sales generated $114 million, $17 million and $823 million of net realized capital gains in 2013, 2012 and 2011, respectively.  The sales in 2013 primarily related to fixed income and equity securities in connection with portfolio repositioning and ongoing portfolio management.   The sales in 2012 primarily related to corporate, ABS and U.S. government and agencies fixed income securities in connection with portfolio repositioning, which were partially offset by losses on sales of CMBS, Subprime RMBS and CLOs in connection with risk reduction activities.  The sales in 2011 were primarily due to $779 million of net gains on sales of corporate, foreign government, U.S. government and ABS securities.

 

Valuation and settlements of derivative instruments generated net realized capital gains of $14 million in 2013, net realized capital gains of $35 million in 2012 and net realized capital losses of $202 million in 2011.  The net realized capital gains on derivative instruments in 2013 and 2012 primarily comprised gains on credit default swaps due to the tightening of credit spreads on the underlying credit names.  The net realized capital losses on derivative instruments in 2011 primarily included losses on interest rate risk management due to decreases in interest rates.

 

MARKET RISK

 

Market risk is the risk that we will incur losses due to adverse changes in interest rates, credit spreads, equity prices or currency exchange rates.  Adverse changes to these rates and prices may occur due to changes in fiscal policy, the economic climate, the liquidity of a market or market segment, insolvency or financial distress of key market makers or participants or changes in market perceptions of credit worthiness and/or risk tolerance.  Our primary market risk exposures are to changes in interest rates, credit spreads and equity prices.

 

The active management of market risk is integral to our results of operations.  We may use the following approaches to manage exposure to market risk within defined tolerance ranges:  1) rebalancing existing asset or liability portfolios, 2) changing the type of investments purchased in the future and 3) using derivative instruments to modify the market risk characteristics of existing assets and liabilities or assets expected to be purchased.  For a more detailed discussion of our use of derivative financial instruments, see Note 8 of the consolidated financial statements.

 

Overview  In formulating and implementing guidelines for investing funds, we seek to earn returns that enhance our ability to offer competitive rates and prices to customers while contributing to attractive and stable profits and long-term capital growth.  Accordingly, our investment decisions and objectives are a function of the underlying risks and product profiles.

 

Investment policies define the overall framework for managing market and other investment risks, including accountability and controls over risk management activities.  These investment policies, which have been approved by our board of directors, specify the investment limits and strategies that are appropriate given our liquidity, surplus, product profile and regulatory requirements.  Executive oversight of investment activities is conducted primarily through our board of directors and investment committee.  Asset-liability management (“ALM”) policies further define the overall framework for managing market and investment risks.  ALM focuses on strategies to

 

36



 

enhance yields, mitigate market risks and optimize capital to improve profitability and returns while factoring in future expected cash requirements to repay liabilities.  ALM activities follow asset-liability policies that have been approved by our board of directors.  These ALM policies specify limits, ranges and/or targets for investments that best meet our business objectives in light of our product liabilities.

 

We use quantitative and qualitative market-based approaches to measure, monitor and manage market risk.  We evaluate our exposure to market risk through the use of multiple measures including but not limited to duration, value-at-risk, scenario analysis and sensitivity analysis.  Duration measures the price sensitivity of assets and liabilities to changes in interest rates.  For example, if interest rates increase 100 basis points, the fair value of an asset with a duration of 5 is expected to decrease in value by 5%.  Value-at-risk is a statistical estimate of the probability that the change in fair value of a portfolio will exceed a certain amount over a given time horizon.  Scenario analysis estimates the potential changes in the fair value of a portfolio that could occur under different hypothetical market conditions defined by changes to multiple market risk factors: interest rates, credit spreads, equity prices or currency exchange rates.  Sensitivity analysis estimates the potential changes in the fair value of a portfolio that could occur under different hypothetical shocks to a market risk factor.  In general, we establish investment portfolio asset allocation and market risk limits based upon a combination of duration, value-at-risk, scenario analysis and sensitivity analysis.  The asset allocation limits place restrictions on the total funds that may be invested within an asset class.  Comprehensive day-to-day management of market risk within defined tolerance ranges occurs as portfolio managers buy and sell within their respective markets based upon the acceptable boundaries established by investment policies.  This day-to-day management is integrated with and informed by the activities of the ALM organization.  This integration is intended to result in a prudent, methodical and effective adjudication of market risk and return, conditioned by the unique demands and dynamics of our product liabilities and supported by the continuous application of advanced risk technology and analytics.

 

Interest rate risk is the risk that we will incur a loss due to adverse changes in interest rates relative to the characteristics of our interest bearing assets and liabilities.  This risk arises from many of our primary activities, as we invest substantial funds in interest-sensitive assets and issue interest-sensitive liabilities.  Interest rate risk includes risks related to changes in U.S. Treasury yields and other key risk-free reference yields.

 

We manage the interest rate risk in our assets relative to the interest rate risk in our liabilities.  One of the measures used to quantify this exposure is duration.  The difference in the duration of our assets relative to our liabilities is our duration gap.  To calculate the duration gap between assets and liabilities, we project asset and liability cash flows and calculate their net present value using a risk-free market interest rate adjusted for credit quality, sector attributes, liquidity and other specific risks.  Duration is calculated by revaluing these cash flows at alternative interest rates and determining the percentage change in aggregate fair value.  The cash flows used in this calculation include the expected maturity and repricing characteristics of our derivative financial instruments, all other financial instruments, and certain other items including annuity liabilities and other interest-sensitive liabilities.  The projections include assumptions (based upon historical market experience and our experience) that reflect the effect of changing interest rates on the prepayment, lapse, leverage and/or option features of instruments, where applicable.  The preceding assumptions relate primarily to mortgage-backed securities, municipal housing bonds, callable municipal and corporate obligations, and fixed rate single and flexible premium deferred annuities.

 

As of December 31, 2013, the difference between our asset and liability duration was a (0.93) gap compared to a (1.19) gap as of December 31, 2012.  A negative duration gap indicates that the fair value of our liabilities is more sensitive to interest rate movements than the fair value of our assets.

 

We seek to invest premiums, contract charges and deposits to generate future cash flows that will fund future claims, benefits and expenses, and that will earn stable returns across a wide variety of interest rate and economic scenarios.  To achieve this objective and limit interest rate risk, we adhere to a philosophy of managing the duration of assets and related liabilities within predetermined tolerance levels.  This philosophy is executed using duration targets for fixed income investments in addition to interest rate swaps, futures, forwards, caps, floors and swaptions to reduce the interest rate risk resulting from mismatches between existing assets and liabilities, and financial futures and other derivative instruments to hedge the interest rate risk of anticipated purchases and sales of investments and product sales to customers.

 

Based upon the information and assumptions used in the duration calculation, and interest rates in effect as of December 31, 2013, we estimate that a 100 basis point immediate, parallel increase in interest rates (“rate shock”) would increase the net fair value of the assets and liabilities by $316 million, compared to an increase of $495 million as of December 31, 2012, reflecting year to year changes in duration.  The selection of a 100 basis point

 

37



 

immediate, parallel change in interest rates should not be construed as our prediction of future market events, but only as an illustration of the potential effect of such an event.  The estimate excludes the traditional and interest-sensitive life insurance products that are not considered financial instruments and the $12.11 billion of assets supporting them and the associated liabilities.  The $12.11 billion of assets excluded from the calculation increased from $10.99 billion as of December 31, 2012.  Based on assumptions described above, in the event of a 100 basis point immediate increase in interest rates, the assets supporting life insurance products would decrease in value by $705 million, compared to a decrease of $689 million as of December 31, 2012.

 

To the extent that conditions differ from the assumptions we used in these calculations, duration and rate shock measures could be significantly impacted.  Additionally, our calculations assume that the current relationship between short-term and long-term interest rates (the term structure of interest rates) will remain constant over time.  As a result, these calculations may not fully capture the effect of non-parallel changes in the term structure of interest rates and/or large changes in interest rates.

 

Credit spread risk is the risk that we will incur a loss due to adverse changes in credit spreads (“spreads”).  This risk arises from many of our primary activities, as we invest substantial funds in spread-sensitive fixed income assets.

 

We manage the spread risk in our assets.  One of the measures used to quantify this exposure is spread duration.  Spread duration measures the price sensitivity of the assets to changes in spreads.  For example, if spreads increase 100 basis points, the fair value of an asset exhibiting a spread duration of 5 is expected to decrease in value by 5%.

 

Spread duration is calculated similarly to interest rate duration.  As of December 31, 2013, the spread duration of assets was 5.36, compared to 5.49 as of December 31, 2012.  Based upon the information and assumptions we use in this spread duration calculation, and spreads in effect as of December 31, 2013, we estimate that a 100 basis point immediate, parallel increase in spreads across all asset classes, industry sectors and credit ratings (“spread shock”) would decrease the net fair value of the assets by $2.41 billion compared to $2.75 billion as of December 31, 2012.  Reflected in the duration calculation are the effects of our tactical actions that use credit default swaps to manage spread risk.  The selection of a 100 basis point immediate parallel change in spreads should not be construed as our prediction of future market events, but only as an illustration of the potential effect of such an event.

 

Equity price risk is the risk that we will incur losses due to adverse changes in the general levels of the equity markets.  As of December 31, 2013, we held $2.71 billion in securities with equity risk (including primarily equity securities, limited partnership interests, non-redeemable preferred securities and equity-linked notes), compared to $2.27 billion as of December 31, 2012.

 

As of December 31, 2013, our portfolio of securities with equity risk had a cash market portfolio beta of 1.14, compared to a beta of 0.78 as of December 31, 2012.  Beta represents a widely used methodology to describe, quantitatively, an investment’s market risk characteristics relative to an index such as the Standard & Poor’s 500 Composite Price Index (“S&P 500”).  Based on the beta analysis, we estimate that if the S&P 500 increases or decreases by 10%, the fair value of our equity investments will increase or decrease by 11.4%, respectively.  Based upon the information and assumptions we used to calculate beta as of December 31, 2013, we estimate that an immediate decrease in the S&P 500 of 10% would decrease the net fair value of our equity investments by $309 million, compared to $177 million as of December 31, 2012, and an immediate increase in the S&P 500 of 10% would increase the net fair value by $309 million compared to $177 million as of December 31, 2012.  The selection of a 10% immediate decrease or increase in the S&P 500 should not be construed as our prediction of future market events, but only as an illustration of the potential effect of such an event.

 

The beta of our securities with equity risk was determined by calculating the change in the fair value of the portfolio resulting from stressing the equity market up and down 10%.  The illustrations noted above may not reflect our actual experience if the future composition of the portfolio (hence its beta) and correlation relationships differ from the historical relationships.

 

As of December 31, 2013 and 2012, we had separate accounts assets, including those classified as held for sale, related to variable annuity and variable life contracts with account values totaling $6.74 billion and $6.61 billion, respectively.  Equity risk exists for contract charges based on separate account balances and guarantees for death and/or income benefits provided by our variable products.  In 2006, we disposed of substantially all of the variable annuity business through reinsurance agreements with The Prudential Insurance Company of America, a subsidiary of Prudential Financial Inc. and therefore mitigated this aspect of our risk.  Equity risk for our variable life business relates to contract charges and policyholder benefits.  Total variable life contract charges for 2013 and 2012 were

 

38



 

$67 million and $71 million, respectively.  Separate account liabilities related to variable life contracts were $900 million and $767 million as of December 31, 2013 and 2012, respectively.

 

As of December 31, 2013 and 2012 we had $3.71 billion and $3.63 billion, respectively, in equity-indexed annuity liabilities that provide customers with interest crediting rates based on the performance of the S&P 500.  We hedge the majority of the risk associated with these liabilities using equity-indexed options and futures and eurodollar futures, maintaining risk within specified value-at-risk limits.  $2.26 billion of the December 31, 2013 balance are a component of the pending LBL sale.

 

Foreign currency exchange rate risk is the risk that we will incur economic losses due to adverse changes in foreign currency exchange rates.  This risk primarily arises from our foreign investments in limited partnership interests.  We also have investments in certain fixed income securities that are denominated in foreign currencies; however, derivatives are used to hedge approximately 100% of this foreign currency risk.  As of December 31, 2013, we had $226 million in foreign currency denominated investments, compared to $187 million as of December 31, 2012.

 

Based upon the information and assumptions used as of December 31, 2013, we estimate that a 10% immediate unfavorable change in each of the foreign currency exchange rates to which we are exposed would decrease the value of our foreign currency denominated instruments by $23 million, compared with an estimated $19 million decrease as of December 31, 2012.  The selection of a 10% immediate decrease in all currency exchange rates should not be construed as our prediction of future market events, but only as an illustration of the potential effect of such an event.

 

The modeling technique we use to report our currency exposure does not take into account correlation among foreign currency exchange rates.  Even though we believe it is very unlikely that all of the foreign currency exchange rates that we are exposed to would simultaneously decrease by 10%, we nonetheless stress test our portfolio under this and other hypothetical extreme adverse market scenarios.  Our actual experience may differ from these results because of assumptions we have used or because significant liquidity and market events could occur that we did not foresee.

 

CAPITAL RESOURCES AND LIQUIDITY

 

Capital resources consist of shareholder’s equity and notes due to related parties, representing funds deployed or available to be deployed to support business operations.  The following table summarizes our capital resources as of December 31.

 

($ in millions)

 

2013

 

2012

 

2011

 

Common stock, retained income and additional capital paid-in

$

5,142

$

5,680

$

5,255

 

Accumulated other comprehensive income

 

928

 

1,633

 

812

 

Total shareholder’s equity

 

6,070

 

7,313

 

6,067

 

Notes due to related parties

 

282

 

496

 

700

 

Total capital resources

$

6,352

$

7,809

$

6,767

 

 

Shareholder’s equity decreased in 2013, primarily due to decreased unrealized net capital gains on investments, the $500 million return of capital to AIC, and the net loss.  Shareholder’s equity increased in 2012, primarily due to increased unrealized net capital gains on investments and net income.

 

Notes due to related parties decreased $214 million and $204 million in 2013 and 2012, respectively.  In both 2013 and 2012, the Company repaid $200 million of the surplus note issued to AIC.  See Note 5 of the consolidated financial statements for further detail.

 

Financial ratings and strength The following table summarizes our financial strength ratings as of December 31, 2013.

 

Rating agency

 

Rating

A.M. Best Company, Inc.

 

A+ (“Superior”)

Standard & Poor’s Ratings Services

 

A+ (“Strong”)

Moody’s Investors Service, Inc.

 

A1 (“Good”)

 

39



 

Our ratings are influenced by many factors including our operating and financial performance, asset quality, liquidity, asset/liability management, overall portfolio mix, financial leverage (i.e., debt), exposure to risks, the current level of operating leverage and AIC’s ratings.

 

In January 2014, A.M. Best affirmed our financial strength rating of A+ and the outlook for the rating remained stable.  In April 2013, Moody’s affirmed our financial strength rating of A1 and the outlook for the rating was revised to stable from negative.  In May 2013, S&P affirmed our financial strength rating of A+ and the outlook for the rating was revised to stable from negative.  In the future, if our financial position is less than rating agency expectations including those related to capitalization at the parent company, AIC or the Company, we could be exposed to a downgrade in our ratings which we do not view as being material to our business model or strategies.

 

Subsequent to the announcement of the pending sale of LBL, the rating agencies initiated reviews of LBL’s ratings and outlook.  Moody’s downgraded LBL from A1 to Baa1 and revised the rating outlook from stable to negative.  Both the rating and outlook will be finalized after the transaction closes.  S&P downgraded LBL from A+ to BBB+ and placed LBL on CreditWatch negative.  Both the rating and CreditWatch will be finalized after the transaction closes.  A.M. Best placed LBL’s rating under review with negative implications, pending a final determination on both the rating and outlook after the transaction closes.  The Moody’s, S&P and A.M. Best ratings and outlook of the Company are unaffected by the sale of LBL.

 

The Company, AIC and the Corporation are party to the Amended and Restated Intercompany Liquidity Agreement (“Liquidity Agreement”) which allows for short-term advances of funds to be made between parties for liquidity and other general corporate purposes.  The Liquidity Agreement does not establish a commitment to advance funds on the part of any party.  The Company and AIC each serve as a lender and borrower and the Corporation serves only as a lender.  The Company also has a capital support agreement with AIC.  Under the capital support agreement, AIC is committed to provide capital to the Company to maintain an adequate capital level.  The maximum amount of potential funding under each of these agreements is $1.00 billion.

 

In addition to the Liquidity Agreement, the Company also has an intercompany loan agreement with the Corporation.  The amount of intercompany loans available to the Company is at the discretion of the Corporation.  The maximum amount of loans the Corporation will have outstanding to all its eligible subsidiaries at any given point in time is limited to $1.00 billion.  The Corporation may use commercial paper borrowings, bank lines of credit and securities lending to fund intercompany borrowings.

 

ALIC and its life insurance subsidiaries prepare their statutory-basis financial statements in conformity with accounting practices prescribed or permitted by the insurance department of the applicable state of domicile.  Statutory surplus is a measure that is often used as a basis for determining dividend paying capacity, operating leverage and premium growth capacity, and it is also reviewed by rating agencies in determining their ratings.  As of December 31, 2013, ALIC’s statutory surplus is $2.88 billion compared to $3.38 billion as of December 31, 2012.

 

The National Association of Insurance Commissioners (“NAIC”) has developed a set of financial relationships or tests known as the Insurance Regulatory Information System to assist state regulators in monitoring the financial condition of insurance companies and identifying companies that require special attention or actions by insurance regulatory authorities.  The NAIC analyzes financial data provided by insurance companies using prescribed ratios, each with defined “usual ranges”.  Generally, regulators will begin to monitor an insurance company if its ratios fall outside the usual ranges for four or more of the ratios.  If an insurance company has insufficient capital, regulators may act to reduce the amount of insurance it can issue.  The ratios of our insurance companies are within these ranges.

 

Liquidity sources and uses  Our potential sources of funds principally include the following.

 

·                  Receipt of insurance premiums

·                  Contractholder fund deposits

·                  Reinsurance recoveries

·                  Receipts of principal, interest and dividends on investments

·                  Sales of investments

·                  Funds from securities lending and line of credit agreements

·                  Intercompany loans

·                  Capital contributions from parent

·                  Tax refunds/settlements

 

40



 

Our potential uses of funds principally include the following.

 

·                  Payment of contract benefits, maturities, surrenders and withdrawals

·                  Reinsurance cessions and payments

·                  Operating costs and expenses

·                  Purchase of investments

·                  Repayment of securities lending and line of credit agreements

·                  Payment or repayment of intercompany loans

·                  Dividends and return of capital to parent

·                  Tax payments/settlements

·                  Debt service expenses and repayment

 

We actively manage our financial position and liquidity levels in light of changing market, economic, and business conditions.  Liquidity is managed at both the entity and enterprise level across the Company, and is assessed on both base and stressed level liquidity needs.  We believe we have sufficient liquidity to meet these needs.  Additionally, we have existing intercompany agreements in place that facilitate liquidity management across the Company to enhance flexibility.

 

Allstate parent company capital capacity  The Corporation has at the parent holding company level deployable assets totaling $2.56 billion as of December 31, 2013 comprising cash and investments that are generally saleable within one quarter.  This provides funds for the parent company’s fixed charges and other corporate purposes.

 

We paid a $500 million return of capital to AIC in 2013. We did not receive any capital contributions in 2013, 2012 or 2011.

 

The sale of LBL is expected to generate deployable capital of approximately $1 billion.  As allowed by regulatory authorities and subject to dividend limitations and approvals the capital may be returned to AIC.  The $1 billion includes the estimated gain on the sale on a statutory-basis of accounting in the range of approximately $350 million to $400 million and the release of risk-based capital.  During 2014, ALIC will not be able to pay dividends to AIC without prior Illinois Department of Insurance approval.

 

The Company has access to additional borrowing to support liquidity through the Corporation as follows.  The amount available to the Company is at the discretion of the Corporation.

 

·               A commercial paper facility with a borrowing limit of $1.00 billion to cover short-term cash needs.  As of December 31, 2013, there were no balances outstanding and therefore the remaining borrowing capacity was $1.00 billion; however, the outstanding balance can fluctuate daily.

·                  A $1.00 billion unsecured revolving credit facility is available for short-term liquidity requirements and backs the commercial paper facility.  The Corporation has the option to extend the expiration of its initial five year term by one year at the first and second anniversary of the facility, upon approval of existing or replacement lenders.  In April 2013, the Corporation utilized the option on the first anniversary of the facility and extended the facility by one year making its current expiration April 2018.  The facility is fully subscribed among 12 lenders with the largest commitment being $115 million.  The commitments of the lenders are several and no lender is responsible for any other lender’s commitment if such lender fails to make a loan under the facility.  This facility contains an increase provision that would allow up to an additional $500 million of borrowing.  This facility has a financial covenant requiring that the Corporation not exceed a 37.5% debt to capitalization ratio as defined in the agreement.  This ratio was 15.5% as of December 31, 2013.  Although the right to borrow under the facility is not subject to a minimum rating requirement, the costs of maintaining the facility and borrowing under it are based on the ratings of the Corporation’s senior unsecured, unguaranteed long-term debt.  There were no borrowings under the credit facility during 2013.  The total amount outstanding at any point in time under the combination of the commercial paper program and the credit facility cannot exceed the amount that can be borrowed under the credit facility.

·                  A universal shelf registration statement was filed by the Corporation with the Securities and Exchange Commission on April 30, 2012.  The Corporation can use this shelf registration to issue an unspecified amount of debt securities, common stock (including 451 million shares of treasury stock as of December 31, 2013), preferred stock, depositary shares, warrants, stock purchase contracts, stock purchase units and securities of trust subsidiaries.  The specific terms of any securities the Corporation issues under this registration statement will be provided in the applicable prospectus supplements.

 

41



 

Liquidity exposure  Contractholder funds were $23.60 billion as of December 31, 2013.  The following table summarizes contractholder funds by their contractual withdrawal provisions as of December 31, 2013.

 

($ in millions) 

 

 

 

Percent
to total

 

Not subject to discretionary withdrawal

3,793

 

16.1

%

 

Subject to discretionary withdrawal with adjustments:

 

 

 

 

 

 

Specified surrender charges (1)

 

6,837

 

13.7

 

 

Market value adjustments (2)

 

3,247

 

29.0

 

 

Subject to discretionary withdrawal without adjustments (3)

 

9,727

 

41.2

 

 

Total contractholder funds (4)

23,604

 

100.0

%

 

 

 

 

 

 

(1)     Includes $3.29 billion of liabilities with a contractual surrender charge of less than 5% of the account balance.

 

 

(2)     $2.45 billion of the contracts with market value adjusted surrenders have a 30-45 day period at the end of their initial and subsequent interest rate guarantee periods (which are typically 5, 6, 7 or 10 years) during which there is no surrender charge or market value adjustment.

 

 

(3)     78% of these contracts have a minimum interest crediting rate guarantee of 3% or higher.

 

 

(4)     Includes $911 million of contractholder funds on variable annuities reinsured to The Prudential Insurance Company of America, a subsidiary of Prudential Financial Inc., in 2006.

 

 

Retail life and annuity products may be surrendered by customers for a variety of reasons.  Reasons unique to individual customers include a current or unexpected need for cash or a change in life insurance coverage needs.  Other key factors that may impact the likelihood of customer surrender include the level of the contract surrender charge, the length of time the contract has been in force, distribution channel, market interest rates, equity market conditions and potential tax implications.  In addition, the propensity for retail life insurance policies to lapse is lower than it is for fixed annuities because of the need for the insured to be re-underwritten upon policy replacement.  Surrenders and partial withdrawals for our retail annuities decreased 20.0% in 2013 compared to 2012.  The surrender and partial withdrawal rate on deferred fixed annuities and interest-sensitive life insurance products, based on the beginning of year contractholder funds, was 10.4% and 11.5% in 2013 and 2012, respectively.  We strive to promptly pay customers who request cash surrenders; however, statutory regulations generally provide up to six months in most states to fulfill surrender requests.

 

Our asset-liability management practices enable us to manage the differences between the cash flows generated by our investment portfolio and the expected cash flow requirements of our life insurance and annuity product obligations.

 

Certain remote events and circumstances could constrain our, the Corporation’s or AIC’s liquidity.  Those events and circumstances include, for example, a catastrophe resulting in extraordinary losses, a downgrade in the Corporation’s senior long-term debt rating of A3, A- and a- (from Moody’s, S&P and A.M. Best, respectively) to non-investment grade status of below Baa3/BBB-/bb, a downgrade in AIC’s financial strength rating from Aa3, AA- and A+ (from Moody’s, S&P and A.M. Best, respectively) to below Baa2/BBB/A-, or a downgrade in our financial strength ratings from A1, A+ and A+ (from Moody’s, S&P and A.M. Best, respectively) to below A3/A-/A-.  The rating agencies also consider the interdependence of our individually rated entities; therefore, a rating change in one entity could potentially affect the ratings of other related entities.

 

Cash flows  As reflected in our Consolidated Statements of Cash Flows, lower cash provided by operating cash flows in 2013 compared to 2012 was primarily due to lower net investment income, partially offset by lower contract benefits paid.  Higher cash provided by operating cash flows in 2012 compared to 2011 was primarily due to income tax refunds in 2012 compared to income tax payments in 2011, partially offset by lower net investment income.

 

Higher cash provided by investing activities in 2013 compared to 2012 was due to higher investment collections and higher financing needs to fund institutional product maturities.  Lower cash provided by investing activities in 2012 compared to 2011 was primarily due to lower financing needs as reflected in lower sales of fixed income securities, partially offset by decreased purchases of fixed income securities.

 

Higher cash used in financing activities in 2013 compared to 2012 was primarily due to a $1.75 billion institutional product maturity.  Lower cash used in financing activities in 2012 compared to 2011 was primarily due to decreased maturities of institutional products and lower surrenders and partial withdrawals on fixed annuities.

 

42



 

Contractual obligations and commitments  Our contractual obligations as of December 31, 2013 and the payments due by period are shown in the following table.

 

($ in millions)

 

Total

 

 

Less than
1 year

 

 

1-3 years

 

 

4-5 years

 

 

Over
5 years

 

 

Liabilities for collateral (1)

328

 

328

 

--

 

--

 

--

 

 

Contractholder funds (2) 

 

52,503

 

 

5,177

 

 

8,444

 

 

7,063

 

 

31,819

 

 

Reserve for life-contingent contract benefits (2)

 

33,677

 

 

981

 

 

1,943

 

 

1,898

 

 

28,855

 

 

Notes due to related parties (3)

 

630

 

 

17

 

 

32

 

 

38

 

 

543

 

 

Payable to affiliates, net

 

100

 

 

100

 

 

--

 

 

--

 

 

--

 

 

Other liabilities and accrued expenses (4)(5)

 

338

 

 

243

 

 

57

 

 

24

 

 

14

 

 

Total contractual cash obligations

87,576

 

6,846

 

10,476

 

9,023

 

61,231

 

 

 

 

 

(1)     Liabilities for collateral are typically fully secured with cash or short-term investments.  We manage our short-term liquidity position to ensure the availability of a sufficient amount of liquid assets to extinguish short-term liabilities as they come due in the normal course of business, including utilizing potential sources of liquidity as disclosed previously.

(2)     Contractholder funds represent interest-bearing liabilities arising from the sale of products such as interest-sensitive life, fixed annuities, including immediate annuities without life contingencies, and institutional products.  The reserve for life-contingent contract benefits relates primarily to traditional life insurance, immediate annuities with life contingencies and voluntary accident and health insurance.  These amounts reflect the present value of estimated cash payments to be made to contractholders and policyholders.  Certain of these contracts, such as immediate annuities without life contingencies and institutional products, involve payment obligations where the amount and timing of the payment is essentially fixed and determinable.  These amounts relate to (i) policies or contracts where we are currently making payments and will continue to do so and (ii) contracts where the timing of a portion or all of the payments has been determined by the contract.  Other contracts, such as interest-sensitive life, fixed deferred annuities, traditional life insurance, immediate annuities with life contingencies and voluntary accident and health insurance, involve payment obligations where a portion or all of the amount and timing of future payments is uncertain.  For these contracts, we are not currently making payments and will not make payments until (i) the occurrence of an insurable event such as death or illness or (ii) the occurrence of a payment triggering event such as the surrender or partial withdrawal on a policy or deposit contract, which is outside of our control.  We have estimated the timing of payments related to these contracts based on historical experience and our expectation of future payment patterns.  Uncertainties relating to these liabilities include mortality, morbidity, expenses, customer lapse and withdrawal activity, estimated additional deposits for interest-sensitive life contracts, and renewal premium for life policies, which may significantly impact both the timing and amount of future payments.  Such cash outflows reflect adjustments for the estimated timing of mortality, retirement, and other appropriate factors, but are undiscounted with respect to interest.  As a result, the sum of the cash outflows shown for all years in the table exceeds the corresponding liabilities of $34.55 billion for contractholder funds and $13.48 billion for reserve for life-contingent contract benefits as included in the Consolidated Statements of Financial Position as of December 31, 2013, including those classified as held for sale.  The liability amount in the Consolidated Statements of Financial Position reflects the discounting for interest as well as adjustments for the timing of other factors as described above.

(3)     Amount differs from the balance presented on the Consolidated Statements of Financial Position as of December 31, 2013 because the notes due to related parties amount above includes interest.

(4)     Other liabilities primarily include accrued expenses, claim payments and other checks outstanding.

(5)     Balance sheet liabilities not included in the table above include unearned and advance premiums of $14 million and gross deferred tax liabilities of $1.34 billion.  These items were excluded as they do not meet the definition of a contractual liability as we are not contractually obligated to pay these amounts to third parties.  Rather, they represent an accounting mechanism that allows us to present our financial statements on an accrual basis.  In addition, other liabilities of $216 million were not included in the table above because they did not represent a contractual obligation or the amount and timing of their eventual payment was sufficiently uncertain.

 

Our contractual commitments as of December 31, 2013 and the periods in which the commitments expire are shown in the following table.

 

($ in millions)

 

Total

 

Less than
1 year

 

1-3
years

 

4-5
years

 

Over 5
years

 

Other commitments - conditional

32

32

--

--

--

 

Other commitments - unconditional

 

1,366

 

16

 

93

 

135

 

1,122

 

Total commitments

1,398

48

93

135

1,122

 

 

Contractual commitments represent investment commitments such as private placements, limited partnership interests and other loans.  Limited partnership interests are typically funded over the commitment period which is shorter than the contractual expiration date of the partnership and as a result, the actual timing of the funding may vary.

 

We have agreements in place for services we conduct, generally at cost, between subsidiaries relating to insurance, reinsurance, loans and capitalization.  All material intercompany transactions have appropriately been eliminated in consolidation.  Intercompany transactions among insurance subsidiaries and affiliates have been approved by the appropriate departments of insurance as required.

 

43



 

For a more detailed discussion of our off-balance sheet arrangements, see Note 8 of the consolidated financial statements.

 

REGULATION AND LEGAL PROCEEDINGS

 

We are subject to extensive regulation and we are involved in various legal and regulatory actions, all of which have an effect on specific aspects of our business.  For a detailed discussion of the legal and regulatory actions in which we are involved, see Note 12 of the consolidated financial statements.

 

PENDING ACCOUNTING STANDARDS

 

There are several pending accounting standards that we have not implemented because the implementation date has not yet occurred.  For a discussion of these pending standards, see Note 2 of the consolidated financial statements.

 

The effect of implementing certain accounting standards on our financial results and financial condition is often based in part on market conditions at the time of implementation of the standard and other factors we are unable to determine prior to implementation.  For this reason, we are sometimes unable to estimate the effect of certain pending accounting standards until the relevant authoritative body finalizes these standards or until we implement them.

 

Item 7A.  Quantitative and Qualitative Disclosures About Market Risk

 

Information required for Item 7A is incorporated by reference to the material under the caption “Market Risk” in Part II, Item 7 of this report.

 

44



 

Item 8. Financial Statements and Supplementary Data

 

ALLSTATE LIFE INSURANCE COMPANY AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

 

($ in millions)

 

Year Ended December 31,

 

 

 

2013

 

2012

 

2011

 

 

 

 

 

 

 

 

 

Revenues

 

 

 

 

 

 

 

Premiums (net of reinsurance ceded of $367, $402 and $447)

$

613

$

593

$

624

 

Contract charges (net of reinsurance ceded of $251, $252 and $283)

 

1,054

 

1,029

 

1,008

 

Net investment income

 

2,485

 

2,597

 

2,637

 

Realized capital gains and losses:

 

 

 

 

 

 

 

Total other-than-temporary impairment losses

 

(49)

 

(60)

 

(279)

 

Portion of loss recognized in other comprehensive income

 

(3)

 

(8)

 

(14)

 

Net other-than-temporary impairment losses recognized in earnings

 

(52)

 

(68)

 

(293)

 

Sales and other realized capital gains and losses

 

128

 

52

 

683

 

Total realized capital gains and losses

 

76

 

(16)

 

390

 

 

 

4,228

 

4,203

 

4,659

 

Costs and expenses

 

 

 

 

 

 

 

Contract benefits (net of reinsurance ceded of $331, $644 and $631)

 

1,606

 

1,521

 

1,502

 

Interest credited to contractholder funds (net of reinsurance ceded of $27, $28 and $27)

 

1,251

 

1,289

 

1,608

 

Amortization of deferred policy acquisition costs

 

240

 

324

 

430

 

Operating costs and expenses

 

434

 

437

 

394

 

Restructuring and related charges

 

6

 

--

 

1

 

Interest expense

 

23

 

45

 

45

 

 

 

3,560

 

3,616

 

3,980

 

 

 

 

 

 

 

 

 

(Loss) gain on disposition of operations

 

(687)

 

18

 

15

 

 

 

 

 

 

 

 

 

(Loss) income from operations before income tax expense

 

(19)

 

605

 

694

 

 

 

 

 

 

 

 

 

Income tax expense

 

19

 

179

 

225

 

 

 

 

 

 

 

 

 

Net (loss) income

 

(38)

 

426

 

469

 

 

 

 

 

 

 

 

 

Other comprehensive (loss) income, after-tax

 

 

 

 

 

 

 

Change in unrealized net capital gains and losses

 

(707)

 

821

 

275

 

Change in unrealized foreign currency translation adjustments

 

2

 

--

 

(1)

 

Other comprehensive (loss) income, after-tax

 

(705)

 

821

 

274

 

 

 

 

 

 

 

 

 

Comprehensive (loss) income

$

(743)

$

1,247

$

743

 

 

See notes to consolidated financial statements.

45



 

ALLSTATE LIFE INSURANCE COMPANY AND SUBSIDIARES

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

 

($ in millions, except par value data) 

 

December 31,

 

 

 

2013

 

2012

 

Assets

 

 

 

 

 

Investments

 

 

 

 

 

Fixed income securities, at fair value (amortized cost $27,427 and $41,194)

$

28,756

$

44,876

 

Mortgage loans

 

4,173

 

5,943

 

Equity securities, at fair value (cost $565 and $310)

 

650

 

345

 

Limited partnership interests

 

2,064

 

1,924

 

Short-term, at fair value (amortized cost $590 and $875)

 

590

 

875

 

Policy loans

 

623

 

836

 

Other

 

1,088

 

1,067

 

Total investments

 

37,944

 

55,866

 

Cash

 

93

 

341

 

Deferred policy acquisition costs

 

1,331

 

1,834

 

Reinsurance recoverables

 

2,754

 

4,570

 

Accrued investment income

 

358

 

489

 

Other assets

 

256

 

401

 

Separate Accounts

 

5,039

 

6,610

 

Assets held for sale

 

15,593

 

--

 

Total assets

$

63,368

$

70,111

 

Liabilities

 

 

 

 

 

Contractholder funds

$

23,604

$

38,634

 

Reserve for life-contingent contract benefits

 

11,589

 

14,117

 

Unearned premiums

 

6

 

20

 

Payable to affiliates, net

 

100

 

111

 

Other liabilities and accrued expenses

 

838

 

1,286

 

Deferred income taxes

 

941

 

1,524

 

Notes due to related parties

 

282

 

496

 

Separate Accounts

 

5,039

 

6,610

 

Liabilities held for sale

 

14,899

 

--

 

Total liabilities

 

57,298

 

62,798

 

Commitments and Contingent Liabilities (Notes 8 and 12)

 

 

 

 

 

Shareholder’s Equity

 

 

 

 

 

Redeemable preferred stock - series A, $100 par value, 1,500,000 shares authorized, none issued

 

--

 

--

 

Redeemable preferred stock - series B, $100 par value, 1,500,000 shares authorized, none issued

 

--

 

--

 

Common stock, $227 par value, 23,800 shares authorized and outstanding

 

5

 

5

 

Additional capital paid-in

 

2,690

 

3,190

 

Retained income

 

2,447

 

2,485

 

Accumulated other comprehensive income:

 

 

 

 

 

Unrealized net capital gains and losses:

 

 

 

 

 

Unrealized net capital gains and losses on fixed income securities with OTTI

 

31

 

(5)

 

Other unrealized net capital gains and losses

 

997

 

2,405

 

Unrealized adjustment to DAC, DSI and insurance reserves

 

(101)

 

(766)

 

Total unrealized net capital gains and losses

 

927

 

1,634

 

Unrealized foreign currency translation adjustments

 

1

 

(1)

 

Total accumulated other comprehensive income

 

928

 

1,633

 

Total shareholder’s equity

 

6,070

 

7,313

 

Total liabilities and shareholder’s equity

$

63,368

$

70,111

 

 

See notes to consolidated financial statements.

46



 

ALLSTATE LIFE INSURANCE COMPANY AND SUBSIDIARES

CONSOLIDATED STATEMENTS OF SHAREHOLDER’S EQUITY

 

($ in millions)

 

Year Ended December 31,

 

 

 

2013

 

2012

 

2011

 

 

 

 

 

 

 

 

 

Common stock

$

5

$

5

$

5

 

 

 

 

 

 

 

 

 

Additional capital paid-in

 

 

 

 

 

 

 

Balance, beginning of year

 

3,190

 

3,190

 

3,189

 

Return of capital

 

(500)

 

--

 

--

 

Gain on purchase of investments from affiliate

 

--

 

--

 

1

 

Balance, end of year

 

2,690

 

3,190

 

3,190

 

 

 

 

 

 

 

 

 

Retained income

 

 

 

 

 

 

 

Balance, beginning of year

 

2,485

 

2,060

 

1,587

 

Net (loss) income

 

(38)

 

426

 

469

 

Loss on reinsurance agreement with an affiliate

 

--

 

(1)

 

--

 

Forgiveness of payable due to parent

 

--

 

--

 

4

 

Balance, end of year

 

2,447

 

2,485

 

2,060

 

 

 

 

 

 

 

 

 

Accumulated other comprehensive income

 

 

 

 

 

 

 

Balance, beginning of year

 

1,633

 

812

 

538

 

Change in unrealized net capital gains and losses

 

(707)

 

821

 

275

 

Change in unrealized foreign currency translation adjustments

 

2

 

--

 

(1)

 

Balance, end of year

 

928

 

1,633

 

812

 

 

 

 

 

 

 

 

 

Total shareholder’s equity

$

6,070

$

7,313

$

6,067

 

 

See notes to consolidated financial statements.

47



 

ALLSTATE LIFE INSURANCE COMPANY AND SUBSIDIARES

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

($ in millions)

 

Year Ended December 31,

 

 

 

2013

 

2012

 

2011

 

Cash flows from operating activities

 

 

 

 

 

 

 

Net (loss) income

$

(38)

$

426

$

469

 

Adjustments to reconcile net (loss) income to net cash provided by operating activities:

 

 

 

 

 

 

 

Amortization and other non-cash items

 

(73)

 

(25)

 

(61)

 

Realized capital gains and losses

 

(76)

 

16

 

(390)

 

Loss (gain) on disposition of operations

 

687

 

(18)

 

(15)

 

Interest credited to contractholder funds

 

1,251

 

1,289

 

1,608

 

Changes in:

 

 

 

 

 

 

 

Policy benefits and other insurance reserves

 

(634)

 

(656)

 

(568)

 

Unearned premiums

 

(2)

 

(3)

 

(4)

 

Deferred policy acquisition costs

 

(14)

 

62

 

189

 

Reinsurance recoverables, net

 

(54)

 

(157)

 

(259)

 

Income taxes

 

33

 

248

 

164

 

Other operating assets and liabilities

 

(65)

 

(35)

 

(46)

 

Net cash provided by operating activities

 

1,015

 

1,147

 

1,087

 

Cash flows from investing activities

 

 

 

 

 

 

 

Proceeds from sales

 

 

 

 

 

 

 

Fixed income securities

 

4,046

 

6,674

 

11,490

 

Equity securities

 

265

 

22

 

70

 

Limited partnership interests

 

387

 

201

 

175

 

Mortgage loans

 

24

 

15

 

97

 

Other investments

 

38

 

111

 

153

 

Investment collections

 

 

 

 

 

 

 

Fixed income securities

 

4,168

 

3,077

 

3,072

 

Mortgage loans

 

926

 

1,022

 

692

 

Other investments

 

88

 

84

 

93

 

Investment purchases

 

 

 

 

 

 

 

Fixed income securities

 

(4,348)

 

(7,458)

 

(10,002)

 

Equity securities

 

(453)

 

(201)

 

(14)

 

Limited partnership interests

 

(597)

 

(507)

 

(397)

 

Mortgage loans

 

(522)

 

(449)

 

(820)

 

Other investments

 

(81)

 

(159)

 

(340)

 

Change in short-term investments, net

 

(108)

 

16

 

463

 

Change in policy loans and other investments, net

 

76

 

56

 

(280)

 

Disposition of operations

 

--

 

13

 

--

 

Net cash provided by investing activities

 

3,909

 

2,517

 

4,452

 

Cash flows from financing activities

 

 

 

 

 

 

 

Contractholder fund deposits

 

2,062

 

2,061

 

1,871

 

Contractholder fund withdrawals

 

(6,520)

 

(5,490)

 

(7,218)

 

Return of capital

 

(500)

 

--

 

--

 

Repayment of notes due to related parties

 

(214)

 

(204)

 

--

 

Net cash used in financing activities

 

(5,172)

 

(3,633)

 

(5,347)

 

Net (decrease) increase in cash

 

(248)

 

31

 

192

 

Cash at beginning of year

 

341

 

310

 

118

 

Cash at end of year

$

93

$

341

$

310

 

 

See notes to consolidated financial statements.

48



 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

 

1.  General

 

Basis of presentation

 

The accompanying consolidated financial statements include the accounts of Allstate Life Insurance Company (“ALIC”) and its wholly owned subsidiaries (collectively referred to as the “Company”).  ALIC is wholly owned by Allstate Insurance Company (“AIC”), which is wholly owned by Allstate Insurance Holdings, LLC, a wholly owned subsidiary of The Allstate Corporation (the “Corporation”).  These consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”).  All significant intercompany accounts and transactions have been eliminated.

 

To conform to the current year presentation, certain amounts in the prior year notes to consolidated financial statements have been reclassified.

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes.  Actual results could differ from those estimates.

 

Nature of operations

 

The Company sells life insurance and voluntary accident and health insurance products.  The principal products are interest-sensitive, traditional and variable life insurance.  Effective January 1, 2014, the Company no longer offers fixed annuities such as deferred and immediate annuities.  Institutional products consisting of funding agreements sold to unaffiliated trusts that use them to back medium-term notes were offered prior to 2009.  The following table summarizes premiums and contract charges by product.

 

($ in millions)

 

2013

 

2012

 

2011

Premiums

 

 

 

 

 

 

  Traditional life insurance

$

471

$

449

$

420

  Immediate annuities with life contingencies

 

37

 

45

 

106

  Accident and health insurance

 

105

 

99

 

98

     Total premiums

 

613

 

593

 

624

 

 

 

 

 

 

 

Contract charges

 

 

 

 

 

 

  Interest-sensitive life insurance

 

1,036

 

1,011

 

975

  Fixed annuities

 

18

 

18

 

33

     Total contract charges

 

1,054

 

1,029

 

1,008

        Total premiums and contract charges

$

1,667

$

1,622

$

1,632

 

The Company, through several subsidiaries, is authorized to sell life insurance and retirement products in all 50 states, the District of Columbia, Puerto Rico, the U.S. Virgin Islands and Guam.  For 2013, the top geographic locations for statutory premiums and annuity considerations were California, Texas, Florida and New York.  No other jurisdiction accounted for more than 5% of statutory premiums and annuity considerations.  The Company distributes its products through Allstate exclusive agencies and exclusive financial specialists, and workplace enrolling independent agents in New York.

 

The Company has exposure to market risk as a result of its investment portfolio.  Market risk is the risk that the Company will incur realized and unrealized net capital losses due to adverse changes in interest rates, credit spreads, equity prices or currency exchange rates.  The Company’s primary market risk exposures are to changes in interest rates, credit spreads and equity prices.  Interest rate risk is the risk that the Company will incur a loss due to adverse changes in interest rates relative to the interest rate characteristics of its interest bearing assets and liabilities.  This risk arises from many of the Company’s primary activities, as it invests substantial funds in interest-sensitive assets and issues interest-sensitive liabilities.  Interest rate risk includes risks related to changes in U.S. Treasury yields and other key risk-free reference yields.  Credit spread risk is the risk that the Company will incur a loss due to adverse changes in credit spreads.  This risk arises from many of the Company’s primary activities, as the Company invests substantial funds in spread-sensitive fixed income assets.  Equity price risk is the risk that the Company will incur losses due to adverse changes in the general levels of the equity markets.

 

The Company monitors economic and regulatory developments that have the potential to impact its business.  Federal and state laws and regulations affect the taxation of insurance companies and life insurance and annuity products.  Congress and various state legislatures from time to time consider legislation that would reduce or eliminate the favorable policyholder tax treatment currently applicable to life insurance and annuities.  Congress and

 

50



 

various state legislatures also consider proposals to reduce the taxation of certain products or investments that may compete with life insurance or annuities.  Legislation that increases the taxation on insurance products or reduces the taxation on competing products could lessen the advantage or create a disadvantage for certain of the Company’s products making them less competitive.  Such proposals, if adopted, could have an adverse effect on the Company’s financial position or ability to sell such products and could result in the surrender of some existing contracts and policies.  In addition, changes in the federal estate tax laws could negatively affect the demand for the types of life insurance used in estate planning.

 

2.  Summary of Significant Accounting Policies

 

Investments

 

Fixed income securities include bonds, asset-backed securities (“ABS”), residential mortgage-backed securities (“RMBS”), commercial mortgage-backed securities (“CMBS”) and redeemable preferred stocks.  Fixed income securities, which may be sold prior to their contractual maturity, are designated as available for sale and are carried at fair value.  The difference between amortized cost and fair value, net of deferred income taxes, certain deferred policy acquisition costs (“DAC”), certain deferred sales inducement costs (“DSI”) and certain reserves for life-contingent contract benefits, is reflected as a component of accumulated other comprehensive income.  Cash received from calls, principal payments and make-whole payments is reflected as a component of proceeds from sales and cash received from maturities and pay-downs, including prepayments, is reflected as a component of investment collections within the Consolidated Statements of Cash Flows.

 

Mortgage loans are carried at unpaid principal balances, net of unamortized premium or discount and valuation allowances.  Valuation allowances are established for impaired loans when it is probable that contractual principal and interest will not be collected.

 

Equity securities primarily include common stocks, exchange traded and mutual funds, non-redeemable preferred stocks and real estate investment trust equity investments.  Equity securities are designated as available for sale and are carried at fair value.  The difference between cost and fair value, net of deferred income taxes, is reflected as a component of accumulated other comprehensive income.

 

Investments in limited partnership interests, including interests in private equity/debt funds, real estate funds, hedge funds and tax credit funds, where the Company’s interest is so minor that it exercises virtually no influence over operating and financial policies are accounted for in accordance with the cost method of accounting; all other investments in limited partnership interests are accounted for in accordance with the equity method of accounting (“EMA”).

 

Short-term investments, including money market funds, commercial paper and other short-term investments, are carried at fair value.  Policy loans are carried at unpaid principal balances.  Other investments primarily consist of agent loans, bank loans, notes due from related party and derivatives.  Agent loans are loans issued to exclusive Allstate agents and are carried at unpaid principal balances, net of valuation allowances and unamortized deferred fees or costs.  Bank loans are primarily senior secured corporate loans and are carried at amortized cost.  Notes due from related party are carried at outstanding principal balances.  Derivatives are carried at fair value.

 

Investment income primarily consists of interest, dividends, income from certain derivative transactions, income from cost method limited partnership interests, and, in 2013 and 2012, income from EMA limited partnership interests.  Interest is recognized on an accrual basis using the effective yield method and dividends are recorded at the ex-dividend date.  Interest income for ABS, RMBS and CMBS is determined considering estimated pay-downs, including prepayments, obtained from third party data sources and internal estimates.  Actual prepayment experience is periodically reviewed and effective yields are recalculated when differences arise between the prepayments originally anticipated and the actual prepayments received and currently anticipated.  For ABS, RMBS and CMBS of high credit quality with fixed interest rates, the effective yield is recalculated on a retrospective basis.  For all others, the effective yield is recalculated on a prospective basis.  Accrual of income is suspended for other-than-temporarily impaired fixed income securities when the timing and amount of cash flows expected to be received is not reasonably estimable.  Accrual of income is suspended for mortgage loans, bank loans and agent loans that are in default or when full and timely collection of principal and interest payments is not probable.  Cash receipts on investments on nonaccrual status are generally recorded as a reduction of carrying value.  Income from cost method limited partnership interests is recognized upon receipt of amounts distributed by the partnerships.  Income from EMA limited partnership interests is recognized based on the Company’s share of the partnerships’ net income, including unrealized gains and losses, and is recognized on a delay due to the availability

 

51



 

of the related financial statements.  Income recognition on private equity/debt funds, real estate funds and tax credit funds is generally on a three month delay and income recognition on other funds is generally on a one month delay.

 

Realized capital gains and losses include gains and losses on investment sales, write-downs in value due to other-than-temporary declines in fair value, adjustments to valuation allowances on mortgage loans and agent loans, periodic changes in fair value and settlements of certain derivatives including hedge ineffectiveness, and, in 2011, income from EMA limited partnership interests.  Realized capital gains and losses on investment sales, including principal payments, are determined on a specific identification basis.

 

Derivative and embedded derivative financial instruments

 

Derivative financial instruments include interest rate swaps, credit default swaps, futures (interest rate and equity), options (including swaptions), interest rate caps, warrants, foreign currency swaps, foreign currency forwards and certain investment risk transfer reinsurance agreements.  Derivatives required to be separated from the host instrument and accounted for as derivative financial instruments (“subject to bifurcation”) are embedded in certain fixed income securities, equity-indexed life and annuity contracts, reinsured variable annuity contracts and certain funding agreements.

 

All derivatives are accounted for on a fair value basis and reported as other investments, other assets, other liabilities and accrued expenses or contractholder funds.  Embedded derivative instruments subject to bifurcation are also accounted for on a fair value basis and are reported together with the host contract.  The change in fair value of derivatives embedded in certain fixed income securities and subject to bifurcation is reported in realized capital gains and losses.  The change in fair value of derivatives embedded in life and annuity product contracts and subject to bifurcation is reported in contract benefits or interest credited to contractholder funds.  Cash flows from embedded derivatives subject to bifurcation and derivatives receiving hedge accounting are reported consistently with the host contracts and hedged risks, respectively, within the Consolidated Statements of Cash Flows.  Cash flows from other derivatives are reported in cash flows from investing activities within the Consolidated Statements of Cash Flows.

 

When derivatives meet specific criteria, they may be designated as accounting hedges and accounted for as fair value, cash flow, foreign currency fair value or foreign currency cash flow hedges.  The hedged item may be either all or a specific portion of a recognized asset, liability or an unrecognized firm commitment attributable to a particular risk for fair value hedges.  At the inception of the hedge, the Company formally documents the hedging relationship and risk management objective and strategy.  The documentation identifies the hedging instrument, the hedged item, the nature of the risk being hedged and the methodology used to assess the effectiveness of the hedging instrument in offsetting the exposure to changes in the hedged item’s fair value attributable to the hedged risk.  For a cash flow hedge, this documentation includes the exposure to changes in the variability in cash flows attributable to the hedged risk.  The Company does not exclude any component of the change in fair value of the hedging instrument from the effectiveness assessment.  At each reporting date, the Company confirms that the hedging instrument continues to be highly effective in offsetting the hedged risk.  Ineffectiveness in fair value hedges and cash flow hedges, if any, is reported in realized capital gains and losses.

 

Fair value hedges   The change in fair value of hedging instruments used in fair value hedges of investment assets or a portion thereof is reported in net investment income, together with the change in fair value of the hedged items.  The change in fair value of hedging instruments used in fair value hedges of contractholder funds liabilities or a portion thereof is reported in interest credited to contractholder funds, together with the change in fair value of the hedged items.  Accrued periodic settlements on swaps are reported together with the changes in fair value of the swaps in net investment income or interest credited to contractholder funds.  The amortized cost for fixed income securities, the carrying value for mortgage loans or the carrying value of the hedged liability is adjusted for the change in fair value of the hedged risk.

 

Cash flow hedges   For hedging instruments used in cash flow hedges, the changes in fair value of the derivatives representing the effective portion of the hedge are reported in accumulated other comprehensive income.  Amounts are reclassified to net investment income or realized capital gains and losses as the hedged or forecasted transaction affects income.  Accrued periodic settlements on derivatives used in cash flow hedges are reported in net investment income.  The amount reported in accumulated other comprehensive income for a hedged transaction is limited to the lesser of the cumulative gain or loss on the derivative less the amount reclassified to income, or the cumulative gain or loss on the derivative needed to offset the cumulative change in the expected future cash flows on the hedged transaction from inception of the hedge less the derivative gain or loss previously reclassified from accumulated other comprehensive income to income.  If the Company expects at any time that the loss reported in accumulated other comprehensive income would lead to a net loss on the combination of the hedging instrument and

 

52



 

the hedged transaction which may not be recoverable, a loss is recognized immediately in realized capital gains and losses.  If an impairment loss is recognized on an asset or an additional obligation is incurred on a liability involved in a hedge transaction, any offsetting gain in accumulated other comprehensive income is reclassified and reported together with the impairment loss or recognition of the obligation.

 

Termination of hedge accounting   If, subsequent to entering into a hedge transaction, the derivative becomes ineffective (including if the hedged item is sold or otherwise extinguished, the occurrence of a hedged forecasted transaction is no longer probable or the hedged asset becomes other-than-temporarily impaired), the Company may terminate the derivative position.  The Company may also terminate derivative instruments or redesignate them as non-hedge as a result of other events or circumstances.  If the derivative instrument is not terminated when a fair value hedge is no longer effective, the future gains and losses recognized on the derivative are reported in realized capital gains and losses.  When a fair value hedge is no longer effective, is redesignated as non-hedge or when the derivative has been terminated, the fair value gain or loss on the hedged asset, liability or portion thereof which has already been recognized in income while the hedge was in place and used to adjust the amortized cost for fixed income securities, the carrying value for mortgage loans or the carrying value of the hedged liability, is amortized over the remaining life of the hedged asset, liability or portion thereof, and reflected in net investment income or interest credited to contractholder funds beginning in the period that hedge accounting is no longer applied.  If the hedged item in a fair value hedge is an asset that has become other-than-temporarily impaired, the adjustment made to the amortized cost for fixed income securities or the carrying value for mortgage loans is subject to the accounting policies applied to other-than-temporarily impaired assets.

 

When a derivative instrument used in a cash flow hedge of an existing asset or liability is no longer effective or is terminated, the gain or loss recognized on the derivative is reclassified from accumulated other comprehensive income to income as the hedged risk impacts income.  If the derivative instrument is not terminated when a cash flow hedge is no longer effective, the future gains and losses recognized on the derivative are reported in realized capital gains and losses.  When a derivative instrument used in a cash flow hedge of a forecasted transaction is terminated because it is probable the forecasted transaction will not occur, the gain or loss recognized on the derivative is immediately reclassified from accumulated other comprehensive income to realized capital gains and losses in the period that hedge accounting is no longer applied.

 

Non-hedge derivative financial instruments   For derivatives for which hedge accounting is not applied, the income statement effects, including fair value gains and losses and accrued periodic settlements, are reported either in realized capital gains and losses or in a single line item together with the results of the associated asset or liability for which risks are being managed.

 

Securities loaned

 

The Company’s business activities include securities lending transactions, which are used primarily to generate net investment income.  The proceeds received in conjunction with securities lending transactions are reinvested in short-term investments.  These transactions are short-term in nature, usually 30 days or less.

 

The Company receives cash collateral for securities loaned in an amount generally equal to 102% of the fair value of securities and records the related obligations to return the collateral in other liabilities and accrued expenses.  The carrying value of these obligations approximates fair value because of their relatively short-term nature.  The Company monitors the market value of securities loaned on a daily basis and obtains additional collateral as necessary under the terms of the agreements to mitigate counterparty credit risk.  The Company maintains the right and ability to repossess the securities loaned on short notice.

 

Recognition of premium revenues and contract charges, and related benefits and interest credited

 

Traditional life insurance products consist principally of products with fixed and guaranteed premiums and benefits, primarily term and whole life insurance products.  Voluntary accident and health insurance products are expected to remain in force for an extended period.  Premiums from these products are recognized as revenue when due from policyholders.  Benefits are reflected in contract benefits and recognized in relation to premiums, so that profits are recognized over the life of the policy.

 

Immediate annuities with life contingencies, including certain structured settlement annuities, provide insurance protection over a period that extends beyond the period during which premiums are collected.  Premiums from these products are recognized as revenue when received at the inception of the contract.  Benefits and expenses are recognized in relation to premiums.  Profits from these policies come from investment income, which is recognized over the life of the contract.

 

53



 

Interest-sensitive life contracts, such as universal life and single premium life, are insurance contracts whose terms are not fixed and guaranteed.  The terms that may be changed include premiums paid by the contractholder, interest credited to the contractholder account balance and contract charges assessed against the contractholder account balance.  Premiums from these contracts are reported as contractholder fund deposits.  Contract charges consist of fees assessed against the contractholder account balance for the cost of insurance (mortality risk), contract administration and surrender of the contract prior to contractually specified dates.  These contract charges are recognized as revenue when assessed against the contractholder account balance.  Contract benefits include life-contingent benefit payments in excess of the contractholder account balance.

 

Contracts that do not subject the Company to significant risk arising from mortality or morbidity are referred to as investment contracts.  Fixed annuities, including market value adjusted annuities, equity-indexed annuities and immediate annuities without life contingencies, and funding agreements (primarily backing medium-term notes) are considered investment contracts.  Consideration received for such contracts is reported as contractholder fund deposits.  Contract charges for investment contracts consist of fees assessed against the contractholder account balance for maintenance, administration and surrender of the contract prior to contractually specified dates, and are recognized when assessed against the contractholder account balance.

 

Interest credited to contractholder funds represents interest accrued or paid on interest-sensitive life and investment contracts.  Crediting rates for certain fixed annuities and interest-sensitive life contracts are adjusted periodically by the Company to reflect current market conditions subject to contractually guaranteed minimum rates.  Crediting rates for indexed life and annuities and indexed funding agreements are generally based on a specified interest rate index or an equity index, such as the Standard & Poor’s (“S&P”) 500 Index.  Interest credited also includes amortization of DSI expenses.  DSI is amortized into interest credited using the same method used to amortize DAC.

 

Contract charges for variable life and variable annuity products consist of fees assessed against the contractholder account balances for contract maintenance, administration, mortality, expense and surrender of the contract prior to contractually specified dates.  Contract benefits incurred for variable annuity products include guaranteed minimum death, income, withdrawal and accumulation benefits.  Substantially all of the Company’s variable annuity business is ceded through reinsurance agreements and the contract charges and contract benefits related thereto are reported net of reinsurance ceded.

 

Deferred policy acquisition and sales inducement costs

 

Costs that are related directly to the successful acquisition of new or renewal life insurance and investment contracts are deferred and recorded as DAC.  These costs are principally agents’ and brokers’ remuneration and certain underwriting expenses.  DSI costs, which are deferred and recorded as other assets, relate to sales inducements offered on sales to new customers, principally on annuity and interest-sensitive life contracts.  These sales inducements are primarily in the form of additional credits to the customer’s account balance or enhancements to interest credited for a specified period which are in excess of the rates currently being credited to similar contracts without sales inducements.  All other acquisition costs are expensed as incurred and included in operating costs and expenses.  Amortization of DAC is included in amortization of deferred policy acquisition costs and is described in more detail below.  DSI is amortized into income using the same methodology and assumptions as DAC and is included in interest credited to contractholder funds.  DAC and DSI are periodically reviewed for recoverability and adjusted if necessary.

 

For traditional life insurance, DAC is amortized over the premium paying period of the related policies in proportion to the estimated revenues on such business.  Assumptions used in the amortization of DAC and reserve calculations are established at the time the policy is issued and are generally not revised during the life of the policy.  Any deviations from projected business in force resulting from actual policy terminations differing from expected levels and any estimated premium deficiencies may result in a change to the rate of amortization in the period such events occur.  Generally, the amortization periods for these policies approximates the estimated lives of the policies.

 

For interest-sensitive life, fixed annuities and other investment contracts, DAC and DSI are amortized in proportion to the incidence of the total present value of gross profits, which includes both actual historical gross profits (“AGP”) and estimated future gross profits (“EGP”) expected to be earned over the estimated lives of the contracts.  The amortization is net of interest on the prior period DAC balance using rates established at the inception of the contracts.  Actual amortization periods generally range from 15-30 years; however, incorporating estimates of the rate of customer surrenders, partial withdrawals and deaths generally results in the majority of the DAC being amortized during the surrender charge period, which is typically 10-20 years for interest-sensitive life and 5-10 years for fixed annuities.  The cumulative DAC and DSI amortization is reestimated and adjusted by a

 

54



 

cumulative charge or credit to income when there is a difference between the incidence of actual versus expected gross profits in a reporting period or when there is a change in total EGP.  When DAC or DSI amortization or a component of gross profits for a quarterly period is potentially negative (which would result in an increase of the DAC or DSI balance) as a result of negative AGP, the specific facts and circumstances surrounding the potential negative amortization are considered to determine whether it is appropriate for recognition in the consolidated financial statements.  Negative amortization is only recorded when the increased DAC or DSI balance is determined to be recoverable based on facts and circumstances.  Recapitalization of DAC and DSI is limited to the originally deferred costs plus interest.

 

AGP and EGP primarily consist of the following components: contract charges for the cost of insurance less mortality costs and other benefits; investment income and realized capital gains and losses less interest credited; and surrender and other contract charges less maintenance expenses.  The principal assumptions for determining the amount of EGP are persistency, mortality, expenses, investment returns, including capital gains and losses on assets supporting contract liabilities, interest crediting rates to contractholders, and the effects of any hedges.  For products whose supporting investments are exposed to capital losses in excess of the Company’s expectations which may cause periodic AGP to become temporarily negative, EGP and AGP utilized in DAC and DSI amortization may be modified to exclude the excess capital losses.

 

The Company performs quarterly reviews of DAC and DSI recoverability for interest-sensitive life, fixed annuities and other investment contracts in the aggregate using current assumptions.  If a change in the amount of EGP is significant, it could result in the unamortized DAC or DSI not being recoverable, resulting in a charge which is included as a component of amortization of deferred policy acquisition costs or interest credited to contractholder funds, respectively.

 

The DAC and DSI balances presented include adjustments to reflect the amount by which the amortization of DAC and DSI would increase or decrease if the unrealized capital gains or losses in the respective product investment portfolios were actually realized.  The adjustments are recorded net of tax in accumulated other comprehensive income.  DAC, DSI and deferred income taxes determined on unrealized capital gains and losses and reported in accumulated other comprehensive income recognize the impact on shareholder’s equity consistently with the amounts that would be recognized in the income statement on realized capital gains and losses.

 

Customers of the Company may exchange one insurance policy or investment contract for another offered by the Company, or make modifications to an existing investment or life contract issued by the Company.  These transactions are identified as internal replacements for accounting purposes.  Internal replacement transactions determined to result in replacement contracts that are substantially unchanged from the replaced contracts are accounted for as continuations of the replaced contracts.  Unamortized DAC and DSI related to the replaced contracts continue to be deferred and amortized in connection with the replacement contracts.  For interest-sensitive life and investment contracts, the EGP of the replacement contracts are treated as a revision to the EGP of the replaced contracts in the determination of amortization of DAC and DSI.  For traditional life insurance policies, any changes to unamortized DAC that result from replacement contracts are treated as prospective revisions.  Any costs associated with the issuance of replacement contracts are characterized as maintenance costs and expensed as incurred.  Internal replacement transactions determined to result in a substantial change to the replaced contracts are accounted for as an extinguishment of the replaced contracts, and any unamortized DAC and DSI related to the replaced contracts are eliminated with a corresponding charge to amortization of deferred policy acquisition costs or interest credited to contractholder funds, respectively.

 

The costs assigned to the right to receive future cash flows from certain business purchased from other insurers are also classified as DAC in the Consolidated Statements of Financial Position.  The costs capitalized represent the present value of future profits expected to be earned over the lives of the contracts acquired.  These costs are amortized as profits emerge over the lives of the acquired business and are periodically evaluated for recoverability.  The present value of future profits was $8 million and $10 million as of December 31, 2013 and 2012, respectively.  Amortization expense of the present value of future profits was $2 million, $3 million and $2 million in 2013, 2012 and 2011, respectively.

 

Reinsurance

 

In the normal course of business, the Company seeks to limit aggregate and single exposure to losses on large risks by purchasing reinsurance.  The Company has also used reinsurance to effect the acquisition or disposition of certain blocks of business.  The amounts reported as reinsurance recoverables include amounts billed to reinsurers on losses paid as well as estimates of amounts expected to be recovered from reinsurers on insurance liabilities and contractholder funds that have not yet been paid.  Reinsurance recoverables on unpaid losses are estimated based

 

55



 

upon assumptions consistent with those used in establishing the liabilities related to the underlying reinsured contracts.  Insurance liabilities are reported gross of reinsurance recoverables.  Reinsurance premiums are generally reflected in income in a manner consistent with the recognition of premiums on the reinsured contracts.  Reinsurance does not extinguish the Company’s primary liability under the policies written.  Therefore, the Company regularly evaluates the financial condition of its reinsurers and establishes allowances for uncollectible reinsurance as appropriate.

 

Goodwill

 

Goodwill represents the excess of amounts paid for acquiring businesses over the fair value of the net assets acquired.  The goodwill balance was $5 million as of both December 31, 2013 and 2012.  Goodwill is not amortized but is tested for impairment at least annually.  The Company performs its annual goodwill impairment testing during the fourth quarter of each year based upon data as of the close of the third quarter.  The Company also reviews goodwill for impairment whenever events or changes in circumstances, such as deteriorating or adverse market conditions, indicate that it is more likely than not that the carrying amount of goodwill may exceed its implied fair value.  Goodwill impairment evaluations indicated no impairment as of December 31, 2013 or 2012.

 

Income taxes

 

The income tax provision is calculated under the liability method.  Deferred tax assets and liabilities are recorded based on the difference between the financial statement and tax bases of assets and liabilities at the enacted tax rates.  The principal assets and liabilities giving rise to such differences are unrealized capital gains and losses, DAC, insurance reserves and differences in tax bases of invested assets.  A deferred tax asset valuation allowance is established when there is uncertainty that such assets will be realized.

 

Reserve for life-contingent contract benefits

 

The reserve for life-contingent contract benefits payable under insurance policies, including traditional life insurance, life-contingent immediate annuities and voluntary accident and health insurance products, is computed on the basis of long-term actuarial assumptions of future investment yields, mortality, morbidity, policy terminations and expenses.  These assumptions, which for traditional life insurance are applied using the net level premium method, include provisions for adverse deviation and generally vary by characteristics such as type of coverage, year of issue and policy duration.  To the extent that unrealized gains on fixed income securities would result in a premium deficiency if those gains were realized, the related increase in reserves for certain immediate annuities with life contingencies is recorded net of tax as a reduction of unrealized net capital gains included in accumulated other comprehensive income.

 

Contractholder funds

 

Contractholder funds represent interest-bearing liabilities arising from the sale of products such as interest-sensitive life insurance, fixed annuities and funding agreements.  Contractholder funds primarily comprise cumulative deposits received and interest credited to the contractholder less cumulative contract benefits, surrenders, withdrawals, maturities and contract charges for mortality or administrative expenses.  Contractholder funds also include reserves for secondary guarantees on interest-sensitive life insurance and certain fixed annuity contracts and reserves for certain guarantees on reinsured variable annuity contracts.

 

Held for sale classification

 

Business is classified as held for sale when management has approved or received approval to sell the business, the sale is probable to occur during the next 12 months at a price that is reasonable in relation to its current fair value and certain other specified criteria are met.  A business classified as held for sale is recorded at the lower of its carrying amount or estimated fair value less cost to sell.  If the carrying amount of the business exceeds its estimated fair value less cost to sell, a loss is recognized.  Assets and liabilities related to a business classified as held for sale are segregated in the Consolidated Statement of Position in the period in which the business is classified as held for sale.

 

Separate accounts

 

Separate accounts assets are carried at fair value.  The assets of the separate accounts are legally segregated and available only to settle separate account contract obligations.  Separate accounts liabilities represent the contractholders’ claims to the related assets and are carried at an amount equal to the separate accounts assets.  Investment income and realized capital gains and losses of the separate accounts accrue directly to the contractholders and therefore are not included in the Company’s Consolidated Statements of Operations and

 

56



 

Comprehensive Income.  Deposits to and surrenders and withdrawals from the separate accounts are reflected in separate accounts liabilities and are not included in consolidated cash flows.

 

Absent any contract provision wherein the Company provides a guarantee, variable annuity and variable life insurance contractholders bear the investment risk that the separate accounts’ funds may not meet their stated investment objectives.  Substantially all of the Company’s variable annuity business was reinsured beginning in 2006.

 

Off-balance sheet financial instruments

 

Commitments to invest, commitments to purchase private placement securities, commitments to extend loans, financial guarantees and credit guarantees have off-balance sheet risk because their contractual amounts are not recorded in the Company’s Consolidated Statements of Financial Position (see Note 8 and Note 12).

 

Adopted accounting standards

 

Disclosures about Offsetting Assets and Liabilities

 

In December 2011 and January 2013, the Financial Accounting Standards Board (“FASB”) issued guidance requiring expanded disclosures, including both gross and net information, for derivatives, repurchase and reverse repurchase agreements, and securities borrowing and securities lending transactions that are either offset in the reporting entity’s financial statements or those that are subject to an enforceable master netting arrangement or similar agreement.  The Company adopted the new guidance in the first quarter of 2013.  The new guidance affects disclosures only and therefore had no impact on the Company’s results of operations or financial position.

 

Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income

 

In February 2013, the FASB issued guidance requiring expanded disclosures about the amounts reclassified out of accumulated other comprehensive income by component.  The guidance requires the presentation of significant amounts reclassified out of accumulated other comprehensive income by income statement line item but only if the amount reclassified is required under GAAP to be reclassified to net income in its entirety in the same reporting period.  For other amounts that are not required under GAAP to be reclassified in their entirety to net income, cross-reference to other disclosures that provide additional detail about those amounts is required.  The Company adopted the new guidance in the first quarter of 2013.  The new guidance affects disclosures only and therefore had no impact on the Company’s results of operations or financial position.

 

Pending accounting standard

 

Accounting for Investments in Qualified Affordable Housing Projects

 

In January 2014, the FASB issued guidance which allows entities that invest in certain qualified affordable housing projects through limited liability entities the option to account for these investments using the proportional amortization method if certain conditions are met.  Under the proportional amortization method, the entity amortizes the initial cost of the investment in proportion to the tax credits and other tax benefits received and recognizes the net investment performance in the income statement as a component of income tax expense or benefit.  The guidance is effective for reporting periods beginning after December 15, 2014 and is to be applied retrospectively.  The Company is in the process of evaluating the impact of adoption, which is not expected to be material to the Company’s results of operations and financial position.

 

57



 

3.  Held for Sale Transaction

 

On July 17, 2013, the Company entered into a definitive agreement with Resolution Life Holdings, Inc. to sell Lincoln Benefit Life Company (“LBL”), LBL’s life insurance business generated through independent master brokerage agencies, and all of LBL’s deferred fixed annuity and long-term care insurance business for $600 million subject to certain adjustments as of the closing date.  The transaction is subject to regulatory approvals and other customary closing conditions.  The Company expects the closing to occur in April 2014.  The estimated loss on disposition of $521 million, after-tax, was recorded in 2013, excluding any impact of unrealized net capital gains and losses.  This transaction met the criteria for held for sale accounting.  As a result, the related assets and liabilities are included as single line items in the asset and liability sections of the Consolidated Statement of Financial Position as of December 31, 2013.  The following table summarizes the assets and liabilities held for sale as of December 31, 2013.

 

($ in millions) 

 

 

Assets

 

 

Investments

 

 

Fixed income securities

$

10,167 

Mortgage loans

 

1,367 

Short-term investments

 

160 

Policy loans

 

198 

Other investments

 

91 

Total investments

 

11,983 

Deferred policy acquisition costs

 

743 

Reinsurance recoverables, net

 

1,660 

Accrued investment income

 

109 

Other assets

 

79 

Separate Accounts

 

1,701 

Assets held for sale

 

16,275 

Less: Loss accrual

 

(682)

Total assets held for sale

$

15,593 

Liabilities

 

 

Reserve for life-contingent contract benefits

$

1,894 

Contractholder funds

 

10,945 

Unearned premiums

 

12 

Deferred income taxes

 

151 

Other liabilities and accrued expenses

 

196 

Separate Accounts

 

1,701 

Total liabilities held for sale

$

14,899 

 

Included in shareholder’s equity is $85 million of accumulated other comprehensive income related to assets held for sale.

 

4.  Supplemental Cash Flow Information

 

Non-cash modifications of certain mortgage loans, fixed income securities, limited partnership interests and other investments, as well as mergers completed with equity securities, totaled $306 million, $231 million and $486 million in 2013, 2012 and 2011, respectively.

 

58



 

Liabilities for collateral received in conjunction with the Company’s securities lending program were $322 million, $543 million and $220 million as of December 31, 2013, 2012 and 2011, respectively, and are reported in other liabilities and accrued expenses.  Obligations to return cash collateral for over-the-counter (“OTC”) and cleared derivatives were $6 million, $18 million and $43 million as of December 31, 2013, 2012 and 2011, respectively, and are reported in other liabilities and accrued expenses or other investments.  The accompanying cash flows are included in cash flows from operating activities in the Consolidated Statements of Cash Flows along with the activities resulting from management of the proceeds, which for the years ended December 31 are as follows:

 

($ in millions)

 

2013

 

2012

 

2011

Net change in proceeds managed

 

 

 

 

 

 

Net change in short-term investments

$

235 

$

(298)

$

202 

     Operating cash flow provided (used)

 

235 

 

(298)

 

202 

Net change in cash

 

(2)

 

-- 

 

-- 

     Net change in proceeds managed

$

233 

$

(298)

$

202 

 

 

 

 

 

 

 

Net change in liabilities

 

 

 

 

 

 

Liabilities for collateral, beginning of year

$

(561)

$

(263)

$

(465)

Liabilities for collateral, end of year

 

(328)

 

(561)

 

(263)

     Operating cash flow (used) provided

$

(233)

$

298 

$

(202)

 

In 2011, a payable associated with the pension benefit obligations due to AIC totaling $4 million was forgiven.  The forgiveness of the payable reflects a non-cash financing activity.

 

5.  Related Party Transactions

 

Business operations

 

The Company uses services performed by its affiliates, AIC and Allstate Investments LLC, and business facilities owned or leased and operated by AIC in conducting its business activities.  In addition, the Company shares the services of employees with AIC.  The Company reimburses its affiliates for the operating expenses incurred on behalf of the Company.  The Company is charged for the cost of these operating expenses based on the level of services provided.  Operating expenses, including compensation, retirement and other benefit programs (see Note 16), allocated to the Company were $456 million, $451 million and $399 million in 2013, 2012 and 2011, respectively.  A portion of these expenses relate to the acquisition of business, which are deferred and amortized into income as described in Note 2.

 

Structured settlement annuities

 

The Company issued $7 million, $35 million and $56 million of structured settlement annuities, a type of immediate annuity, in 2013, 2012 and 2011, respectively, at prices determined using interest rates in effect at the time of purchase, to fund structured settlements in matters involving AIC.  Of these amounts, $4 million, $3 million and $11 million relate to structured settlement annuities with life contingencies and are included in premium revenue for 2013, 2012 and 2011, respectively.  Effective March 22, 2013, the Company no longer offers structured settlement annuities.

 

In most cases, these annuities were issued under a “qualified assignment” whereby Allstate Assignment Corporation (“AAC”) and prior to July 1, 2001 Allstate Settlement Corporation (“ASC”), both wholly owned subsidiaries of ALIC, purchased annuities from ALIC and assumed AIC’s obligation to make future payments.

 

AIC issued surety bonds to guarantee the payment of structured settlement benefits assumed by ASC (from both AIC and non-related parties) and funded by certain annuity contracts issued by the Company through June 30, 2001.  ASC entered into a General Indemnity Agreement pursuant to which it indemnified AIC for any liabilities associated with the surety bonds and gave AIC certain collateral security rights with respect to the annuities and certain other rights in the event of any defaults covered by the surety bonds.  For contracts written on or after July 1, 2001, AIC no longer issues surety bonds to guarantee the payment of structured settlement benefits.  Alternatively, ALIC guarantees the payment of structured settlement benefits on all contracts issued on or after July 1, 2001.  Reserves recorded by the Company for annuities that are guaranteed by the surety bonds of AIC were $4.72 billion and $4.77 billion as of December 31, 2013 and 2012, respectively.

 

59



 

Broker-Dealer agreement

 

The Company receives distribution services from Allstate Financial Services, LLC, an affiliated broker-dealer company, for certain annuity and variable life insurance contracts sold by Allstate exclusive agencies.  For these services, the Company incurred commission and other distribution expenses of $13 million, $11 million and $15 million in 2013, 2012 and 2011, respectively.

 

Reinsurance

 

The Company has coinsurance reinsurance agreements with its unconsolidated affiliate American Heritage Life Insurance Company (“AHL”) whereby the Company assumes certain interest-sensitive life insurance, fixed annuity contracts and accident and health insurance policies.  The amounts assumed are disclosed in Note 10.

 

In September 2012, Lincoln Benefit Life Company, a consolidated subsidiary of ALIC, entered into a coinsurance reinsurance agreement with Lincoln Benefit Reinsurance Company (“LB Re”), an unconsolidated affiliate of the Company, to cede certain interest-sensitive life insurance policies to LB Re.  In connection with the agreement, the Company recorded reinsurance recoverables of $2 million and paid $3 million in cash.  The $1 million loss on the transaction was recorded as a decrease to retained income since the transaction was between affiliates under common control.

 

ALIC enters into certain intercompany reinsurance transactions with its wholly owned subsidiaries.  ALIC enters into these transactions in order to maintain underwriting control and spread risk among various legal entities.  These reinsurance agreements have been approved by the appropriate regulatory authorities.  All significant intercompany transactions have been eliminated in consolidation.

 

Income taxes

 

The Company is a party to a federal income tax allocation agreement with the Corporation (see Note 13).

 

Notes due to related parties

 

Notes due to related parties outstanding as of December 31 consisted of the following:

 

($ in millions)

 

2013

 

2012

6.35% Note, due 2018, to AIC

$

$

7

5.75% Note, due 2018, to AIC

 

-- 

 

4

5.75% Note, due 2018, to AIC

 

-- 

 

10

7.00% Surplus Note, due 2028, to AIC (1)

 

-- 

 

200

6.74% Surplus Note, due 2029, to Kennett (1)

 

25 

 

25

5.06% Surplus Note, due 2035, to Kennett (1)

 

100 

 

100

6.18% Surplus Note, due 2036, to Kennett (1)

 

100 

 

100

5.93% Surplus Note, due 2038, to Kennett (1)

 

50 

 

50

     Total notes due to related parties

$

282 

$

496

 

 

(1) No payment of principal or interest is permitted on the surplus notes without the written approval from the proper regulatory authority.  The regulatory authority could prohibit the payment of interest and principal on the surplus notes if certain statutory capital requirements are not met.  Permission to pay interest on the surplus notes was granted in both 2013 and 2012.

 

On August 1, 2005, ALIC entered into an agreement with Kennett Capital Inc. (“Kennett”), an unconsolidated affiliate of ALIC, whereby ALIC sold to Kennett a $100 million 5.06% surplus note due July 1, 2035 issued by ALIC Reinsurance Company (“ALIC Re”), a wholly owned subsidiary of ALIC.  As payment, Kennett issued a full recourse 4.86% note due July 1, 2035 to ALIC for the same amount.  As security for the performance of Kennett’s obligations under the agreement and note, Kennett granted ALIC a pledge of and security interest in Kennett’s right, title and interest in the surplus notes and their proceeds. Under the terms of the agreement, ALIC may sell and Kennett may choose to buy additional surplus notes, if and when additional surplus notes are issued.

 

On June 30, 2006, ALIC sold Kennett a $100 million redeemable surplus note issued by ALIC Re.  The surplus note is due June 1, 2036 with an initial rate of 6.18% that will reset every ten years to the then current ten year Constant Maturity Treasury yield (“CMT”), plus 1.14%.  As payment, Kennett issued a full recourse note due June 1, 2036 to ALIC for the same amount with an initial interest rate of 5.98% that will reset every ten years to the then current ten year CMT, plus 0.94%.

 

60



 

On June 30, 2008, ALIC sold Kennett a $50 million redeemable surplus note issued by ALIC Re.  The surplus note is due June 1, 2038 with an initial rate of 5.93% that will reset every ten years to the then current ten year CMT, plus 2.09%.   As payment, Kennett issued a full recourse note due June 1, 2038 to ALIC for the same amount with an initial interest rate of 5.73% that will reset every ten years to the then current ten year CMT, plus 1.89%.

 

On December 18, 2009, ALIC sold Kennett a $25 million redeemable surplus note issued by ALIC Re.  The surplus note is due December 1, 2029 with an initial rate of 6.74% that will reset every ten years to the then current ten year CMT, plus 3.25%.  As payment, Kennett issued a full recourse note due December 1, 2029 to ALIC for the same amount with an initial interest rate of 5.19% that will reset every ten years to the then current ten year CMT, plus 1.70%.

 

The notes due from Kennett are classified as other investments.  In each of 2013, 2012 and 2011, the Company recorded net investment income on these notes of $15 million.  In each of 2013, 2012 and 2011, the Company incurred $16 million of interest expense related to the surplus notes due to Kennett.

 

On November 17, 2008, the Company issued a $400 million 7.00% surplus note due November 17, 2028 to AIC in exchange for cash.  In both 2013 and 2012, the Company repaid $200 million of principal on this surplus note.  In 2013, 2012 and 2011, the Company incurred interest expense on this surplus note of $7 million, $27 million and $28 million, respectively.

 

In March 2011, in accordance with an asset purchase agreement between Road Bay Investments, LLC (“RBI”), a consolidated subsidiary of ALIC, and AIC, RBI purchased from AIC real estate with a fair value of $10 million on the date of sale and issued a 5.75% note due March 24, 2018 to AIC for the same amount.  In 2013, RBI repaid the entire principal of this note.  In April 2011, RBI purchased from AIC mortgage loans with a fair value of $4 million on the date of sale and issued a 5.75% note due April 19, 2018 to AIC for the same amount.  In 2013, RBI repaid the entire principal of this note.  In August 2011, RBI purchased from AIC fixed income securities with a fair value of $7 million on the date of sale and issued a 6.35% note due August 23, 2018 to AIC for the same amount.  Since the transactions were between affiliates under common control, the purchased investments were recorded by RBI at AIC’s carrying value on the date of sale.  The investments that were purchased were impaired; therefore, the carrying value on the date of sale equaled fair value.  In 2013, 2012 and 2011, the Company incurred interest expense on these notes of $1 million, $1 million and $745 thousand respectively.

 

Liquidity and intercompany loan agreements

 

The Company, AIC and the Corporation are party to the Amended and Restated Intercompany Liquidity Agreement (“Liquidity Agreement”) which allows for short-term advances of funds to be made between parties for liquidity and other general corporate purposes.  The Liquidity Agreement does not establish a commitment to advance funds on the part of any party.  The Company and AIC each serve as a lender and borrower and the Corporation serves only as a lender.  The maximum amount of advances each party may make or receive is limited to $1 billion.  Netting or offsetting of advances made and received is not permitted.  Advances between the parties are required to have specified due dates less than or equal to 364 days from the date of the advance and be payable upon demand by written request from the lender at least ten business days prior to the demand date.  The borrower may make prepayments of the outstanding principal balance of an advance without penalty.  Advances will bear interest equal to or greater than the rate applicable to 30-day commercial paper issued by the Corporation on the date the advance is made with an adjustment on the first day of each month thereafter.  The Company had no amounts outstanding under the Liquidity Agreement as of December 31, 2013 or 2012.

 

In addition to the Liquidity Agreement, the Company has an intercompany loan agreement with the Corporation.  The amount of intercompany loans available to the Company is at the discretion of the Corporation.  The maximum amount of loans the Corporation will have outstanding to all its eligible subsidiaries at any given point in time is limited to $1 billion.  The Corporation may use commercial paper borrowings, bank lines of credit and securities lending to fund intercompany borrowings.  The Company had no amounts outstanding under the intercompany loan agreement as of December 31, 2013 or 2012.

 

RBI, a consolidated subsidiary of ALIC, has a Revolving Loan Credit Agreement (“Credit Agreement”) with AHL, according to which AHL agreed to extend revolving credit loans to RBI.  As security for its obligations under the Credit Agreement, RBI entered into a Pledge and Security Agreement with AHL, according to which RBI agreed to grant a pledge of and security interest in RBI’s right, title, and interest in certain assets of RBI.  The Company had no amounts outstanding under the Credit Agreement as of December 31, 2013 or 2012.

 

61



 

Capital support agreement

 

The Company has a Capital Support Agreement with AIC.  Under the terms of this agreement, AIC agrees to provide capital to maintain the amount of statutory capital and surplus necessary to maintain a company action level risk-based capital (“RBC”) ratio of at least 150%.  AIC’s obligation to provide capital to the Company under the agreement is limited to an aggregate amount of $1 billion.  In exchange for providing this capital, the Company will pay AIC an annual commitment fee of 1% of the amount of the Capital and Surplus maximum that remains available on January 1 of such year.  The Company or AIC have the right to terminate this agreement when: 1) the Company qualifies for a financial strength rating from S&P’s, Moody’s or A.M. Best, without giving weight to the existence of this agreement, that is the same or better than its rating with such support; 2) the Company’s RBC ratio is at least 300%; or 3) AIC no longer directly or indirectly owns at least 50% of the voting stock of the Company.  As of December 31, 2013 and 2012, no capital had been provided by AIC under this agreement.

 

Investment purchases and sales

 

In November 2011, Allstate Finance Company, LLC (“AFC”), a consolidated subsidiary of ALIC, paid $176 million in cash to purchase loans issued to exclusive Allstate agents (“agent loans”) with a fair value of $175 million on the date of sale and $1 million of accrued investment income from Allstate Bank, an unconsolidated affiliate of ALIC.  Since the transaction was between affiliates under common control, the agent loans were recorded by AFC at Allstate Bank’s carrying value on the date of sale, which was the outstanding unpaid principal balance, net of valuation allowance and deferred fees, of $176 million and $1 million of accrued investment income.  The $1 million difference between the fair value of assets received and Allstate Bank’s carrying value was recorded as an increase to additional capital paid-in.

 

Pension benefit plans

 

Effective November 30, 2011, the Corporation became the sponsor of the defined benefit pension plans that cover most full-time employees, certain part-time employees and employee-agents.  Prior to November 30, 2011, AIC was the sponsor of these plans.  In connection with the change in sponsorship, amounts payable by the Company to the previous plan sponsor, AIC, totaling $4 million were forgiven which was recorded as an increase to retained income.

 

Return of capital

 

In December 2013, the Company paid a return of capital of $500 million to AIC, which was recorded as a reduction of additional capital paid-in on the Consolidated Statements of Financial Position.

 

62



 

6.  Investments

 

Fair values

 

The amortized cost, gross unrealized gains and losses and fair value for fixed income securities are as follows:

 

($ in millions)

 

Amortized

 

Gross unrealized

 

Fair

 

 

 

cost

 

Gains

 

Losses

 

value

 

December 31, 2013

 

 

 

 

 

 

 

 

 

U.S. government and agencies

$

678

$

90

$

(2)

$

766

 

Municipal

 

3,135

 

231

 

(62)

 

3,304

 

Corporate

 

20,397

 

1,214

 

(295)

 

21,316

 

Foreign government

 

715

 

83

 

(6)

 

792

 

ABS

 

1,011

 

30

 

(34)

 

1,007

 

RMBS

 

752

 

50

 

(12)

 

790

 

CMBS

 

724

 

47

 

(7)

 

764

 

Redeemable preferred stock

 

15

 

2

 

-- 

 

17

 

Total fixed income securities

$

27,427

$

1,747

$

(418)

$

28,756

 

 

 

 

 

 

 

 

 

 

 

December 31, 2012

 

 

 

 

 

 

 

 

 

U.S. government and agencies

$

2,137

$

242

$

-- 

$

2,379

 

Municipal

 

4,153

 

612

 

(61)

 

4,704

 

Corporate

 

28,748

 

2,896

 

(113)

 

31,531

 

Foreign government

 

1,017

 

164

 

(1)

 

1,180

 

ABS

 

1,921

 

49

 

(105)

 

1,865

 

RMBS

 

1,778

 

82

 

(69)

 

1,791

 

CMBS

 

1,425

 

60

 

(77)

 

1,408

 

Redeemable preferred stock

 

15

 

3

 

-- 

 

18

 

Total fixed income securities

$

41,194

$

4,108

$

(426)

$

44,876

 

 

Scheduled maturities

 

The scheduled maturities for fixed income securities are as follows as of December 31, 2013:

 

($ in millions)

 

Amortized
cost

 

Fair
value

 

Due in one year or less

$

1,106

$

1,132

 

Due after one year through five years

 

5,060

 

5,457

 

Due after five years through ten years

 

10,955

 

11,316

 

Due after ten years

 

7,819

 

8,290

 

 

 

24,940

 

26,195

 

ABS, RMBS and CMBS

 

2,487

 

2,561

 

Total

$

27,427

$

28,756

 

 

Actual maturities may differ from those scheduled as a result of calls and make-whole payments by the issuers.  ABS, RMBS and CMBS are shown separately because of the potential for prepayment of principal prior to contractual maturity dates.

 

63



 

Net investment income

 

Net investment income for the years ended December 31 is as follows:

 

($ in millions)

 

2013

 

2012

 

2011

 

Fixed income securities

$

1,947

$

2,084

$

2,264

 

Mortgage loans

 

345

 

345

 

345

 

Equity securities

 

12

 

9

 

7

 

Limited partnership interests (1)

 

175

 

159

 

49

 

Short-term investments

 

2

 

2

 

3

 

Policy loans

 

49

 

51

 

53

 

Other

 

63

 

61

 

18

 

Investment income, before expense

 

2,593

 

2,711

 

2,739

 

Investment expense

 

(108)

 

(114)

 

(102)

 

Net investment income

$

2,485

$

2,597

$

2,637

 

 

 

 

 

 

 

 

 

 

(1) Income from EMA limited partnerships is reported in net investment income in 2013 and 2012 and realized capital gains and losses in 2011.

 

Realized capital gains and losses

 

Realized capital gains and losses by asset type for the years ended December 31 are as follows:

 

($ in millions)

 

2013

 

2012

 

2011

 

Fixed income securities

$

3

$

(62)

$

539

 

Mortgage loans

 

20

 

8

 

(23)

 

Equity securities

 

45

 

--

 

14

 

Limited partnership interests (1)

 

(6)

 

--

 

62

 

Derivatives

 

14

 

34

 

(203)

 

Other

 

--

 

4

 

1

 

Realized capital gains and losses

$

76

$

(16)

$

390

 

 

 

 

 

 

 

 

 

 

(1) Income from EMA limited partnerships is reported in net investment income in 2013 and 2012 and realized capital gains and losses in 2011.

 

Realized capital gains and losses by transaction type for the years ended December 31 are as follows:

 

($ in millions)

 

2013

 

2012

 

2011

 

Impairment write-downs

$

(33)

$

(51)

$

(242)

 

Change in intent write-downs

 

(19)

 

(17)

 

(51)

 

Net other-than-temporary impairment losses recognized in earnings

 

(52)

 

(68)

 

(293)

 

Sales

 

114

 

17

 

823

 

Valuation of derivative instruments

 

(3)

 

(16)

 

(224)

 

Settlements of derivative instruments

 

17

 

51

 

22

 

EMA limited partnership income

 

--

 

--

 

62

 

Realized capital gains and losses

$

76

$

(16)

$

390

 

 

Gross gains of $94 million, $225 million and $835 million and gross losses of $46 million, $222 million and $124 million were realized on sales of fixed income securities during 2013, 2012 and 2011, respectively.

 

64



 

Other-than-temporary impairment losses by asset type for the years ended December 31 are as follows:

 

($ in millions)

 

2013

 

2012

 

2011

 

 

 

 

 

Included

 

 

 

 

 

Included

 

 

 

 

 

Included

 

 

 

 

 

Gross

 

in OCI

 

Net

 

Gross

 

in OCI

 

Net

 

Gross

 

in OCI

 

Net

 

Fixed income securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Municipal

$

(8)

$

--

$

(8)

$

--

$

--

$

--

$

(14)

$

(3)

$

(17)

 

Corporate

 

--

 

--

 

--

 

(16)

 

(2)

 

(18)

 

(28)

 

6

 

(22)

 

ABS

 

--

 

(2)

 

(2)

 

--

 

--

 

--

 

(8)

 

2

 

(6)

 

RMBS

 

(2)

 

2

 

--

 

(23)

 

(9)

 

(32)

 

(111)

 

(20)

 

(131)

 

CMBS

 

(32)

 

(3)

 

(35)

 

(22)

 

3

 

(19)

 

(66)

 

1

 

(65)

 

Total fixed income securities

 

(42)

 

(3)

 

(45)

 

(61)

 

(8)

 

(69)

 

(227)

 

(14)

 

(241)

 

Mortgage loans

 

11

 

--

 

11

 

5

 

--

 

5

 

(33)

 

--

 

(33)

 

Equity securities

 

(6)

 

--

 

(6)

 

(1)

 

--

 

(1)

 

(5)

 

--

 

(5)

 

Limited partnership interests

 

(9)

 

--

 

(9)

 

(3)

 

--

 

(3)

 

(3)

 

--

 

(3)

 

Other

 

(3)

 

--

 

(3)

 

--

 

--

 

--

 

(11)

 

--

 

(11)

 

Other-than-temporary impairment losses

$

(49)

$

(3)

$

(52)

$

(60)

$

(8)

$

(68)

$

(279)

$

(14)

$

(293)

 

 

The total amount of other-than-temporary impairment losses included in accumulated other comprehensive income at the time of impairment for fixed income securities, which were not included in earnings, are presented in the following table.  The amount excludes $164 million and $134 million as of December 31, 2013 and 2012, respectively, of net unrealized gains related to changes in valuation of the fixed income securities subsequent to the impairment measurement date.

 

($ in millions)

 

December 31,
2013

 

December 31,
2012

 

Municipal

$

(5)

$

(5)

 

Corporate

 

--

 

(1)

 

ABS

 

(10)

 

(14)

 

RMBS

 

(90)

 

(103)

 

CMBS

 

(12)

 

(19)

 

Total

$

(117)

$

(142)

 

 

Rollforwards of the cumulative credit losses recognized in earnings for fixed income securities held as of December 31 are as follows:

 

($ in millions)

 

2013

 

2012

 

2011

 

Beginning balance

$

(345)

$

(581)

$

(701)

 

Additional credit loss for securities previously other-than-temporarily impaired

 

(13)

 

(33)

 

(76)

 

Additional credit loss for securities not previously other-than-temporarily impaired

 

(19)

 

(20)

 

(114)

 

Reduction in credit loss for securities disposed or collected

 

75

 

288

 

288

 

Reduction in credit loss for securities the Company has made the decision to sell or more likely than not will be required to sell

 

2

 

--

 

13

 

Change in credit loss due to accretion of increase in cash flows

 

1

 

1

 

9

 

Ending balance (1)

$

(299)

$

(345)

$

(581)

 

 

 

 

 

 

 

 

 

 

 

 

(1) The December 31, 2013 ending balance includes $60 million of cumulative credit losses recognized in earnings for fixed income securities that are classified as held for sale.

 

The Company uses its best estimate of future cash flows expected to be collected from the fixed income security, discounted at the security’s original or current effective rate, as appropriate, to calculate a recovery value and determine whether a credit loss exists.  The determination of cash flow estimates is inherently subjective and methodologies may vary depending on facts and circumstances specific to the security.  All reasonably available information relevant to the collectability of the security, including past events, current conditions, and reasonable and supportable assumptions and forecasts, are considered when developing the estimate of cash flows expected to be collected.  That information generally includes, but is not limited to, the remaining payment terms of the security, prepayment speeds, foreign exchange rates, the financial condition and future earnings potential of the issue or issuer, expected defaults, expected recoveries, the value of underlying collateral, vintage, geographic concentration,

 

65



 

available reserves or escrows, current subordination levels, third party guarantees and other credit enhancements.  Other information, such as industry analyst reports and forecasts, sector credit ratings, financial condition of the bond insurer for insured fixed income securities, and other market data relevant to the realizability of contractual cash flows, may also be considered.  The estimated fair value of collateral will be used to estimate recovery value if the Company determines that the security is dependent on the liquidation of collateral for ultimate settlement.  If the estimated recovery value is less than the amortized cost of the security, a credit loss exists and an other-than-temporary impairment for the difference between the estimated recovery value and amortized cost is recorded in earnings.  The portion of the unrealized loss related to factors other than credit remains classified in accumulated other comprehensive income.  If the Company determines that the fixed income security does not have sufficient cash flow or other information to estimate a recovery value for the security, the Company may conclude that the entire decline in fair value is deemed to be credit related and the loss is recorded in earnings.

 

Unrealized net capital gains and losses

 

Unrealized net capital gains and losses included in accumulated other comprehensive income are as follows:

 

($ in millions)

 

Fair

 

Gross unrealized

 

Unrealized net

 

December 31, 2013

 

value

 

Gains

 

Losses

 

gains (losses)

 

Fixed income securities

$

28,756

$

1,747

$

(418)

$

1,329

 

Equity securities

 

650

 

90

 

(5)

 

85

 

Short-term investments

 

590

 

--

 

--

 

--

 

Derivative instruments (1)

 

(13)

 

1

 

(14)

 

(13)

 

EMA limited partnerships (2)

 

 

 

 

 

 

 

(2)

 

Investments classified as held for sale

 

 

 

 

 

 

 

190

 

Unrealized net capital gains and losses, pre-tax

 

 

 

 

 

 

 

1,589

 

Amounts recognized for:

 

 

 

 

 

 

 

 

 

Insurance reserves (3)

 

 

 

 

 

 

 

--

 

DAC and DSI (4)

 

 

 

 

 

 

 

(156)

 

Amounts recognized

 

 

 

 

 

 

 

(156)

 

Deferred income taxes

 

 

 

 

 

 

 

(506)

 

Unrealized net capital gains and losses, after-tax

 

 

 

 

 

 

$

927

 

 

 

 

 

 

 

 

 

 

 

 

(1) Included in the fair value of derivative instruments are $1 million classified as assets and $14 million classified as liabilities.

(2) Unrealized net capital gains and losses for limited partnership interests represent the Company’s share of EMA limited partnerships’ other comprehensive income.  Fair value and gross gains and losses are not applicable.

(3) The insurance reserves adjustment represents the amount by which the reserve balance would increase if the net unrealized gains in the applicable product portfolios were realized and reinvested at current lower interest rates, resulting in a premium deficiency.  Although the Company evaluates premium deficiencies on the combined performance of life insurance and immediate annuities with life contingencies, the adjustment primarily relates to structured settlement annuities with life contingencies, in addition to annuity buy-outs and certain payout annuities with life contingencies.

(4) The DAC and DSI adjustment balance represents the amount by which the amortization of DAC and DSI would increase or decrease if the unrealized gains or losses in the respective product portfolios were realized.

 

($ in millions)

 

Fair

 

Gross unrealized

 

Unrealized net

 

December 31, 2012

 

value

 

Gains

 

Losses

 

gains (losses)

 

Fixed income securities

$

44,876

$

4,108

$

(426)

$

3,682

 

Equity securities

 

345

 

36

 

(1)

 

35

 

Short-term investments

 

875

 

--

 

--

 

--

 

Derivative instruments (1)

 

(17)

 

2

 

(19)

 

(17)

 

EMA limited partnerships

 

 

 

 

 

 

 

1

 

Unrealized net capital gains and losses, pre-tax

 

 

 

 

 

 

 

3,701

 

Amounts recognized for:

 

 

 

 

 

 

 

 

 

Insurance reserves

 

 

 

 

 

 

 

(771)

 

DAC and DSI

 

 

 

 

 

 

 

(408)

 

Amounts recognized

 

 

 

 

 

 

 

(1,179)

 

Deferred income taxes

 

 

 

 

 

 

 

(888)

 

Unrealized net capital gains and losses, after-tax

 

 

 

 

 

 

$

1,634

 

 

 

(1) Included in the fair value of derivative instruments are $2 million classified as assets and $19 million classified as liabilities.

 

66



 

Change in unrealized net capital gains and losses

 

The change in unrealized net capital gains and losses for the years ended December 31 is as follows:

 

($ in millions)

 

2013

 

2012

 

2011

 

Fixed income securities

$

(2,353)

$

1,735

$

1,219

 

Equity securities

 

50

 

(1)

 

(11)

 

Derivative instruments

 

4

 

(5)

 

5

 

EMA limited partnerships

 

(3)

 

--

 

1

 

Investments classified as held for sale

 

190

 

--

 

--

 

Total

 

(2,112)

 

1,729

 

1,214

 

Amounts recognized for:

 

 

 

 

 

 

 

Insurance reserves

 

771

 

(177)

 

(585)

 

DAC and DSI

 

252

 

(288)

 

(207)

 

Amounts recognized

 

1,023

 

(465)

 

(792)

 

Deferred income taxes

 

382

 

(443)

 

(147)

 

(Decrease) increase in unrealized net capital gains and losses, after-tax

$

(707)

$

821

$

275

 

 

Portfolio monitoring

 

The Company has a comprehensive portfolio monitoring process to identify and evaluate each fixed income and equity security whose carrying value may be other-than-temporarily impaired.

 

For each fixed income security in an unrealized loss position, the Company assesses whether management with the appropriate authority has made the decision to sell or whether it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes.  If a security meets either of these criteria, the security’s decline in fair value is considered other than temporary and is recorded in earnings.

 

If the Company has not made the decision to sell the fixed income security and it is not more likely than not the Company will be required to sell the fixed income security before recovery of its amortized cost basis, the Company evaluates whether it expects to receive cash flows sufficient to recover the entire amortized cost basis of the security.  The Company calculates the estimated recovery value by discounting the best estimate of future cash flows at the security’s original or current effective rate, as appropriate, and compares this to the amortized cost of the security.  If the Company does not expect to receive cash flows sufficient to recover the entire amortized cost basis of the fixed income security, the credit loss component of the impairment is recorded in earnings, with the remaining amount of the unrealized loss related to other factors recognized in other comprehensive income.

 

For equity securities, the Company considers various factors, including whether it has the intent and ability to hold the equity security for a period of time sufficient to recover its cost basis.  Where the Company lacks the intent and ability to hold to recovery, or believes the recovery period is extended, the equity security’s decline in fair value is considered other than temporary and is recorded in earnings.

 

For fixed income and equity securities managed by third parties, either the Company has contractually retained its decision making authority as it pertains to selling securities that are in an unrealized loss position or it recognizes any unrealized loss at the end of the period through a charge to earnings.

 

The Company’s portfolio monitoring process includes a quarterly review of all securities to identify instances where the fair value of a security compared to its amortized cost (for fixed income securities) or cost (for equity securities) is below established thresholds.  The process also includes the monitoring of other impairment indicators such as ratings, ratings downgrades and payment defaults.  The securities identified, in addition to other securities for which the Company may have a concern, are evaluated for potential other-than-temporary impairment using all reasonably available information relevant to the collectability or recovery of the security.  Inherent in the Company’s evaluation of other-than-temporary impairment for these fixed income and equity securities are assumptions and estimates about the financial condition and future earnings potential of the issue or issuer.  Some of the factors that may be considered in evaluating whether a decline in fair value is other than temporary are: 1) the financial condition, near-term and long-term prospects of the issue or issuer, including relevant industry specific market conditions and trends, geographic location and implications of rating agency actions and offering prices; 2) the specific reasons that a security is in an unrealized loss position, including overall market conditions which could affect liquidity; and 3) the length of time and extent to which the fair value has been less than amortized cost or cost.

 

67



 

The following table summarizes the gross unrealized losses and fair value of fixed income and equity securities by the length of time that individual securities have been in a continuous unrealized loss position.

 

($ in millions)

 

Less than 12 months

 

12 months or more

 

Total

 

 

 

Number

 

Fair

 

Unrealized

 

Number

 

Fair

 

Unrealized

 

unrealized

 

 

 

of issues

 

value

 

losses

 

of issues

 

value

 

losses

 

losses

 

December 31, 2013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government and agencies

 

4

$

76

$

(2)

 

--

$

--

$

--

$

(2)

 

Municipal

 

63

 

347

 

(24)

 

21

 

99

 

(38)

 

(62)

 

Corporate

 

530

 

5,191

 

(224)

 

48

 

467

 

(71)

 

(295)

 

Foreign government

 

7

 

76

 

(4)

 

1

 

13

 

(2)

 

(6)

 

ABS

 

17

 

162

 

(1)

 

42

 

400

 

(33)

 

(34)

 

RMBS

 

35

 

42

 

(2)

 

47

 

129

 

(10)

 

(12)

 

CMBS

 

5

 

14

 

--

 

6

 

52

 

(7)

 

(7)

 

Redeemable preferred stock

 

--

 

--

 

--

 

--

 

--

 

--

 

--

 

Total fixed income securities

 

661

 

5,908

 

(257)

 

165

 

1,160

 

(161)

 

(418)

 

Equity securities

 

25

 

80

 

(5)

 

--

 

--

 

--

 

(5)

 

Total fixed income and equity securities

 

686

$

5,988

$

(262)

 

165

$

1,160

$

(161)

$

(423)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment grade fixed income securities

 

526

$

5,272

$

(236)

 

110

$

834

$

(112)

$

(348)

 

Below investment grade fixed income securities

 

135

 

636

 

(21)

 

55

 

326

 

(49)

 

(70)

 

Total fixed income securities

 

661

$

5,908

$

(257)

 

165

$

1,160

$

(161)

$

(418)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2012

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government and agencies

 

1

$

15

$

--

 

--

$

--

$

--

$

--

 

Municipal

 

11

 

101

 

(7)

 

50

 

395

 

(54)

 

(61)

 

Corporate

 

79

 

1,086

 

(27)

 

66

 

829

 

(86)

 

(113)

 

Foreign government

 

2

 

121

 

(1)

 

--

 

--

 

--

 

(1)

 

ABS

 

5

 

38

 

--

 

76

 

763

 

(105)

 

(105)

 

RMBS

 

49

 

30

 

--

 

164

 

442

 

(69)

 

(69)

 

CMBS

 

10

 

65

 

--

 

43

 

358

 

(77)

 

(77)

 

Redeemable preferred stock

 

--

 

--

 

--

 

1

 

--

 

--

 

--

 

Total fixed income securities

 

157

 

1,456

 

(35)

 

400

 

2,787

 

(391)

 

(426)

 

Equity securities

 

3

 

57

 

(1)

 

1

 

--

 

--

 

(1)

 

Total fixed income and equity securities

 

160

$

1,513

$

(36)

 

401

$

2,787

$

(391)

$

(427)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment grade fixed income securities

 

132

$

1,244

$

(29)

 

262

$

1,919

$

(195)

$

(224)

 

Below investment grade fixed income securities

 

25

 

212

 

(6)

 

138

 

868

 

(196)

 

(202)

 

Total fixed income securities

 

157

$

1,456

$

(35)

 

400

$

2,787

$

(391)

$

(426)

 

 

As of December 31, 2013, $331 million of unrealized losses are related to securities with an unrealized loss position less than 20% of amortized cost or cost, the degree of which suggests that these securities do not pose a high risk of being other-than-temporarily impaired.  Of the $331 million, $276 million are related to unrealized losses on investment grade fixed income securities.  Investment grade is defined as a security having a rating of Aaa, Aa, A or Baa from Moody’s, a rating of AAA, AA, A or BBB from S&P, Fitch, Dominion, Kroll or Realpoint, a rating of aaa, aa, a or bbb from A.M. Best, or a comparable internal rating if an externally provided rating is not available.  Unrealized losses on investment grade securities are principally related to increasing risk-free interest rates or widening credit spreads since the time of initial purchase.

 

As of December 31, 2013, the remaining $92 million of unrealized losses are related to securities in unrealized loss positions greater than or equal to 20% of amortized cost.  Investment grade fixed income securities comprising $72 million of these unrealized losses were evaluated based on factors such as discounted cash flows and the financial condition and near-term and long-term prospects of the issue or issuer and were determined to have adequate resources to fulfill contractual obligations.  Of the $92 million, $20 million are related to below investment grade fixed income securities.  Of these amounts, $15 million are related to below investment grade fixed income securities that had been in an unrealized loss position greater than or equal to 20% of amortized cost for a period of twelve or more consecutive months as of December 31, 2013.

 

ABS, RMBS and CMBS in an unrealized loss position were evaluated based on actual and projected collateral losses relative to the securities’ positions in the respective securitization trusts, security specific expectations of cash flows, and credit ratings.  This evaluation also takes into consideration credit enhancement, measured in terms of (i)

 

68



 

subordination from other classes of securities in the trust that are contractually obligated to absorb losses before the class of security the Company owns, (ii) the expected impact of other structural features embedded in the securitization trust beneficial to the class of securities the Company owns, such as overcollateralization and excess spread, and (iii) for ABS and RMBS in an unrealized loss position, credit enhancements from reliable bond insurers, where applicable.  Municipal bonds in an unrealized loss position were evaluated based on the quality of the underlying securities.  Unrealized losses on equity securities are primarily related to temporary equity market fluctuations of securities that are expected to recover.

 

As of December 31, 2013, the Company has not made the decision to sell and it is not more likely than not the Company will be required to sell fixed income securities with unrealized losses before recovery of the amortized cost basis.  As of December 31, 2013, the Company had the intent and ability to hold equity securities with unrealized losses for a period of time sufficient for them to recover.

 

Limited partnerships

 

As of December 31, 2013 and 2012, the carrying value of equity method limited partnerships totaled $1.46 billion and $1.31 billion, respectively.  The Company recognizes an impairment loss for equity method limited partnerships when evidence demonstrates that the loss is other than temporary.  Evidence of a loss in value that is other than temporary may include the absence of an ability to recover the carrying amount of the investment or the inability of the investee to sustain a level of earnings that would justify the carrying amount of the investment.  The Company had no write-downs related to equity method limited partnerships in 2013 or 2012.  In 2011, the Company had write-downs related to equity method limited partnerships of $1 million.

 

As of December 31, 2013 and 2012, the carrying value for cost method limited partnerships was $605 million and $617 million, respectively.  To determine if an other-than-temporary impairment has occurred, the Company evaluates whether an impairment indicator has occurred in the period that may have a significant adverse effect on the carrying value of the investment.  Impairment indicators may include: significantly reduced valuations of the investments held by the limited partnerships; actual recent cash flows received being significantly less than expected cash flows; reduced valuations based on financing completed at a lower value; completed sale of a material underlying investment at a price significantly lower than expected; or any other adverse events since the last financial statements received that might affect the fair value of the investee’s capital.  Additionally, the Company’s portfolio monitoring process includes a quarterly review of all cost method limited partnerships to identify instances where the net asset value is below established thresholds for certain periods of time, as well as investments that are performing below expectations, for further impairment consideration.  If a cost method limited partnership is other-than-temporarily impaired, the carrying value is written down to fair value, generally estimated to be equivalent to the reported net asset value of the underlying funds.  In 2013, 2012 and 2011, the Company had write-downs related to cost method limited partnerships of $9 million, $3 million and $2 million, respectively.

 

Mortgage loans

 

The Company’s mortgage loans are commercial mortgage loans collateralized by a variety of commercial real estate property types located throughout the United States and totaled, net of valuation allowance, $4.17 billion and $5.94 billion as of December 31, 2013 and 2012, respectively.  Substantially all of the commercial mortgage loans are non-recourse to the borrower.  The following table shows the principal geographic distribution of commercial real estate represented in the Company’s mortgage loan portfolio.  No other state represented more than 5% of the portfolio as of December 31.

 

(% of mortgage loan portfolio carrying value)

 

2013

 

2012

 

California

 

24.0

%

24.2

%

Illinois

 

9.7

 

7.8

 

New Jersey

 

7.2

 

6.5

 

Texas

 

6.3

 

6.0

 

New York

 

6.2

 

6.6

 

District of Columbia

 

5.4

 

3.8

 

Florida

 

5.2

 

4.3

 

Pennsylvania

 

3.9

 

5.1

 

 

69



 

The types of properties collateralizing the mortgage loans as of December 31 are as follows:

 

(% of mortgage loan portfolio carrying value)

 

2013

 

2012

 

Office buildings

 

28.3

%

28.0

%

Retail

 

22.9

 

24.0

 

Apartment complex

 

19.2

 

17.4

 

Warehouse

 

18.6

 

20.4

 

Other

 

11.0

 

10.2

 

Total

 

100.0

%

100.0

%

 

The contractual maturities of the mortgage loan portfolio as of December 31, 2013 are as follows:

 

($ in millions)

 

Number
of loans

 

Carrying
value

 

Percent

 

2014

 

23

$

325

 

7.8

%

2015

 

38

 

616

 

14.8

 

2016

 

34

 

334

 

8.0

 

2017

 

40

 

449

 

10.8

 

Thereafter

 

193

 

2,449

 

58.6

 

Total

 

328

$

4,173

 

100.0

%

 

Mortgage loans are evaluated for impairment on a specific loan basis through a quarterly credit monitoring process and review of key credit quality indicators.  Mortgage loans are considered impaired when it is probable that the Company will not collect the contractual principal and interest.  Valuation allowances are established for impaired loans to reduce the carrying value to the fair value of the collateral less costs to sell or the present value of the loan’s expected future repayment cash flows discounted at the loan’s original effective interest rate.  Impaired mortgage loans may not have a valuation allowance when the fair value of the collateral less costs to sell is higher than the carrying value.  Valuation allowances are adjusted for subsequent changes in the fair value of the collateral less costs to sell.  Mortgage loans are charged off against their corresponding valuation allowances when there is no reasonable expectation of recovery.  The impairment evaluation is non-statistical in respect to the aggregate portfolio but considers facts and circumstances attributable to each loan.  It is not considered probable that additional impairment losses, beyond those identified on a specific loan basis, have been incurred as of December 31, 2013.

 

Accrual of income is suspended for mortgage loans that are in default or when full and timely collection of principal and interest payments is not probable.  Cash receipts on mortgage loans on nonaccrual status are generally recorded as a reduction of carrying value.

 

Debt service coverage ratio is considered a key credit quality indicator when mortgage loans are evaluated for impairment.  Debt service coverage ratio represents the amount of estimated cash flows from the property available to the borrower to meet principal and interest payment obligations.  Debt service coverage ratio estimates are updated annually or more frequently if conditions are warranted based on the Company’s credit monitoring process.

 

The following table reflects the carrying value of non-impaired fixed rate and variable rate mortgage loans summarized by debt service coverage ratio distribution as of December 31.

 

($ in millions)

 

2013

 

2012

 

Debt service coverage
ratio distribution

 

Fixed rate
mortgage
loans

 

Variable rate
mortgage
loans

 

Total

 

Fixed rate
mortgage
loans

 

Variable rate
mortgage
loans

 

Total

 

Below 1.0

$

153

$

--

$

153

$

266

$

--

$

266

 

1.0 - 1.25

 

560

 

--

 

560

 

1,158

 

--

 

1,158

 

1.26 - 1.50

 

1,167

 

2

 

1,169

 

1,364

 

17

 

1,381

 

Above 1.50

 

2,176

 

38

 

2,214

 

2,854

 

129

 

2,983

 

Total non-impaired mortgage loans

$

4,056

$

40

$

4,096

$

5,642

$

146

$

5,788

 

 

Mortgage loans with a debt service coverage ratio below 1.0 that are not considered impaired primarily relate to instances where the borrower has the financial capacity to fund the revenue shortfalls from the properties for the foreseeable term, the decrease in cash flows from the properties is considered temporary, or there are other risk mitigating circumstances such as additional collateral, escrow balances or borrower guarantees.

 

70



 

The net carrying value of impaired mortgage loans as of December 31 is as follows:

 

($ in millions)

 

2013

 

 

2012

 

Impaired mortgage loans with a valuation allowance

$

77

 

$

147

 

Impaired mortgage loans without a valuation allowance

 

--

 

 

8

 

Total impaired mortgage loans

$

77

 

$

155

 

Valuation allowance on impaired mortgage loans

$

21

 

$

42

 

 

The average balance of impaired loans was $86 million, $202 million and $207 million during 2013, 2012 and 2011, respectively.

 

The rollforward of the valuation allowance on impaired mortgage loans for the years ended December 31 is as follows:

 

($ in millions)

 

2013

 

2012

 

2011

Beginning balance

$

42

$

63

$

84

Net (decrease) increase in valuation allowance

 

(11)

 

(5)

 

33

Charge offs

 

(8)

 

(16)

 

(54)

Mortgage loans classified as held for sale

 

(2)

 

--

 

--

Ending balance

$

21

$

42

$

63

 

The carrying value of past due mortgage loans as of December 31 is as follows:

 

($ in millions)

 

2013

 

 

2012

 

Less than 90 days past due

$

--

 

$

20

 

90 days or greater past due

 

--

 

 

4

 

Total past due

 

--

 

 

24

 

Current loans

 

4,173

 

 

5,919

 

Total mortgage loans

$

4,173

 

$

5,943

 

 

Municipal bonds

 

The Company maintains a diversified portfolio of municipal bonds.  The following table shows the principal geographic distribution of municipal bond issuers represented in the Company’s portfolio as of December 31.  No other state represents more than 5% of the portfolio.

 

(% of municipal bond portfolio carrying value)

 

2013

 

2012

 

California

 

15.9

%

14.1

%

Texas

 

13.5

 

11.8

 

Oregon

 

5.4

 

4.7

 

New Jersey

 

5.2

 

4.5

 

New York

 

5.2

 

7.1

 

Illinois

 

5.1

 

4.3

 

 

Concentration of credit risk

 

As of December 31, 2013, the Company is not exposed to any credit concentration risk of a single issuer and its affiliates greater than 10% of the Company’s shareholder’s equity.

 

Securities loaned

 

The Company’s business activities include securities lending programs with third parties, mostly large banks.  As of December 31, 2013 and 2012, fixed income securities with a carrying value of $312 million and $525 million, respectively, were on loan under these agreements.  Interest income on collateral, net of fees, was $1 million in each of 2013, 2012 and 2011.

 

Other investment information

 

Included in fixed income securities are below investment grade assets totaling $2.89 billion and $3.35 billion as of December 31, 2013 and 2012, respectively.

 

As of December 31, 2013, fixed income securities and short-term investments with a carrying value of $53 million were on deposit with regulatory authorities as required by law.

 

71



 

As of December 31, 2013, the carrying value of fixed income securities that were non-income producing was $11 million.

 

7.  Fair Value of Assets and Liabilities

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  The hierarchy for inputs used in determining fair value maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that observable inputs be used when available.  Assets and liabilities recorded on the Consolidated Statements of Financial Position at fair value are categorized in the fair value hierarchy based on the observability of inputs to the valuation techniques as follows:

 

Level 1:     Assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company can access.

 

Level 2:     Assets and liabilities whose values are based on the following:

 

(a)  Quoted prices for similar assets or liabilities in active markets;

(b)  Quoted prices for identical or similar assets or liabilities in markets that are not active; or

(c)  Valuation models whose inputs are observable, directly or indirectly, for substantially the full term of the asset or liability.

 

Level 3:     Assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement.  Unobservable inputs reflect the Company’s estimates of the assumptions that market participants would use in valuing the assets and liabilities.

 

The availability of observable inputs varies by instrument.  In situations where fair value is based on internally developed pricing models or inputs that are unobservable in the market, the determination of fair value requires more judgment.  The degree of judgment exercised by the Company in determining fair value is typically greatest for instruments categorized in Level 3.  In many instances, valuation inputs used to measure fair value fall into different levels of the fair value hierarchy.  The category level in the fair value hierarchy is determined based on the lowest level input that is significant to the fair value measurement in its entirety.  The Company uses prices and inputs that are current as of the measurement date, including during periods of market disruption.  In periods of market disruption, the ability to observe prices and inputs may be reduced for many instruments.

 

The Company is responsible for the determination of fair value and the supporting assumptions and methodologies.  The Company gains assurance that assets and liabilities are appropriately valued through the execution of various processes and controls designed to ensure the overall reasonableness and consistent application of valuation methodologies, including inputs and assumptions, and compliance with accounting standards.  For fair values received from third parties or internally estimated, the Company’s processes and controls are designed to ensure that the valuation methodologies are appropriate and consistently applied, the inputs and assumptions are reasonable and consistent with the objective of determining fair value, and the fair values are accurately recorded.  For example, on a continuing basis, the Company assesses the reasonableness of individual fair values that have stale security prices or that exceed certain thresholds as compared to previous fair values received from valuation service providers or brokers or derived from internal models.  The Company performs procedures to understand and assess the methodologies, processes and controls of valuation service providers.  In addition, the Company may validate the reasonableness of fair values by comparing information obtained from valuation service providers or brokers to other third party valuation sources for selected securities.  The Company performs ongoing price validation procedures such as back-testing of actual sales, which corroborate the various inputs used in internal models to market observable data.  When fair value determinations are expected to be more variable, the Company validates them through reviews by members of management who have relevant expertise and who are independent of those charged with executing investment transactions.

 

The Company has two types of situations where investments are classified as Level 3 in the fair value hierarchy.  The first is where quotes continue to be received from independent third-party valuation service providers and all significant inputs are market observable; however, there has been a significant decrease in the volume and level of activity for the asset when compared to normal market activity such that the degree of market observability has declined to a point where categorization as a Level 3 measurement is considered appropriate.  The indicators considered in determining whether a significant decrease in the volume and level of activity for a specific asset has occurred include the level of new issuances in the primary market, trading volume in the secondary market, the level

 

72



 

of credit spreads over historical levels, applicable bid-ask spreads, and price consensus among market participants and other pricing sources.

 

The second situation where the Company classifies securities in Level 3 is where specific inputs significant to the fair value estimation models are not market observable.  This primarily occurs in the Company’s use of broker quotes to value certain securities where the inputs have not been corroborated to be market observable, and the use of valuation models that use significant non-market observable inputs.

 

Certain assets are not carried at fair value on a recurring basis, including investments such as mortgage loans, limited partnership interests, bank loans and policy loans.  Accordingly, such investments are only included in the fair value hierarchy disclosure when the investment is subject to remeasurement at fair value after initial recognition and the resulting remeasurement is reflected in the consolidated financial statements.  In addition, derivatives embedded in fixed income securities are not disclosed in the hierarchy as free-standing derivatives since they are presented with the host contracts in fixed income securities.

 

In determining fair value, the Company principally uses the market approach which generally utilizes market transaction data for the same or similar instruments.  To a lesser extent, the Company uses the income approach which involves determining fair values from discounted cash flow methodologies.  For the majority of Level 2 and Level 3 valuations, a combination of the market and income approaches is used.

 

Summary of significant valuation techniques for assets and liabilities measured at fair value on a recurring basis

 

Level 1 measurements

 

·       Fixed income securities:  Comprise certain U.S. Treasuries.  Valuation is based on unadjusted quoted prices for identical assets in active markets that the Company can access.

 

·       Equity securities:  Comprise actively traded, exchange-listed equity securities. Valuation is based on unadjusted quoted prices for identical assets in active markets that the Company can access.

 

·       Short-term:  Comprise actively traded money market funds that have daily quoted net asset values for identical assets that the Company can access.

 

·       Separate account assets:  Comprise actively traded mutual funds that have daily quoted net asset values for identical assets that the Company can access.  Net asset values for the actively traded mutual funds in which the separate account assets are invested are obtained daily from the fund managers.

 

·       Assets held for sale:  Comprise U.S. Treasury fixed income securities, short-term investments and separate account assets.  The valuation is based on the respective asset type as described above.

 

Level 2 measurements

 

·       Fixed income securities:

 

U.S. government and agencies:  The primary inputs to the valuation include quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields and credit spreads.

 

Municipal:  The primary inputs to the valuation include quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields and credit spreads.

 

Corporate, including privately placed:  The primary inputs to the valuation include quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields and credit spreads.  Also included are privately placed securities valued using a discounted cash flow model that is widely accepted in the financial services industry and uses market observable inputs and inputs derived principally from, or corroborated by, observable market data.  The primary inputs to the discounted cash flow model include an interest rate yield curve, as well as published credit spreads for similar assets in markets that are not active that incorporate the credit quality and industry sector of the issuer.

 

Foreign government:  The primary inputs to the valuation include quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields and credit spreads.

 

ABS and RMBS:  The primary inputs to the valuation include quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields, prepayment speeds, collateral performance and credit spreads.  Certain ABS are valued based on non-binding broker quotes whose inputs have been corroborated to be market observable.

 

73



 

CMBS:  The primary inputs to the valuation include quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields, collateral performance and credit spreads.

 

Redeemable preferred stock:  The primary inputs to the valuation include quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields, underlying stock prices and credit spreads.

 

·       Equity securities:  The primary inputs to the valuation include quoted prices or quoted net asset values for identical or similar assets in markets that are not active.

 

·       Short-term:  The primary inputs to the valuation include quoted prices for identical or similar assets in markets that are not active, contractual cash flows, benchmark yields and credit spreads.  For certain short-term investments, amortized cost is used as the best estimate of fair value.

 

·       Other investments:  Free-standing exchange listed derivatives that are not actively traded are valued based on quoted prices for identical instruments in markets that are not active.

 

OTC derivatives, including interest rate swaps, foreign currency swaps, foreign exchange forward contracts, certain options and certain credit default swaps, are valued using models that rely on inputs such as interest rate yield curves, currency rates, and counterparty credit spreads that are observable for substantially the full term of the contract.  The valuation techniques underlying the models are widely accepted in the financial services industry and do not involve significant judgment.

 

·       Assets held for sale:  Comprise U.S. government and agencies, municipal, corporate, foreign government, ABS, RMBS and CMBS fixed income securities, and short-term investments.  The valuation is based on the respective asset type as described above.

 

Level 3 measurements

 

·       Fixed income securities:

 

Municipal:  Municipal bonds that are not rated by third party credit rating agencies but are rated by the National Association of Insurance Commissioners (“NAIC”).  The primary inputs to the valuation of these municipal bonds include quoted prices for identical or similar assets in markets that exhibit less liquidity relative to those markets supporting Level 2 fair value measurements, contractual cash flows, benchmark yields and credit spreads.  Also includes auction rate securities (“ARS”) primarily backed by student loans that have become illiquid due to failures in the auction market are valued using a discounted cash flow model that is widely accepted in the financial services industry and uses significant non-market observable inputs, including the anticipated date liquidity will return to the market.

 

Corporate, including privately placed:  Primarily valued based on non-binding broker quotes where the inputs have not been corroborated to be market observable.  Also included are equity-indexed notes which are valued using a discounted cash flow model that is widely accepted in the financial services industry and uses significant non-market observable inputs, such as volatility.  Other inputs include an interest rate yield curve, as well as published credit spreads for similar assets that incorporate the credit quality and industry sector of the issuer.

 

ABS, RMBS and CMBS:  Valued based on non-binding broker quotes received from brokers who are familiar with the investments and where the inputs have not been corroborated to be market observable.

 

·       Equity securities:  The primary inputs to the valuation include quoted prices or quoted net asset values for identical or similar assets in markets that exhibit less liquidity relative to those markets supporting Level 2 fair value measurements.

 

·       Other investments:  Certain OTC derivatives, such as interest rate caps, certain credit default swaps and certain options (including swaptions), are valued using models that are widely accepted in the financial services industry.  These are categorized as Level 3 as a result of the significance of non-market observable inputs such as volatility.  Other primary inputs include interest rate yield curves and credit spreads.

 

·       Assets held for sale:  Comprise municipal, corporate, ABS and CMBS fixed income securities.  The valuation is based on the respective asset type as described above.

 

·       Contractholder funds:  Derivatives embedded in certain life and annuity contracts are valued internally using models widely accepted in the financial services industry that determine a single best estimate of fair value for

 

74



 

the embedded derivatives within a block of contractholder liabilities.  The models primarily use stochastically determined cash flows based on the contractual elements of embedded derivatives, projected option cost and applicable market data, such as interest rate yield curves and equity index volatility assumptions.  These are categorized as Level 3 as a result of the significance of non-market observable inputs.

 

·       Liabilities held for sale:  Comprise derivatives embedded in life and annuity contracts.  The valuation is the same as described above for contractholder funds.

 

Assets and liabilities measured at fair value on a non-recurring basis

 

Mortgage loans written-down to fair value in connection with recognizing impairments are valued based on the fair value of the underlying collateral less costs to sell.  Limited partnership interests written-down to fair value in connection with recognizing other-than-temporary impairments are valued using net asset values.  The carrying value of the LBL business was written-down to fair value in connection with being classified as held for sale.

 

The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring and non-recurring basis as of December 31, 2013.

 

($ in millions)

 

Quoted prices
in active
markets for
identical assets

(Level 1)

 

 

Significant
other
observable
inputs

(Level 2)

 

 

Significant
unobservable
inputs

(Level 3)

 

 

Counterparty
and cash
collateral

netting

 

 

Balance as of
December 31,
2013

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government and agencies

$

145

 

$

621

 

$

--

 

 

 

 

$

766

Municipal

 

--

 

 

3,185

 

 

119

 

 

 

 

 

3,304

Corporate

 

--

 

 

20,308

 

 

1,008

 

 

 

 

 

21,316

Foreign government

 

--

 

 

792

 

 

--

 

 

 

 

 

792

ABS

 

--

 

 

895

 

 

112

 

 

 

 

 

1,007

RMBS

 

--

 

 

790

 

 

--

 

 

 

 

 

790

CMBS

 

--

 

 

763

 

 

1

 

 

 

 

 

764

Redeemable preferred stock

 

--

 

 

16

 

 

1

 

 

 

 

 

17

Total fixed income securities

 

145

 

 

27,370

 

 

1,241

 

 

 

 

 

28,756

Equity securities

 

593

 

 

51

 

 

6

 

 

 

 

 

650

Short-term investments

 

129

 

 

461

 

 

--

 

 

 

 

 

590

Other investments: Free-standing derivatives

 

--

 

 

268

 

 

9

 

$

(11)

 

 

266

Separate account assets

 

5,039

 

 

--

 

 

--

 

 

 

 

 

5,039

Assets held for sale

 

1,854

 

 

9,812

 

 

362

 

 

 

 

 

12,028

Total recurring basis assets

 

7,760

 

 

37,962

 

 

1,618

 

 

(11)

 

 

47,329

Non-recurring basis (1)

 

--

 

 

--

 

 

17

 

 

 

 

 

17

Total assets at fair value

$

7,760

 

$

 37,962

 

$

1,635

 

$

(11)

 

$

47,346

% of total assets at fair value

 

16.4 %

 

 

80.2 %

 

 

3.4 %

 

 

-- %

 

 

100.0 %

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contractholder funds: Derivatives embedded
in life and annuity contracts

$

--

 

$

--

 

$

(307)

 

 

 

 

$

(307)

Other liabilities: Free-standing derivatives

 

--

 

 

(185)

 

 

(14)

 

$

7

 

 

(192)

Liabilities held for sale

 

--

 

 

--

 

 

(246)

 

 

 

 

 

(246)

Total recurring basis liabilities

 

--

 

 

(185)

 

 

(567)

 

 

7

 

 

(745)

Non-recurring basis (2)

 

--

 

 

--

 

 

(11,088)

 

 

 

 

 

(11,088)

Total liabilities at fair value

$

--

 

$

(185)

 

$

(11,655)

 

$

7

 

$

(11,833)

% of total liabilities at fair value

 

-- %

 

 

1.6 %

 

 

98.5 %

 

 

(0.1) %

 

 

100.0 %

 


(1) Includes $8 million of mortgage loans and $9 million of limited partnership interests written-down to fair value in connection with recognizing other-than-temporary impairments.

(2) Relates to LBL business held for sale (see Note 3).  The total fair value measurement includes $15,593 million of assets held for sale and $(14,899) million of liabilities held for sale, less $12,028 million of assets and $(246) million of liabilities measured at fair value on a recurring basis.

 

75



 

The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring and non-recurring basis as of December 31, 2012.

 

($ in millions)

 

Quoted prices
in active
markets for
identical assets

(Level 1)

 

 

Significant
other
observable
inputs

(Level 2)

 

 

Significant
unobservable
inputs

(Level 3)

 

 

Counterparty
and cash
collateral

netting

 

 

Balance as of
December 31,
2012

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. government and agencies

$

1,074

 

$

1,305

 

$

--

 

 

 

 

$

2,379

Municipal

 

--

 

 

4,366

 

 

338

 

 

 

 

 

4,704

Corporate

 

--

 

 

30,030

 

 

1,501

 

 

 

 

 

31,531

Foreign government

 

--

 

 

1,180

 

 

--

 

 

 

 

 

1,180

ABS

 

--

 

 

1,666

 

 

199

 

 

 

 

 

1,865

RMBS

 

--

 

 

1,791

 

 

--

 

 

 

 

 

1,791

CMBS

 

--

 

 

1,387

 

 

21

 

 

 

 

 

1,408

Redeemable preferred stock

 

--

 

 

17

 

 

1

 

 

 

 

 

18

Total fixed income securities

 

1,074

 

 

41,742

 

 

2,060

 

 

 

 

 

44,876

Equity securities

 

338

 

 

--

 

 

7

 

 

 

 

 

345

Short-term investments

 

220

 

 

655

 

 

--

 

 

 

 

 

875

Other investments: Free-standing derivatives

 

--

 

 

173

 

 

3

 

$

(47)

 

 

129

Separate account assets

 

6,610

 

 

--

 

 

--

 

 

 

 

 

6,610

Other assets

 

2

 

 

--

 

 

1

 

 

 

 

 

3

Total recurring basis assets

 

8,244

 

 

42,570

 

 

2,071

 

 

(47)

 

 

52,838

Non-recurring basis (1)

 

--

 

 

--

 

 

6

 

 

 

 

 

6

Total assets at fair value

$

8,244

 

$

42,570

 

$

2,077

 

$

(47)

 

$

52,844

% of total assets at fair value

 

15.6 %

 

 

80.6 %

 

 

3.9 %

 

 

(0.1) %

 

 

100.0 %

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contractholder funds: Derivatives embedded in life and annuity contracts

$

--

 

$

--

 

$

(553)

 

 

 

 

$

(553)

Other liabilities: Free-standing derivatives

 

--

 

 

(91)

 

 

(30)

 

$

29

 

 

(92)

Total liabilities at fair value

$

--

 

$

(91)

 

$

(583)

 

$

29

 

$

(645)

% of total liabilities at fair value

 

-- %

 

 

14.1 %

 

 

90.4 %

 

 

(4.5) %

 

 

100.0 %

 


(1)   Includes $4 million of mortgage loans, $1 million of limited partnership interests and $1 million of other investments written-down to fair value in connection with recognizing other-than-temporary impairments.

 

76



 

The following table summarizes quantitative information about the significant unobservable inputs used in Level 3 fair value measurements.

 

($ in millions)

 

Fair value

 

Valuation
technique

 

Unobservable
input

 

Range

 

Weighted
average

December 31, 2013

 

 

 

 

 

 

 

 

 

 

Derivatives embedded in life and annuity contracts – Equity-indexed and forward starting options

 

$

(247)

 

Stochastic cash flow model

 

Projected option cost

 

1.0 - 2.0 %

 

1.75 %

 

 

 

 

 

 

 

 

 

 

 

Liabilities held for sale – Equity-indexed and forward starting options

 

$

(246)

 

Stochastic cash flow model

 

Projected option cost

 

1.0 - 2.0 %

 

1.91 %

 

 

 

 

 

 

 

 

 

 

 

December 31, 2012

 

 

 

 

 

 

 

 

 

 

ARS backed by student loans

 

$

202

 

Discounted cash flow model

 

Anticipated date liquidity will return to the market

 

18 - 60 months

 

32 - 44 months

 

 

 

 

 

 

 

 

 

 

 

Derivatives embedded in life and annuity contracts – Equity-indexed and forward starting options

 

$

(419)

 

Stochastic cash flow model

 

Projected option cost

 

1.0 - 2.0 %

 

1.92 %

 

If the projected option cost increased (decreased), it would result in a higher (lower) liability fair value.  If the anticipated date liquidity will return to the market is sooner (later), it would result in a higher (lower) fair value.

 

As of December 31, 2013 and 2012, Level 3 fair value measurements include $1.15 billion and $1.72 billion, respectively, of fixed income securities valued based on non-binding broker quotes where the inputs have not been corroborated to be market observable.  As of December 31, 2013, Level 3 fair value measurements for assets held for sale include $319 million of fixed income securities valued based on non-binding broker quotes where the inputs have not been corroborated to be market observable.  The Company does not develop the unobservable inputs used in measuring fair value; therefore, these are not included in the table above.  However, an increase (decrease) in credit spreads for fixed income securities valued based on non-binding broker quotes would result in a lower (higher) fair value.

 

77



 

The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the year ended December 31, 2013.

 

($ in millions)

 

 

 

 

 

 

Total gains (losses)
included in:

 

 

 

 

 

 

 

 

 

 

 

Balance as of
December 31,
2012

 

 

Net
income
(1)

 

 

OCI

 

 

Transfers
into

Level 3

 

 

Transfers
out of
Level 3

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Municipal

 

$

338

 

 

$

(12

)

 

$

19

 

 

$

--

 

 

$

--

 

Corporate

 

 

1,501

 

 

 

32

 

 

 

(32

)

 

 

84

 

 

 

(172

)

ABS

 

 

199

 

 

 

(2

)

 

 

30

 

 

 

17

 

 

 

(16

)

RMBS

 

 

--

 

 

 

--

 

 

 

--

 

 

 

--

 

 

 

--

 

CMBS

 

 

21

 

 

 

(1

)

 

 

3

 

 

 

--

 

 

 

--

 

Redeemable preferred stock

 

 

1

 

 

 

--

 

 

 

--

 

 

 

--

 

 

 

--

 

Total fixed income securities

 

 

2,060

 

 

 

17

 

 

 

20

 

 

 

101

 

 

 

(188

)

Equity securities

 

 

7

 

 

 

--

 

 

 

--

 

 

 

--

 

 

 

--

 

Free-standing derivatives, net

 

 

(27

)

 

 

19

 

 

 

--

 

 

 

--

 

 

 

--

 

Other assets

 

 

1

 

 

 

(1

)

 

 

--

 

 

 

--

 

 

 

--

 

Assets held for sale

 

 

--

 

 

 

(2

)

 

 

(6

)

 

 

13

 

 

 

(13

)

Total recurring Level 3 assets

 

$

2,041

 

 

$

33

 

 

$

14

 

 

$

114

 

 

$

(201

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contractholder funds: Derivatives embedded in life and annuity contracts

 

$

(553

)

 

$

89

 

 

$

--

 

 

$

--

 

 

$

--

 

Liabilities held for sale

 

 

--

 

 

 

20

 

 

 

--

 

 

 

--

 

 

 

--

 

Total recurring Level 3 liabilities

 

$

(553

)

 

$

109

 

 

$

--

 

 

$

--

 

 

$

--

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transfer to
held for sale

 

 

Purchases/
Issues
(2)

 

 

Sales

 

 

Settlements

 

 

Balance as of
December 31,
2013

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Municipal

 

$

(51

)

 

$

--

 

 

$

(173

)

 

$

(2

)

 

$

119

 

Corporate

 

 

(244

)

 

 

145

 

 

 

(173

)

 

 

(133

)

 

 

1,008

 

ABS

 

 

(85

)

 

 

--

 

 

 

(8

)

 

 

(23

)

 

 

112

 

RMBS

 

 

--

 

 

 

--

 

 

 

--

 

 

 

--

 

 

 

--

 

CMBS

 

 

(5

)

 

 

--

 

 

 

(17

)

 

 

--

 

 

 

1

 

Redeemable preferred stock

 

 

--

 

 

 

--

 

 

 

--

 

 

 

--

 

 

 

1

 

Total fixed income securities

 

 

(385

)

 

 

145

 

 

 

(371

)

 

 

(158

)

 

 

1,241

 

Equity securities

 

 

--

 

 

 

--

 

 

 

(1

)

 

 

--

 

 

 

6

 

Free-standing derivatives, net

 

 

--

 

 

 

9

 

 

 

--

 

 

 

(6

)

 

 

(5

)  (3)

Other assets

 

 

--

 

 

 

--

 

 

 

--

 

 

 

--

 

 

 

--

 

Assets held for sale

 

 

385

 

 

 

--

 

 

 

(10

)

 

 

(5

)

 

 

362

 

Total recurring Level 3 assets

 

$

--

 

 

$

154

 

 

$

(382

)

 

$

(169

)

 

$

1,604

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contractholder funds: Derivatives embedded in life and annuity contracts

 

$

265

 

 

$

(111

)

 

$

--

 

 

$

3

 

 

$

(307

)

Liabilities held for sale

 

 

(265

)

 

 

(6

)

 

 

--

 

 

 

5

 

 

 

(246

)

Total recurring Level 3 liabilities

 

$

--

 

 

$

(117

)

 

$

--

 

 

$

8

 

 

$

(553

)

 

78



 

The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the year ended December 31, 2012.

 

($ in millions)

 

 

 

 

 

Total gains (losses)
included in:

 

 

 

 

 

 

 

 

 

 

Balance as of
December 31,
2011

 

 

Net
income
(1)

 

 

OCI

 

 

Transfers
into

Level 3

 

 

Transfers
out of
Level 3

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Municipal

 

$

387

 

$

(5)

 

$

22

 

$

53

 

$

(10)

 

Corporate

 

 

1,319

 

 

20

 

 

63

 

 

381

 

 

(64)

 

ABS

 

 

254

 

 

24

 

 

59

 

 

42

 

 

(7)

 

RMBS

 

 

47

 

 

--

 

 

--

 

 

--

 

 

(47)

 

CMBS

 

 

30

 

 

(4)

 

 

10

 

 

--

 

 

--

 

Redeemable preferred stock

 

 

1

 

 

--

 

 

--

 

 

--

 

 

--

 

Total fixed income securities

 

 

2,038

 

 

35

 

 

154

 

 

476

 

 

(128)

 

Equity securities

 

 

14

 

 

--

 

 

--

 

 

--

 

 

--

 

Free-standing derivatives, net

 

 

(88)

 

 

25

 

 

--

 

 

--

 

 

--

 

Other assets

 

 

1

 

 

--

 

 

--

 

 

--

 

 

--

 

Total recurring Level 3 assets

 

$

1,965

 

$

60

 

$

154

 

$

476

 

$

(128)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contractholder funds: Derivatives embedded in life and annuity contracts

 

$

(723)

 

$

168

 

$

--

 

$

--

 

$

--

 

Total recurring Level 3 liabilities

 

$

(723)

 

$

168

 

$

--

 

$

--

 

$

--

 

 

 

 

 

Purchases

 

 

Sales

 

 

Issues

 

 

Settlements

 

 

Balance as of
December 31,
2012

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Municipal

 

$

--

 

$

(107)

 

$

--

 

$

(2)

 

$

338

 

Corporate

 

 

125

 

 

(223)

 

 

--

 

 

(120)

 

 

1,501

 

ABS

 

 

11

 

 

(165)

 

 

--

 

 

(19)

 

 

199

 

RMBS

 

 

--

 

 

--

 

 

--

 

 

--

 

 

--

 

CMBS

 

 

--

 

 

--

 

 

--

 

 

(15)

 

 

21

 

Redeemable preferred stock

 

 

1

 

 

(1)

 

 

--

 

 

--

 

 

1

 

Total fixed income securities

 

 

137

 

 

(496)

 

 

--

 

 

(156)

 

 

2,060

 

Equity securities

 

 

5

 

 

(12)

 

 

--

 

 

--

 

 

7

 

Free-standing derivatives, net

 

 

27

 

 

--

 

 

--

 

 

9

 

 

(27)

(2)

Other assets

 

 

--

 

 

--

 

 

--

 

 

--

 

 

1

 

Total recurring Level 3 assets

 

$

169

 

$

(508)

 

$

--

 

$

(147)

 

$

2,041

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contractholder funds: Derivatives embedded in life and annuity contracts

 

$

--

 

$

--

 

$

(79)

 

$

81

 

$

(553)

 

Total recurring Level 3 liabilities

 

$

--

 

$

--

 

$

(79)

 

$

81

 

$

(553)

 

 

 

(1) The effect to net income totals $228 million and is reported in the Consolidated Statements of Operations and Comprehensive Income as follows: $38 million in realized capital gains and losses, $22 million in net investment income, $132 million in interest credited to contractholder funds and $36 million in contract benefits.

(2) Comprises $3 million of assets and $30 million of liabilities.

 

79



 

The following table presents the rollforward of Level 3 assets and liabilities held at fair value on a recurring basis during the year ended December 31, 2011.

 

($ in millions)

 

 

 

 

 

Total gains (losses)
included in:

 

 

 

 

 

 

 

 

 

 

Balance as of
December 31,
2010

 

 

Net
income
(1)

 

 

OCI

 

 

Transfers
into

Level 3

 

 

Transfers
out of
Level 3

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Municipal

 

$

601

 

$

(2)

 

$

7

 

$

48

 

$

(34)

 

Corporate

 

 

1,760

 

 

52

 

 

(35)

 

 

237

 

 

(410)

 

ABS

 

 

1,974

 

 

21

 

 

(65)

 

 

--

 

 

(1,470)

 

RMBS

 

 

1,189

 

 

(57)

 

 

77

 

 

--

 

 

(853)

 

CMBS

 

 

844

 

 

(43)

 

 

111

 

 

65

 

 

(878)

 

Redeemable preferred stock

 

 

1

 

 

--

 

 

--

 

 

--

 

 

--

 

Total fixed income securities

 

 

6,369

 

 

(29)

 

 

95

 

 

350

 

 

(3,645)

 

Equity securities

 

 

29

 

 

(5)

 

 

--

 

 

--

 

 

(10)

 

Free-standing derivatives, net

 

 

(77)

 

 

(37)

 

 

--

 

 

--

 

 

--

 

Other assets

 

 

1

 

 

--

 

 

--

 

 

--

 

 

--

 

Total recurring Level 3 assets

 

$

6,322

 

$

(71)

 

$

95

 

$

350

 

$

(3,655)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contractholder funds: Derivatives embedded in life and annuity contracts

 

$

(653)

 

$

(134)

 

$

--

 

$

--

 

$

--

 

Total recurring Level 3 liabilities

 

$

(653)

 

$

(134)

 

$

--

 

$

--

 

$

--

 

 

 

 

 

Purchases

 

 

Sales

 

 

Issues

 

 

Settlements

 

 

Balance as of
December 31,
2011

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed income securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Municipal

 

$

10

 

$

(241)

 

$

--

 

$

(2)

 

$

387

 

Corporate

 

 

266

 

 

(473)

 

 

--

 

 

(78)

 

 

1,319

 

ABS

 

 

146

 

 

(136)

 

 

--

 

 

(216)

 

 

254

 

RMBS

 

 

--

 

 

(222)

 

 

--

 

 

(87)

 

 

47

 

CMBS

 

 

--

 

 

(66)

 

 

--

 

 

(3)

 

 

30

 

Redeemable preferred stock

 

 

--

 

 

--

 

 

--

 

 

--

 

 

1

 

Total fixed income securities

 

 

422

 

 

(1,138)

 

 

--

 

 

(386)

 

 

2,038

 

Equity securities

 

 

1

 

 

(1)

 

 

--

 

 

--

 

 

14

 

Free-standing derivatives, net

 

 

18

 

 

--

 

 

--

 

 

8

 

 

(88)

(2)

Other assets

 

 

--

 

 

--

 

 

--

 

 

--

 

 

1

 

Total recurring Level 3 assets

 

$

441

 

$

(1,139)

 

$

--

 

$

(378)

 

$

1,965

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contractholder funds: Derivatives embedded in life and annuity contracts

 

$

--

 

$

--

 

$

(100)

 

$

164

 

$

(723)

 

Total recurring Level 3 liabilities

 

$

--

 

$

--

 

$

(100)

 

$

164

 

$

(723)

 

 

 

(1) The effect to net income totals $(205) million and is reported in the Consolidated Statements of Operations and Comprehensive Income as follows: $(101) million in realized capital gains and losses, $34 million in net investment income, $(106) million in interest credited to contractholder funds and $(32) million in contract benefits.

(2) Comprises $1 million of assets and $89 million of liabilities.

 

Transfers between level categorizations may occur due to changes in the availability of market observable inputs, which generally are caused by changes in market conditions such as liquidity, trading volume or bid-ask spreads.  Transfers between level categorizations may also occur due to changes in the valuation source.  For example, in situations where a fair value quote is not provided by the Company’s independent third-party valuation service provider and as a result the price is stale or has been replaced with a broker quote whose inputs have not been corroborated to be market observable, the security is transferred into Level 3.  Transfers in and out of level categorizations are reported as having occurred at the beginning of the quarter in which the transfer occurred.  Therefore, for all transfers into Level 3, all realized and changes in unrealized gains and losses in the quarter of transfer are reflected in the Level 3 rollforward table.

 

80



 

There were no transfers between Level 1 and Level 2 during 2013 or 2011.  During 2012, certain U.S. government securities were transferred into Level 1 from Level 2 as a result of increased liquidity in the market and a sustained increase in the market activity for these assets.

 

During 2011, certain ABS, RMBS and CMBS were transferred into Level 2 from Level 3 as a result of increased liquidity in the market and a sustained increase in the market activity for these assets.  Additionally, in 2011 certain ABS that were valued based on non-binding broker quotes were transferred into Level 2 from Level 3 since the inputs were corroborated to be market observable.

 

Transfers into Level 3 during 2013, 2012 and 2011 included situations where a fair value quote was not provided by the Company’s independent third-party valuation service provider and as a result the price was stale or had been replaced with a broker quote where the inputs had not been corroborated to be market observable resulting in the security being classified as Level 3.  Transfers out of Level 3 during 2013, 2012 and 2011 included situations where a broker quote was used in the prior period and a fair value quote became available from the Company’s independent third-party valuation service provider in the current period.  A quote utilizing the new pricing source was not available as of the prior period, and any gains or losses related to the change in valuation source for individual securities were not significant.

 

The following table provides the change in unrealized gains and losses included in net income for Level 3 assets and liabilities held as of December 31.

 

($ in millions)

 

2013

 

2012

 

2011

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

Fixed income securities:

 

 

 

 

 

 

Municipal

(4)

--

(2)

Corporate

 

13

 

15

 

19

ABS

 

(2)

 

--

 

(35)

CMBS

 

(2)

 

(3)

 

(12)

Total fixed income securities

 

5

 

12

 

(30)

Equity securities

 

--

 

--

 

(4)

Free-standing derivatives, net

 

10

 

6

 

(29)

Other assets

 

(1)

 

--

 

--

Assets held for sale

 

(2)

 

--

 

--

Total recurring Level 3 assets

12

18

(63)

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

Contractholder funds: Derivatives embedded in life and annuity contracts

89

168

(134)

Liabilities held for sale

 

20

 

--

 

--

Total recurring Level 3 liabilities

109

168

(134)

 

The amounts in the table above represent the change in unrealized gains and losses included in net income for the period of time that the asset or liability was determined to be in Level 3.  These gains and losses total $121 million in 2013 and are reported as follows: $9 million in realized capital gains and losses, $9 million in net investment income, $35 million in interest credited to contractholder funds, $74 million in contract benefits and $(6) million in loss on disposition of operations.  These gains and losses total $186 million in 2012 and are reported as follows: $19 million in net investment income, $131 million in interest credited to contractholder funds and $36 million in contract benefits.  These gains and losses total $(197) million in 2011 and are reported as follows: $(105) million in realized capital gains and losses, $42 million in net investment income, $(102) million in interest credited to contractholder funds and $(32) million in contract benefits.

 

81



 

Presented below are the carrying values and fair value estimates of financial instruments not carried at fair value.

 

Financial assets

 

($ in millions)

 

 

December 31, 2013

 

 

December 31, 2012

 

 

 

Carrying

value

 

 

Fair

value

 

 

Carrying

value

 

 

Fair

value

Mortgage loans

 

$

4,173

 

$

4,300

 

$

5,943

 

$

6,223

Cost method limited partnerships

 

 

605

 

 

799

 

 

617

 

 

778

Agent loans

 

 

341

 

 

325

 

 

319

 

 

314

Bank loans

 

 

160

 

 

161

 

 

282

 

 

282

Notes due from related party

 

 

275

 

 

275

 

 

275

 

 

275

Assets held for sale

 

 

1,458

 

 

1,532

 

 

--

 

 

--

 

The fair value of mortgage loans, including those classified as assets held for sale, is based on discounted contractual cash flows or, if the loans are impaired due to credit reasons, the fair value of collateral less costs to sell.  Risk adjusted discount rates are selected using current rates at which similar loans would be made to borrowers with similar characteristics, using similar types of properties as collateral.  The fair value of cost method limited partnerships is determined using reported net asset values of the underlying funds.  The fair value of agent loans, which are reported in other investments, is based on discounted cash flow calculations that use discount rates with a spread over U.S. Treasury rates.  Assumptions used in developing estimated cash flows and discount rates consider the loan’s credit and liquidity risks.  The fair value of bank loans, which are reported in other investments or assets held for sale, is based on broker quotes from brokers familiar with the loans and current market conditions.  The fair value of notes due from related party, which are reported in other investments, is based on discounted cash flow calculations using current interest rates for instruments with comparable terms.  The fair value measurements for mortgage loans, cost method limited partnerships, agent loans, bank loans and notes due from related party and assets held for sale are categorized as Level 3.

 

Financial liabilities

 

($ in millions)

 

 

December 31, 2013

 

 

December 31, 2012

 

 

 

Carrying

value

 

 

Fair

value

 

 

Carrying

value

 

 

Fair

value

Contractholder funds on investment contracts

 

$

15,542

 

$

16,198

 

$

26,984

 

$

27,989

Notes due to related parties

 

 

282

 

 

282

 

 

496

 

 

496

Liability for collateral

 

 

328

 

 

328

 

 

561

 

 

561

Liabilities held for sale

 

 

7,417

 

 

7,298

 

 

--

 

 

--

 

The fair value of contractholder funds on investment contracts, including those classified as liabilities held for sale, is based on the terms of the underlying contracts utilizing prevailing market rates for similar contracts adjusted for the Company’s own credit risk.  Deferred annuities included in contractholder funds are valued using discounted cash flow models which incorporate market value margins, which are based on the cost of holding economic capital, and the Company’s own credit risk.  Immediate annuities without life contingencies and fixed rate funding agreements are valued at the present value of future benefits using market implied interest rates which include the Company’s own credit risk.  The fair value measurements for contractholder funds on investment contracts and liabilities held for sale are categorized as Level 3.

 

The fair value of notes due to related parties is based on discounted cash flow calculations using current interest rates for instruments with comparable terms and considers the Company’s own credit risk.  The liability for collateral is valued at carrying value due to its short-term nature.  The fair value measurements for liability for collateral are categorized as Level 2.  The fair value measurements for notes due to related parties are categorized as Level 3.

 

82



 

8.  Derivative Financial Instruments and Off-balance sheet Financial Instruments

 

The Company uses derivatives to manage risks with certain assets and liabilities arising from the potential adverse impacts from changes in risk-free interest rates, changes in equity market valuations, increases in credit spreads and foreign currency fluctuations, and for asset replication.  The Company does not use derivatives for speculative purposes.

 

Asset-liability management is a risk management strategy that is principally employed to balance the respective interest-rate sensitivities of the Company’s assets and liabilities.  Depending upon the attributes of the assets acquired and liabilities issued, derivative instruments such as interest rate swaps, caps, swaptions and futures are utilized to change the interest rate characteristics of existing assets and liabilities to ensure the relationship is maintained within specified ranges and to reduce exposure to rising or falling interest rates.  The Company uses financial futures and interest rate swaps to hedge anticipated asset purchases and liability issuances and futures and options for hedging the equity exposure contained in its equity indexed life and annuity product contracts that offer equity returns to contractholders.  In addition, the Company uses interest rate swaps to hedge interest rate risk inherent in funding agreements.  The Company uses foreign currency swaps and forwards primarily to reduce the foreign currency risk associated with issuing foreign currency denominated funding agreements and holding foreign currency denominated investments.  Credit default swaps are typically used to mitigate the credit risk within the Company’s fixed income portfolio.

 

The Company may also use derivatives to manage the risk associated with corporate actions, including the sale of a business.  During December 2013, swaptions were utilized to hedge the expected proceeds from the pending disposition of LBL.

 

Asset replication refers to the “synthetic” creation of assets through the use of derivatives and primarily investment grade host bonds to replicate securities that are either unavailable in the cash markets or more economical to acquire in synthetic form.  The Company replicates fixed income securities using a combination of a credit default swap and one or more highly rated fixed income securities to synthetically replicate the economic characteristics of one or more cash market securities.

 

The Company also has derivatives embedded in non-derivative host contracts that are required to be separated from the host contracts and accounted for at fair value with changes in fair value of embedded derivatives reported in net income.  The Company’s primary embedded derivatives are equity options in life and annuity product contracts, which provide equity returns to contractholders; equity-indexed notes containing equity call options, which provide a coupon payout that is determined using one or more equity-based indices; credit default swaps in synthetic collateralized debt obligations, which provide enhanced coupon rates as a result of selling credit protection; and conversion options in fixed income securities, which provide the Company with the right to convert the instrument into a predetermined number of shares of common stock.

 

When derivatives meet specific criteria, they may be designated as accounting hedges and accounted for as fair value, cash flow, foreign currency fair value or foreign currency cash flow hedges.  The Company designates certain of its interest rate and foreign currency swap contracts and certain investment risk transfer reinsurance agreements as fair value hedges when the hedging instrument is highly effective in offsetting the risk of changes in the fair value of the hedged item.  The Company designates certain of its foreign currency swap contracts as cash flow hedges when the hedging instrument is highly effective in offsetting the exposure of variations in cash flows for the hedged risk that could affect net income.  Amounts are reclassified to net investment income or realized capital gains and losses as the hedged item affects net income.

 

The notional amounts specified in the contracts are used to calculate the exchange of contractual payments under the agreements and are generally not representative of the potential for gain or loss on these agreements.  However, the notional amounts specified in credit default swaps where the Company has sold credit protection represent the maximum amount of potential loss, assuming no recoveries.

 

Fair value, which is equal to the carrying value, is the estimated amount that the Company would receive or pay to terminate the derivative contracts at the reporting date.  The carrying value amounts for OTC derivatives are further adjusted for the effects, if any, of enforceable master netting agreements and are presented on a net basis, by counterparty agreement, in the Consolidated Statements of Financial Position.  For certain exchange traded and cleared derivatives, margin deposits are required as well as daily cash settlements of margin accounts.  As of December 31, 2013, the Company pledged $4 million of cash and securities in the form of margin deposits.

 

83



 

For those derivatives which qualify for fair value hedge accounting, net income includes the changes in the fair value of both the derivative instrument and the hedged risk, and therefore reflects any hedging ineffectiveness.  For cash flow hedges, gains and losses are amortized from accumulated other comprehensive income and are reported in net income in the same period the forecasted transactions being hedged impact net income.

 

Non-hedge accounting is generally used for “portfolio” level hedging strategies where the terms of the individual hedged items do not meet the strict homogeneity requirements to permit the application of hedge accounting.  For non-hedge derivatives, net income includes changes in fair value and accrued periodic settlements, when applicable.  With the exception of non-hedge derivatives used for asset replication and non-hedge embedded derivatives, all of the Company’s derivatives are evaluated for their ongoing effectiveness as either accounting hedge or non-hedge derivative financial instruments on at least a quarterly basis.

 

The following table provides a summary of the volume and fair value positions of derivative instruments as well as their reporting location in the Consolidated Statement of Financial Position as of December 31, 2013.

 

($ in millions, except number of contracts)

 

 

 

 

Volume (1)

 

 

 

 

 

 

 

 

 

 

 

Balance sheet location

 

 

Notional
amount

 

 

Number
of
contracts

 

 

Fair
value,
net

 

 

Gross
asset

 

 

Gross
liability

Asset derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives designated as accounting hedging instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency swap agreements

 

Other investments

 

$

16

 

 

n/a

 

$

1

 

$

1

 

$

--

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives not designated as accounting hedging instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swaption agreements

 

Other investments

 

 

1,420

 

 

n/a

 

 

--

 

 

--

 

 

--

Interest rate cap agreements

 

Other investments

 

 

61

 

 

n/a

 

 

2

 

 

2

 

 

--

Equity and index contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options and warrants (2)

 

Other investments

 

 

3

 

 

10,035

 

 

261

 

 

261

 

 

--

Financial futures contracts

 

Other assets

 

 

--

 

 

627

 

 

--

 

 

--

 

 

--

Foreign currency contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forwards

 

Other investments

 

 

47

 

 

n/a

 

 

--

 

 

--

 

 

--

Embedded derivative financial instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Credit default swaps

 

Fixed income securities

 

 

12

 

 

n/a

 

 

(12)

 

 

--

 

 

(12)

Credit default contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Credit default swaps – buying protection

 

Other investments

 

 

1

 

 

n/a

 

 

--

 

 

--

 

 

--

Credit default swaps – selling protection

 

Other investments

 

 

85

 

 

n/a

 

 

2

 

 

2

 

 

--

Other contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other contracts

 

Other assets

 

 

4

 

 

n/a

 

 

--

 

 

--

 

 

--

Subtotal

 

 

 

 

1,633

 

 

10,662

 

 

253

 

 

265

 

 

(12)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total asset derivatives

 

 

 

$

1,649

 

 

10,662

 

$

254

 

$

266

 

$

(12)

 

 

Liability derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives designated as accounting hedging instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency swap agreements

 

Other liabilities & accrued expenses

 

$

132

 

 

n/a

 

$

(15)

 

$

--

 

$

(15)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives not designated as accounting hedging instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swap agreements

 

Other liabilities & accrued expenses

 

 

85

 

 

n/a

 

 

4

 

 

4

 

 

--

Interest rate swaption agreements

 

Other liabilities & accrued expenses

 

 

4,570

 

 

n/a

 

 

1

 

 

1

 

 

--

Interest rate cap agreements

 

Other liabilities & accrued expenses

 

 

262

 

 

n/a

 

 

4

 

 

4

 

 

--

Equity and index contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options

 

Other liabilities & accrued expenses

 

 

55

 

 

10,035

 

 

(165)

 

 

2

 

 

(167)

Embedded derivative financial instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Guaranteed accumulation benefits

 

Contractholder funds

 

 

738

 

 

n/a

 

 

(43)

 

 

--

 

 

(43)

Guaranteed withdrawal benefits

 

Contractholder funds

 

 

506

 

 

n/a

 

 

(13)

 

 

--

 

 

(13)

Equity-indexed and forward starting options in life and annuity product contracts

 

Contractholder funds

 

 

1,693

 

 

n/a

 

 

(247)

 

 

--

 

 

(247)

 

 

Liabilities held for sale

 

 

2,363

 

 

n/a

 

 

(246)

 

 

--

 

 

(246)

Other embedded derivative financial instruments

 

Contractholder funds

 

 

85

 

 

n/a

 

 

(4)

 

 

--

 

 

(4)

Credit default contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Credit default swaps – buying protection

 

Other liabilities & accrued expenses

 

 

171

 

 

n/a

 

 

(2)

 

 

--

 

 

(2)

Credit default swaps – selling protection

 

Other liabilities & accrued expenses

 

 

100

 

 

n/a

 

 

(15)

 

 

--

 

 

(15)

Subtotal

 

 

 

 

10,628

 

 

10,035

 

 

(726)

 

 

11

 

 

(737)

Total liability derivatives

 

 

 

 

10,760

 

 

10,035

 

 

(741)

 

$

11

 

$

(752)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total derivatives

 

 

 

$

12,409

 

 

20,697

 

$

(487)

 

 

 

 

 

 

 

 

 

 

(1)   Volume for OTC derivative contracts is represented by their notional amounts.  Volume for exchange traded derivatives is represented by the number of contracts, which is the basis on which they are traded.  (n/a = not applicable)

 

(2)   In addition to the number of contracts presented in the table, the Company held 837,100 stock warrants.  Stock warrants can be converted to cash upon sale of those instruments or exercised for shares of common stock.

 

84



 

The following table provides a summary of the volume and fair value positions of derivative instruments as well as their reporting location in the Consolidated Statement of Financial Position as of December 31, 2012.

 

($ in millions, except number of contracts)

 

 

 

 

Volume (1)

 

 

 

 

 

 

 

 

 

Asset derivatives

 

Balance sheet location

 

 

Notional
amount

 

 

Number
of
contracts

 

 

Fair
value,
net

 

 

Gross
asset

 

 

Gross
liability

Derivatives designated as accounting hedging instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency swap agreements

 

Other investments

 

$

16

 

 

n/a

 

$

2

 

$

2

 

$

--

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives not designated as accounting hedging instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swap agreements

 

Other investments

 

 

5,541

 

 

n/a

 

 

19

 

 

28

 

 

(9)

Interest rate cap agreements

 

Other investments

 

 

372

 

 

n/a

 

 

1

 

 

1

 

 

--

Financial futures contracts

 

Other assets

 

 

n/a

 

 

2

 

 

--

 

 

--

 

 

--

Equity and index contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options and warrants (2)

 

Other investments

 

 

146

 

 

12,400

 

 

125

 

 

125

 

 

--

Financial futures contracts

 

Other assets

 

 

n/a

 

 

249

 

 

2

 

 

2

 

 

--

Foreign currency contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency forwards

 

Other investments

 

 

44

 

 

n/a

 

 

--

 

 

--

 

 

--

Embedded derivative financial instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Conversion options

 

Fixed income securities

 

 

5

 

 

n/a

 

 

--

 

 

--

 

 

--

Equity-indexed call options

 

Fixed income securities

 

 

90

 

 

n/a

 

 

9

 

 

9

 

 

--

Credit default swaps

 

Fixed income securities

 

 

12

 

 

n/a

 

 

(12)

 

 

--

 

 

(12)

Credit default contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Credit default swaps – buying protection

 

Other investments

 

 

32

 

 

n/a

 

 

(1)

 

 

--

 

 

(1)

Credit default swaps – selling protection

 

Other investments

 

 

100

 

 

n/a

 

 

1

 

 

1

 

 

--

Other contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other contracts

 

Other assets

 

 

4

 

 

n/a

 

 

1

 

 

1

 

 

--

Subtotal

 

 

 

 

6,346

 

 

12,651

 

 

145

 

 

167

 

 

(22)

Total asset derivatives

 

 

 

$

6,362

 

 

12,651

 

$

147

 

$

169

 

$

(22)

 

Liability derivatives

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives designated as accounting hedging instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency swap agreements

 

Other liabilities & accrued expenses

 

$

135

 

 

n/a

 

$

(19)

 

$

--

 

$

(19)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives not designated as accounting  hedging instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate swap agreements

 

Other liabilities & accrued expenses

 

 

1,185

 

 

n/a

 

 

16

 

 

18

 

 

(2)

Interest rate swaption agreements

 

Other liabilities & accrued expenses

 

 

250

 

 

n/a

 

 

--

 

 

--

 

 

--

Interest rate cap agreements

 

Other liabilities & accrued expenses

 

 

429

 

 

n/a

 

 

1

 

 

1

 

 

--

Financial futures contracts

 

Other liabilities & accrued expenses

 

 

--

 

 

357

 

 

--

 

 

--

 

 

--

Equity and index contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options and futures

 

Other liabilities & accrued expenses

 

 

--

 

 

12,262

 

 

(58)

 

 

--

 

 

(58)

Embedded derivative financial instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Guaranteed accumulation benefits

 

Contractholder funds

 

 

820

 

 

n/a

 

 

(86)

 

 

--

 

 

(86)

Guaranteed withdrawal benefits

 

Contractholder funds

 

 

554

 

 

n/a

 

 

(39)

 

 

--

 

 

(39)

Equity-indexed and forward starting options in life and annuity product contracts

 

Contractholder funds

 

 

3,916

 

 

n/a

 

 

(419)

 

 

--

 

 

(419)

Other embedded derivative financial instruments

 

Contractholder funds

 

 

85

 

 

n/a

 

 

(9)

 

 

--

 

 

(9)

Credit default contracts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Credit default swaps – buying protection

 

Other liabilities & accrued expenses

 

 

193

 

 

n/a

 

 

(2)

 

 

--

 

 

(2)

Credit default swaps – selling protection

 

Other liabilities & accrued expenses

 

 

130

 

 

n/a

 

 

(30)

 

 

--

 

 

(30)

Subtotal

 

 

 

 

7,562

 

 

12,619

 

 

(626)

 

 

19

 

 

(645)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total liability derivatives

 

 

 

 

7,697

 

 

12,619

 

 

(645)

 

$

19

 

$

(664)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total derivatives

 

 

 

$

14,059

 

 

25,270

 

$

(498)

 

 

 

 

 

 

 

 

 

(1)   Volume for OTC derivative contracts is represented by their notional amounts.  Volume for exchange traded derivatives is represented by the number of contracts, which is the basis on which they are traded.  (n/a = not applicable)

(2)   In addition to the number of contracts presented in the table, the Company held 837,100 stock warrants.  Stock warrants can be converted to cash upon sale of those instruments or exercised for shares of common stock.

 

85



 

The following table provides gross and net amounts for the Company’s OTC derivatives, all of which are subject to enforceable master netting agreements.

 

($ in millions)

 

 

 

Offsets

 

 

 

 

 

 

 

 

 

Gross
amount

 

Counter-
party
netting

 

Cash
collateral
(received)
pledged

 

Net
amount on
balance
sheet

 

Securities
collateral
(received)
pledged

 

Net
amount

 

December 31, 2013

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset derivatives

14

(11)

--

3

(3)

--

 

Liability derivatives

 

(33)

 

11

 

(4)

 

(26)

 

22

 

(4)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2012

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset derivatives

52

(29)

(18)

5

(5)

--

 

Liability derivatives

 

(63)

 

29

 

--

 

(34)

 

25

 

(9)

 

 

The following table provides a summary of the impacts of the Company’s foreign currency contracts in cash flow hedging relationships for the years ended December 31.

 

($ in millions)

 

2013

 

2012

 

2011

 

Gain (loss) recognized in OCI on derivatives during the period

$

3

$

(6)

$

4

 

Loss recognized in OCI on derivatives during the term of the hedging relationship

 

(13)

 

(17)

 

(12)

 

Loss reclassified from AOCI into income (net investment income)

 

(1)

 

--

 

--

 

Loss reclassified from AOCI into income (realized capital gains and losses)

 

--

 

(1)

 

(1)

 

 

Amortization of net losses from accumulated other comprehensive income related to cash flow hedges is expected to be $2 million during the next twelve months.  There was no hedge ineffectiveness reported in realized gains and losses in 2013, 2012 or 2011.

 

The following tables present gains and losses from valuation, settlements and hedge ineffectiveness reported on derivatives used in fair value hedging relationships and derivatives not designated as accounting hedging instruments in the Consolidated Statements of Operations and Comprehensive Income for the years ended December 31.  In 2013, the Company had no derivatives used in fair value hedging relationships.

 

($ in millions)

 

2013

 

 

 

Realized
capital
gains and
losses

 

Contract
benefits

 

Interest
credited to
contractholder
funds

 

Loss on
disposition
of
operations

 

Total gain
(loss)
recognized in
net income on
derivatives

 

Interest rate contracts

$

3

$

--

$

--

$

(6)

$

(3)

 

Equity and index contracts

 

--

 

--

 

94

 

--

 

94

 

Embedded derivative financial instruments

 

(1)

 

74

 

(75)

 

--

 

(2)

 

Foreign currency contracts

 

(2)

 

--

 

--

 

--

 

(2)

 

Credit default contracts

 

14

 

--

 

--

 

--

 

14

 

Other contracts

 

--

 

--

 

(3)

 

--

 

(3)

 

Total

$

14

$

74

$

16

$

(6)

$

98

 

 

86



 

 

 

 

2012

 

 

 

Net
investment
income

 

 

Realized
capital
gains and
losses

 

 

Contract
benefits

 

 

Interest
credited to
contractholder
funds

 

 

Total gain
(loss)
recognized in
net income on
derivatives

Derivatives in fair value accounting hedging relationships

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

 

$

(1)

 

$

--

 

$

--

 

$

--

 

$

(1

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives not designated as accounting hedging instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

 

 

--

 

 

2

 

 

--

 

 

--

 

 

2

 

Equity and index contracts

 

 

--

 

 

--

 

 

--

 

 

56

 

 

56

 

Embedded derivative financial instruments

 

 

--

 

 

20

 

 

36

 

 

134

 

 

190

 

Foreign currency contracts

 

 

--

 

 

(2)

 

 

--

 

 

--

 

 

(2

)

Credit default contracts

 

 

--

 

 

15

 

 

--

 

 

--

 

 

15

 

Other contracts

 

 

--

 

 

--

 

 

--

 

 

3

 

 

3

 

Subtotal

 

 

--

 

 

35

 

 

36

 

 

193

 

 

264

 

Total

 

$

(1)

 

$

35

 

$

36

 

$

193

 

$

263

 

 

 

 

 

2011

 

 

 

Net
investment
income

 

 

Realized
capital
gains and
losses

 

 

Contract
benefits

 

 

Interest
credited to
contractholder
funds

 

 

Total gain
(loss)
recognized in
net income on
derivatives

Derivatives in fair value accounting hedging relationships

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

 

$

(2)

 

$

(8)

 

$

--

 

$

(5)

 

$

(15

)

Foreign currency and interest rate contracts

 

 

--

 

 

--

 

 

--

 

 

(32)

 

 

(32

)

Subtotal

 

 

(2)

 

 

(8)

 

 

--

 

 

(37)

 

 

(47

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Derivatives not designated as accounting hedging instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest rate contracts

 

 

--

 

 

(151)

 

 

--

 

 

--

 

 

(151

)

Equity and index contracts

 

 

--

 

 

--

 

 

--

 

 

(2)

 

 

(2

)

Embedded derivative financial instruments

 

 

--

 

 

(45)

 

 

(32)

 

 

(38)

 

 

(115

)

Credit default contracts

 

 

--

 

 

2

 

 

--

 

 

--

 

 

2

 

Other contracts

 

 

--

 

 

--

 

 

--

 

 

7

 

 

7

 

Subtotal

 

 

--

 

 

(194)

 

 

(32)

 

 

(33)

 

 

(259

)

Total

 

$

(2)

 

$

(202)

 

$

(32)

 

$

(70)

 

$

(306

)

 

The following table provides a summary of the changes in fair value of the Company’s fair value hedging relationships in the Consolidated Statements of Operations and Comprehensive Income for the years ended December 31.

 

($ in millions)

 

 

Gain (loss) on derivatives

 

 

Gain (loss) on hedged risk

Location of gain or (loss) recognized
in net income on derivatives

 

 

Interest
rate
contracts

 

 

Foreign
currency &
interest rate
contracts

 

 

Contractholder
funds

 

 

Investments

2012

 

 

 

 

 

 

 

 

 

 

 

 

 

Net investment income

 

$

3

 

$

--

 

$

--

 

$

(3

)

Total

 

$

3

 

$

--

 

$

--

 

$

(3

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2011

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest credited to contractholder funds

 

$

(7)

 

$

(34)

 

$

41

 

$

--

 

Net investment income

 

 

26

 

 

--

 

 

--

 

 

(26

)

Realized capital gains and losses

 

 

(8)

 

 

--

 

 

--

 

 

--

 

Total

 

$

11

 

$

(34)

 

$

41

 

$

(26

)

 

87



 

The Company manages its exposure to credit risk by utilizing highly rated counterparties, establishing risk control limits, executing legally enforceable master netting agreements (“MNAs”) and obtaining collateral where appropriate.  The Company uses MNAs for OTC derivative transactions that permit either party to net payments due for transactions and collateral is either pledged or obtained when certain predetermined exposure limits are exceeded.  As of December 31, 2013, counterparties pledged $8 million in cash and securities to the Company, and the Company pledged $23 million in securities to counterparties which includes $14 million of collateral posted under MNAs for contracts containing credit-risk-contingent provisions that are in a liability position and $9 million of collateral posted under MNAs for contracts without credit-risk-contingent liabilities.  The Company has not incurred any losses on derivative financial instruments due to counterparty nonperformance.  Other derivatives, including futures and certain option contracts, are traded on organized exchanges which require margin deposits and guarantee the execution of trades, thereby mitigating any potential credit risk.

 

Counterparty credit exposure represents the Company’s potential loss if all of the counterparties concurrently fail to perform under the contractual terms of the contracts and all collateral, if any, becomes worthless.  This exposure is measured by the fair value of OTC derivative contracts with a positive fair value at the reporting date reduced by the effect, if any, of legally enforceable master netting agreements.

 

The following table summarizes the counterparty credit exposure as of December 31 by counterparty credit rating as it relates to the Company’s OTC derivatives.

 

($ in millions)

 

2013

 

2012

Rating (1)

 

Number
of counter-
parties

 

 

Notional
amount 
(2)

 

 

Credit
exposure 
(2)

 

 

Exposure,
net of
collateral 
(2)

 

Number
of counter-
parties

 

 

Notional
amount 
(2)

 

 

Credit
exposure 
(2)

 

 

Exposure,
net of
collateral 
(2)

A+

 

1

 

$

22

 

$

1

 

$

1

 

1

 

$

19

 

$

--

 

$

--

 

A

 

4

 

 

1,523

 

 

2

 

 

--

 

3

 

 

2,252

 

 

12

 

 

--

 

A-

 

1

 

 

24

 

 

1

 

 

--

 

2

 

 

311

 

 

1

 

 

1

 

BBB+

 

1

 

 

3

 

 

--

 

 

--

 

1

 

 

3,617

 

 

11

 

 

--

 

BBB

 

1

 

 

76

 

 

1

 

 

--

 

--

 

 

--

 

 

--

 

 

--

 

Total

 

8

 

$

1,648

 

$

5

 

$

1

 

7

 

$

6,199

 

$

24

 

$

1

 

 

 

 

 

 

(1)

Rating is the lower of S&P or Moody’s ratings.

(2)

Only OTC derivatives with a net positive fair value are included for each counterparty.

 

Market risk is the risk that the Company will incur losses due to adverse changes in market rates and prices.  Market risk exists for all of the derivative financial instruments the Company currently holds, as these instruments may become less valuable due to adverse changes in market conditions.  To limit this risk, the Company’s senior management has established risk control limits.  In addition, changes in fair value of the derivative financial instruments that the Company uses for risk management purposes are generally offset by the change in the fair value or cash flows of the hedged risk component of the related assets, liabilities or forecasted transactions.

 

Certain of the Company’s derivative instruments contain credit-risk-contingent termination events, cross-default provisions and credit support annex agreements.  Credit-risk-contingent termination events allow the counterparties to terminate the derivative on certain dates if ALIC’s or Allstate Life Insurance Company of New York’s (“ALNY”) financial strength credit ratings by Moody’s or S&P fall below a certain level or in the event ALIC or ALNY are no longer rated by either Moody’s or S&P.  Credit-risk-contingent cross-default provisions allow the counterparties to terminate the derivative instruments if the Company defaults by pre-determined threshold amounts on certain debt instruments.  Credit-risk-contingent credit support annex agreements specify the amount of collateral the Company must post to counterparties based on ALIC’s or ALNY’s financial strength credit ratings by Moody’s or S&P, or in the event ALIC or ALNY are no longer rated by either Moody’s or S&P.

 

88



 

The following summarizes the fair value of derivative instruments with termination, cross-default or collateral credit-risk-contingent features that are in a liability position as of December 31, as well as the fair value of assets and collateral that are netted against the liability in accordance with provisions within legally enforceable MNAs.

 

($ in millions)

 

2013

 

2012

 

Gross liability fair value of contracts containing credit-risk-contingent features

$

25

$

62

 

Gross asset fair value of contracts containing credit-risk-contingent features and subject to MNAs

 

(9)

 

(28)

 

Collateral posted under MNAs for contracts containing credit-risk-contingent features

 

(14)

 

(25)

 

Maximum amount of additional exposure for contracts with credit-risk-contingent features if all features were triggered concurrently

$

2

$

9

 

 

Credit derivatives - selling protection

 

Free-standing credit default swaps (“CDS”) are utilized for selling credit protection against a specified credit event.  A credit default swap is a derivative instrument, representing an agreement between two parties to exchange the credit risk of a specified entity (or a group of entities), or an index based on the credit risk of a group of entities (all commonly referred to as the “reference entity” or a portfolio of “reference entities”), in return for a periodic premium.  In selling protection, CDS are used to replicate fixed income securities and to complement the cash market when credit exposure to certain issuers is not available or when the derivative alternative is less expensive than the cash market alternative.  CDS typically have a five-year term.

 

The following table shows the CDS notional amounts by credit rating and fair value of protection sold.

 

($ in millions)

 

Notional amount

 

 

 

 

 

AA

 

A

 

BBB

 

BB and
lower

 

Total

 

Fair
value

 

December 31, 2013

 

 

 

 

 

 

 

 

 

 

 

 

 

Single name

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment grade corporate debt (1)

$

--

$

5

$

--

$

--

$

5

$

--

 

Baskets

 

 

 

 

 

 

 

 

 

 

 

 

 

First-to-default

 

 

 

 

 

 

 

 

 

 

 

 

 

Municipal

 

--

 

100

 

--

 

--

 

100

 

(15)

 

Index

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment grade corporate debt (1)

 

1

 

20

 

55

 

4

 

80

 

2

 

Total

$

1

$

125

$

55

$

4

$

185

$

(13)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2012

 

 

 

 

 

 

 

 

 

 

 

 

 

Single name

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment grade corporate debt (1)

$

--

$

5

$

--

$

--

$

5

$

--

 

Municipal

 

25

 

--

 

--

 

--

 

25

 

(3)

 

Subtotal

 

25

 

5

 

--

 

--

 

30

 

(3)

 

Baskets

 

 

 

 

 

 

 

 

 

 

 

 

 

First-to-default

 

 

 

 

 

 

 

 

 

 

 

 

 

Municipal

 

--

 

100

 

--

 

--

 

100

 

(26)

 

Index

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment grade corporate debt (1)

 

1

 

26

 

68

 

5

 

100

 

--

 

Total

$

26

$

131

$

68

$

5

$

230

$

(29)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Investment grade corporate debt categorization is based on the rating of the underlying name(s) at initial purchase.

 

 

In selling protection with CDS, the Company sells credit protection on an identified single name, a basket of names in a first-to-default (“FTD”) structure or a specific tranche of a basket, or credit derivative index (“CDX”) that is generally investment grade, and in return receives periodic premiums through expiration or termination of the agreement.  With single name CDS, this premium or credit spread generally corresponds to the difference between the yield on the reference entity’s public fixed maturity cash instruments and swap rates at the time the agreement is executed.  With a FTD basket or a tranche of a basket, because of the additional credit risk inherent in a basket of named reference entities, the premium generally corresponds to a high proportion of the sum of the credit spreads of the names in the basket and the correlation between the names.  CDX is utilized to take a position on multiple (generally 125) reference entities.  Credit events are typically defined as bankruptcy, failure to pay, or restructuring, depending on the nature of the reference entities.  If a credit event occurs, the Company settles with the

 

89



 

counterparty, either through physical settlement or cash settlement.  In a physical settlement, a reference asset is delivered by the buyer of protection to the Company, in exchange for cash payment at par, whereas in a cash settlement, the Company pays the difference between par and the prescribed value of the reference asset.  When a credit event occurs in a single name or FTD basket (for FTD, the first credit event occurring for any one name in the basket), the contract terminates at the time of settlement.  When a credit event occurs in a tranche of a basket, there is no immediate impact to the Company until cumulative losses in the basket exceed the contractual subordination.  To date, realized losses have not exceeded the subordination.  For CDX, the reference entity’s name incurring the credit event is removed from the index while the contract continues until expiration.  The maximum payout on a CDS is the contract notional amount.  A physical settlement may afford the Company with recovery rights as the new owner of the asset.

 

The Company monitors risk associated with credit derivatives through individual name credit limits at both a credit derivative and a combined cash instrument/credit derivative level.  The ratings of individual names for which protection has been sold are also monitored.

 

In addition to the CDS described above, the Company’s synthetic collateralized debt obligations contain embedded credit default swaps which sell protection on a basket of reference entities.  The synthetic collateralized debt obligations are fully funded; therefore, the Company is not obligated to contribute additional funds when credit events occur related to the reference entities named in the embedded credit default swaps.  The Company’s maximum amount at risk equals the amount of its aggregate initial investment in the synthetic collateralized debt obligations.

 

Off-balance sheet financial instruments

 

The contractual amounts of off-balance sheet financial instruments as of December 31 are as follows:

 

($ in millions)

 

2013

 

2012

 

Commitments to invest in limited partnership interests

$

1,366

$

947

 

Commitments to extend mortgage loans

 

1

 

67

 

Private placement commitments

 

5

 

6

 

Other loan commitments

 

26

 

7

 

 

In the preceding table, the contractual amounts represent the amount at risk if the contract is fully drawn upon, the counterparty defaults and the value of any underlying security becomes worthless.  Unless noted otherwise, the Company does not require collateral or other security to support off-balance-sheet financial instruments with credit risk.

 

Commitments to invest in limited partnership interests represent agreements to acquire new or additional participation in certain limited partnership investments.  The Company enters into these agreements in the normal course of business.  Because the investments in limited partnerships are not actively traded, it is not practical to estimate the fair value of these commitments.

 

Commitments to extend mortgage loans are agreements to lend to a borrower provided there is no violation of any condition established in the contract.  The Company enters into these agreements to commit to future loan fundings at a predetermined interest rate.  Commitments generally have fixed expiration dates or other termination clauses.  The fair value of commitments to extend mortgage loans, which are secured by the underlying properties, is zero as of December 31, 2013, and is valued based on estimates of fees charged by other institutions to make similar commitments to similar borrowers.

 

Private placement commitments represent conditional commitments to purchase private placement debt and equity securities at a specified future date.  The Company enters into these agreements in the normal course of business.  The fair value of these commitments generally cannot be estimated on the date the commitment is made as the terms and conditions of the underlying private placement securities are not yet final.

 

Other loan commitments are agreements to lend to a borrower provided there is no violation of any condition established in the contract.  The Company enters into these agreements to commit to future loan fundings at predetermined interest rates.  Commitments generally have varying expiration dates or other termination clauses.  The fair value of these commitments is insignificant.

 

90



 

9.  Reserve for Life-Contingent Contract Benefits and Contractholder Funds

 

As of December 31, the reserve for life-contingent contract benefits consists of the following:

 

($ in millions)

 

2013

 

2012

 

Immediate fixed annuities:

 

 

 

 

 

Structured settlement annuities

$

6,645

$

7,274

 

Other immediate fixed annuities

 

2,279

 

2,382

 

Traditional life insurance

 

2,329

 

2,899

 

Accident and health insurance

 

236

 

1,448

 

Other

 

100

 

114

 

Total reserve for life-contingent contract benefits

$

11,589

$

14,117

 

 

The following table highlights the key assumptions generally used in calculating the reserve for life-contingent contract benefits.

 

Product

 

Mortality

 

Interest rate

 

Estimation method

Structured settlement annuities

 

U.S. population with projected calendar year improvements; mortality rates adjusted for each impaired life based on reduction in life expectancy

 

Interest rate assumptions range from 0% to 9.0%

 

Present value of contractually specified future benefits

 

 

 

 

 

 

 

Other immediate fixed annuities

 

1983 group annuity mortality table with internal modifications; 1983 individual annuity mortality table; Annuity 2000 mortality table with internal modifications; Annuity 2000 mortality table; 1983 individual annuity mortality table with internal modifications

 

Interest rate assumptions range from 0% to 11.5%

 

Present value of expected future benefits based on historical experience

 

 

 

 

 

 

 

Traditional life insurance

 

Actual company experience plus loading

 

Interest rate assumptions range from 2.5% to 11.3%

 

Net level premium reserve method using the Company’s withdrawal experience rates; includes reserves for unpaid claims

 

 

 

 

 

 

 

Accident and health insurance

 

Actual company experience plus loading

 

Interest rate assumptions range from 3.0% to 6.0%

 

Unearned premium; additional contract reserves for mortality risk and unpaid claims

 

 

 

 

 

 

 

Other:
Variable annuity guaranteed minimum death benefits
(1)

 

Annuity 2000 mortality table with internal modifications

 

Interest rate assumptions range from 4.0% to 5.8%

 

Projected benefit ratio applied to cumulative assessments

 

 

 

 

 

 

 

 

(1) In 2006, the Company disposed of substantially all of its variable annuity business through reinsurance agreements with The Prudential Insurance Company of America, a subsidiary of Prudential Financial, Inc. (collectively “Prudential”).

 

To the extent that unrealized gains on fixed income securities would result in a premium deficiency had those gains actually been realized, a premium deficiency reserve is recorded for certain immediate annuities with life contingencies.  A liability of $771 million is included in the reserve for life-contingent contract benefits with respect to this deficiency as of December 31, 2012.  The offset to this liability is recorded as a reduction of the unrealized net capital gains included in accumulated other comprehensive income.  The liability is zero as of December 31, 2013.

 

91



 

As of December 31, contractholder funds consist of the following:

 

($ in millions)

 

2013

 

2012

 

Interest-sensitive life insurance

7,104

10,356

 

Investment contracts:

 

 

 

 

 

Fixed annuities

 

16,172

 

25,851

 

Funding agreements backing medium-term notes

 

89

 

1,867

 

Other investment contracts

 

239

 

560

 

Total contractholder funds

23,604

38,634

 

 

The following table highlights the key contract provisions relating to contractholder funds.

 

Product

 

Interest rate

 

Withdrawal/surrender charges

Interest-sensitive life insurance

 

Interest rates credited range from 0% to 10.0% for equity-indexed life (whose returns are indexed to the S&P 500) and 1.0% to 6.0% for all other products

 

Either a percentage of account balance or dollar amount grading off generally over 20 years

 

 

 

 

 

Fixed annuities

 

Interest rates credited range from 0% to 9.8% for immediate annuities; (8.0)% to 13.5% for equity-indexed annuities (whose returns are indexed to the S&P 500); and 0.1% to 6.0% for all other products

 

Either a declining or a level percentage charge generally over ten years or less. Additionally, approximately 25.8% of fixed annuities are subject to market value adjustment for discretionary withdrawals

 

 

 

 

 

Funding agreements backing

      medium-term notes

 

Interest rates credited range from 1.8% to 5.4%

 

Not applicable

 

 

 

 

 

Other investment contracts:

Guaranteed minimum income, accumulation and withdrawal benefits on variable (1) and fixed annuities and secondary guarantees on interest-sensitive life insurance and fixed annuities

 

Interest rates used in establishing reserves range from 1.7% to 10.3%

 

Withdrawal and surrender charges are based on the terms of the related interest-sensitive life insurance or fixed annuity contract

 

 

 

(1) In 2006, the Company disposed of substantially all of its variable annuity business through reinsurance agreements with Prudential.

 

Contractholder funds include funding agreements held by VIEs issuing medium-term notes.  The VIEs are Allstate Life Funding, LLC, Allstate Financial Global Funding, LLC and Allstate Life Global Funding, and their primary assets are funding agreements used exclusively to back medium-term note programs.

 

Contractholder funds activity for the years ended December 31 is as follows:

 

($ in millions)

 

2013

 

2012

 

2011

Balance, beginning of year

38,634

 

41,669

 

46,458

 

Deposits

 

2,338

 

 

2,180

 

 

1,869

 

Interest credited

 

1,268

 

 

1,296

 

 

1,592

 

Benefits

 

(1,521

)

 

(1,454

)

 

(1,454

)

Surrenders and partial withdrawals

 

(3,279

)

 

(3,969

)

 

(4,908

)

Maturities of and interest payments on institutional products

 

(1,799

)

 

(138

)

 

(867

)

Contract charges

 

(1,032

)

 

(995

)

 

(962

)

Net transfers from separate accounts

 

12

 

 

11

 

 

12

 

Fair value hedge adjustments for institutional products

 

--

 

 

--

 

 

(34

)

Other adjustments

 

(72

)

 

34

 

 

(37

)

Classified as held for sale

 

(10,945

)

 

--

 

 

--

 

Balance, end of year

23,604

 

38,634

 

41,669

 

 

The Company offered various guarantees to variable annuity contractholders.  Liabilities for variable contract guarantees related to death benefits are included in the reserve for life-contingent contract benefits and the liabilities related to the income, withdrawal and accumulation benefits are included in contractholder funds.  All liabilities for variable contract guarantees are reported on a gross basis on the balance sheet with a corresponding reinsurance

 

92



 

recoverable asset for those contracts subject to reinsurance.  In 2006, the Company disposed of substantially all of its variable annuity business through reinsurance agreements with Prudential.

 

Absent any contract provision wherein the Company guarantees either a minimum return or account value upon death, a specified contract anniversary date, partial withdrawal or annuitization, variable annuity and variable life insurance contractholders bear the investment risk that the separate accounts’ funds may not meet their stated investment objectives.  The account balances of variable annuities contracts’ separate accounts with guarantees included $5.20 billion and $5.23 billion of equity, fixed income and balanced mutual funds and $748 million and $721 million of money market mutual funds as of December 31, 2013 and 2012, respectively.

 

The table below presents information regarding the Company’s variable annuity contracts with guarantees.  The Company’s variable annuity contracts may offer more than one type of guarantee in each contract; therefore, the sum of amounts listed exceeds the total account balances of variable annuity contracts’ separate accounts with guarantees.

 

($ in millions)

 

December 31,

 

 

 

2013

 

2012

 

In the event of death

 

 

 

 

 

Separate account value

5,951

5,947

 

Net amount at risk (1)

636

1,044

 

Average attained age of contractholders

 

68 years

 

67 years

 

At annuitization (includes income benefit guarantees)

 

 

 

 

 

Separate account value

1,463

1,416

 

Net amount at risk (2)

252

418

 

Weighted average waiting period until annuitization options available

 

None

 

None

 

For cumulative periodic withdrawals

 

 

 

 

 

Separate account value

488

532

 

Net amount at risk (3)

9

16

 

Accumulation at specified dates

 

 

 

 

 

Separate account value

732

811

 

Net amount at risk (4)

27

50

 

Weighted average waiting period until guarantee date

 

5 years

 

6 years

 

 

 

 

 

 

 

 

(1) Defined as the estimated current guaranteed minimum death benefit in excess of the current account balance as of the balance sheet date.

(2) Defined as the estimated present value of the guaranteed minimum annuity payments in excess of the current account balance.

(3) Defined as the estimated current guaranteed minimum withdrawal balance (initial deposit) in excess of the current account balance as of the balance sheet date.

(4) Defined as the estimated present value of the guaranteed minimum accumulation balance in excess of the current account balance.

 

The liability for death and income benefit guarantees is equal to a benefit ratio multiplied by the cumulative contract charges earned, plus accrued interest less contract excess guarantee benefit payments.  The benefit ratio is calculated as the estimated present value of all expected contract excess guarantee benefits divided by the present value of all expected contract charges.  The establishment of reserves for these guarantees requires the projection of future fund values, mortality, persistency and customer benefit utilization rates.  These assumptions are periodically reviewed and updated.  For guarantees related to death benefits, benefits represent the projected excess guaranteed minimum death benefit payments.  For guarantees related to income benefits, benefits represent the present value of the minimum guaranteed annuitization benefits in excess of the projected account balance at the time of annuitization.

 

Projected benefits and contract charges used in determining the liability for certain guarantees are developed using models and stochastic scenarios that are also used in the development of estimated expected gross profits.  Underlying assumptions for the liability related to income benefits include assumed future annuitization elections based on factors such as the extent of benefit to the potential annuitant, eligibility conditions and the annuitant’s attained age.  The liability for guarantees is re-evaluated periodically, and adjustments are made to the liability balance through a charge or credit to contract benefits.

 

Guarantees related to the majority of withdrawal and accumulation benefits are considered to be derivative financial instruments; therefore, the liability for these benefits is established based on its fair value.

 

93



 

The following table summarizes the liabilities for guarantees.

 

($ in millions)

 

Liability for
guarantees related to
death benefits and
interest-sensitive life
products

 

Liability for
guarantees
related to
income
benefits

 

Liability for
guarantees related
to accumulation
and withdrawal
benefits

 

Total

Balance, December 31, 2012 (1)

309

 

235

 

129

 

673

 

Less reinsurance recoverables

 

113

 

 

220

 

 

125

 

 

458

 

Net balance as of December 31, 2012

 

196

 

 

15

 

 

4

 

 

215

 

Incurred guarantee benefits

 

83

 

 

(1

)

 

5

 

 

87

 

Paid guarantee benefits

 

(2

)

 

--

 

 

--

 

 

(2

)

Net change

 

81

 

 

(1

)

 

5

 

 

85

 

Net balance as of December 31, 2013

 

277

 

 

14

 

 

9

 

 

300

 

Plus reinsurance recoverables

 

100

 

 

99

 

 

56

 

 

255

 

Balance, December 31, 2013 (2)

377

 

113

 

65

 

555

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2011 (3)

289

 

191

 

164

 

644

 

Less reinsurance recoverables

 

116

 

 

175

 

 

162

 

 

453

 

Net balance as of December 31, 2011

 

173

 

 

16

 

 

2

 

 

191

 

Incurred guarantee benefits

 

25

 

 

(1

)

 

2

 

 

26

 

Paid guarantee benefits

 

(2

)

 

--

 

 

--

 

 

(2

)

Net change

 

23

 

 

(1

)

 

2

 

 

24

 

Net balance as of December 31, 2012

 

196

 

 

15

 

 

4

 

 

215

 

Plus reinsurance recoverables

 

113

 

 

220

 

 

125

 

 

458

 

Balance, December 31, 2012 (1)

309

 

235

 

129

 

673

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Included in the total liability balance as of December 31, 2012 are reserves for variable annuity death benefits of $112 million, variable annuity income benefits of $221 million, variable annuity accumulation benefits of $86 million, variable annuity withdrawal benefits of $39 million and other guarantees of $215 million.

(2) Included in the total liability balance as of December 31, 2013 are reserves for variable annuity death benefits of $98 million, variable annuity income benefits of $99 million, variable annuity accumulation benefits of $43 million, variable annuity withdrawal benefits of $13 million and other guarantees of $302 million.

(3) Included in the total liability balance as of December 31, 2011 are reserves for variable annuity death benefits of $116 million, variable annuity income benefits of $175 million, variable annuity accumulation benefits of $105 million, variable annuity withdrawal benefits of $57 million and other guarantees of $191 million.

 

 

94



 

10.  Reinsurance

 

The Company reinsures certain of its risks to other insurers primarily under yearly renewable term, coinsurance and modified coinsurance agreements.  These agreements result in a passing of the agreed-upon percentage of risk to the reinsurer in exchange for negotiated reinsurance premium payments.  Modified coinsurance is similar to coinsurance, except that the cash and investments that support the liability for contract benefits are not transferred to the assuming company and settlements are made on a net basis between the companies.

 

For certain term life insurance policies issued prior to October 2009, the Company ceded up to 90% of the mortality risk depending on the year of policy issuance under coinsurance agreements to a pool of fourteen unaffiliated reinsurers.  Effective October 2009, mortality risk on term business is ceded under yearly renewable term agreements under which the Company cedes mortality in excess of its retention, which is consistent with how the Company generally reinsures its permanent life insurance business.  The following table summarizes those retention limits by period of policy issuance.

 

Period

 

Retention limits

April 2011 through current

 

Single life: $5 million per life, $3 million age 70 and over, and $10 million for contracts that meet specific criteria Joint life: $8 million per life, and $10 million for contracts that meet specific criteria

 

 

 

July 2007 through March 2011

 

$5 million per life, $3 million age 70 and over, and $10 million for contracts that meet specific criteria

 

 

 

September 1998 through June 2007

 

$2 million per life, in 2006 the limit was increased to $5 million for instances when specific criteria were met

 

 

 

August 1998 and prior

 

Up to $1 million per life

 

In addition, the Company has used reinsurance to effect the acquisition or disposition of certain blocks of business.  The Company had reinsurance recoverables of $1.51 billion and $1.69 billion as of December 31, 2013 and 2012, respectively, due from Prudential related to the disposal of substantially all of its variable annuity business that was effected through reinsurance agreements.  In 2013, premiums and contract charges of $120 million, contract benefits of $139 million, interest credited to contractholder funds of $22 million, and operating costs and expenses of $23 million were ceded to Prudential.  In 2012, premiums and contract charges of $128 million, contract benefits of $91 million, interest credited to contractholder funds of $23 million, and operating costs and expenses of $25 million were ceded to Prudential.  In 2011, premiums and contract charges of $152 million, contract benefits of $121 million, interest credited to contractholder funds of $20 million, and operating costs and expenses of $27 million were ceded to Prudential.  In addition, as of December 31, 2013 and 2012 the Company had reinsurance recoverables of $156 million and $160 million, respectively, due from subsidiaries of Citigroup (Triton Insurance and American Health and Life Insurance) and Scottish Re (U.S.) Inc. in connection with the disposition of substantially all of the direct response distribution business in 2003.

 

As of December 31, 2013, the gross life insurance in force was $540.16 billion of which $195.41 billion was ceded to the unaffiliated reinsurers.

 

The effects of reinsurance on premiums and contract charges for the years ended December 31 are as follows:

 

($ in millions)

 

2013

 

 

2012

 

 

2011

 

 

Direct

$

2,093

 

$

2,121

 

$

2,229

 

 

Assumed

 

 

 

 

 

 

 

 

 

 

Affiliate

 

124

 

 

115

 

 

113

 

 

Non-affiliate

 

68

 

 

40

 

 

20

 

 

Ceded-non-affiliate

 

(618

)

 

(654

)

 

(730

)

 

Premiums and contract charges, net of reinsurance

$

1,667

 

$

1,622

 

$

1,632

 

 

 

95



 

The effects of reinsurance on contract benefits for the years ended December 31 are as follows:

 

($ in millions)

 

2013

 

2012

 

2011

Direct

$

1,805 

$

2,051 

$

2,036 

Assumed

 

 

 

 

 

 

   Affiliate

 

82 

 

80 

 

78 

   Non-affiliate

 

50 

 

34 

 

19 

Ceded-non-affiliate

 

(331)

 

(644)

 

(631)

Contract benefits, net of reinsurance

$

1,606 

$

1,521 

$

1,502 

 

The effects of reinsurance on interest credited to contractholder funds for the years ended December 31 are as follows:

 

($ in millions)

 

2013

 

2012

 

2011

Direct

$

1,240 

$

1,288 

$

1,614 

Assumed

 

 

 

 

 

 

   Affiliate

 

 

10 

 

10 

   Non-affiliate

 

29 

 

19 

 

11 

Ceded-non-affiliate

 

(27)

 

(28)

 

(27)

Interest credited to contractholder funds, net of reinsurance

$

1,251 

$

1,289 

$

1,608 

 

Reinsurance recoverables on paid and unpaid benefits as of December 31 are summarized in the following table.

 

($ in millions)

 

2013

 

2012

Annuities

$

1,648

$

1,831

Life insurance

 

1,025

 

1,606

Long-term care insurance

 

78

 

1,049

Other

 

3

 

84

    Total

$

2,754

$

4,570

 

As of December 31, 2013 and 2012, approximately 92% and 95%, respectively, of the Company’s reinsurance recoverables are due from companies rated A- or better by S&P.

 

11.  Deferred Policy Acquisition and Sales Inducement Costs

 

Deferred policy acquisition costs for the years ended December 31 are as follows:

 

($ in millions)

 

2013

 

2012

 

2011

Balance, beginning of year

$

1,834 

$

2,165 

$

2,526 

Acquisition costs deferred

 

254 

 

262 

 

241 

Amortization charged to income

 

(240)

 

(324)

 

(430)

Effect of unrealized gains and losses

 

226 

 

(269)

 

(172)

Classified as held for sale

 

(743)

 

-- 

 

-- 

Balance, end of year

$

1,331 

$

1,834 

$

2,165 

 

DSI activity, which primarily relates to fixed annuities and interest-sensitive life contracts, for the years ended December 31 was as follows:

 

($ in millions)

 

2013

 

2012

 

2011

Balance, beginning of year

$

41 

$

41 

$

86 

Sales inducements deferred

 

24 

 

22 

 

Amortization charged to income

 

(7)

 

(14)

 

(23)

Effect of unrealized gains and losses

 

12 

 

(8)

 

(29)

Classified as held for sale

 

(28)

 

-- 

 

-- 

Balance, end of year

$

42 

$

41 

$

41 

 

96



 

12.  Guarantees and Contingent Liabilities

 

Guaranty funds

 

Under state insurance guaranty fund laws, insurers doing business in a state can be assessed, up to prescribed limits, for certain obligations of insolvent insurance companies to policyholders and claimants.  Amounts assessed to each company are typically related to its proportion of business written in each state.  The Company’s policy is to accrue assessments when the entity for which the insolvency relates has met its state of domicile’s statutory definition of insolvency and the amount of the loss is reasonably estimable.  In most states, the definition is met with a declaration of financial insolvency by a court of competent jurisdiction.  In certain states there must also be a final order of liquidation.  As of December 31, 2013 and 2012, the liability balance included in other liabilities and accrued expenses was $27 million and $40 million, respectively.  The related premium tax offsets included in other assets were $31 million and $32 million as of December 31, 2013 and 2012, respectively.

 

Guarantees

 

The Company owns certain fixed income securities that obligate the Company to exchange credit risk or to forfeit principal due, depending on the nature or occurrence of specified credit events for the reference entities.  In the event all such specified credit events were to occur, the Company’s maximum amount at risk on these fixed income securities, as measured by the amount of the aggregate initial investment, was $4 million as of December 31, 2013.  The obligations associated with these fixed income securities expire at various dates on or before March 11, 2018.

 

Related to the disposal through reinsurance of substantially all of the Company’s variable annuity business to Prudential in 2006, the Company and the Corporation have agreed to indemnify Prudential for certain pre-closing contingent liabilities (including extra-contractual liabilities of the Company and liabilities specifically excluded from the transaction) that the Company has agreed to retain.  In addition, the Company and the Corporation will each indemnify Prudential for certain post-closing liabilities that may arise from the acts of the Company and its agents, including in connection with the Company’s provision of transition services.  The reinsurance agreements contain no limitations or indemnifications with regard to insurance risk transfer, and transferred all of the future risks and responsibilities for performance on the underlying variable annuity contracts to Prudential, including those related to benefit guarantees.  Management does not believe this agreement will have a material effect on results of operations, cash flows or financial position of the Company.

 

In the normal course of business, the Company provides standard indemnifications to contractual counterparties in connection with numerous transactions, including acquisitions and divestitures.  The types of indemnifications typically provided include indemnifications for breaches of representations and warranties, taxes and certain other liabilities, such as third party lawsuits.  The indemnification clauses are often standard contractual terms and are entered into in the normal course of business based on an assessment that the risk of loss would be remote.  The terms of the indemnifications vary in duration and nature.  In many cases, the maximum obligation is not explicitly stated and the contingencies triggering the obligation to indemnify have not occurred and are not expected to occur.  Consequently, the maximum amount of the obligation under such indemnifications is not determinable.  Historically, the Company has not made any material payments pursuant to these obligations.

 

The aggregate liability balance related to all guarantees was not material as of December 31, 2013.

 

Regulation and Compliance

 

The Company is subject to changing social, economic and regulatory conditions.  From time to time, regulatory authorities or legislative bodies seek to impose additional regulations regarding agent and broker compensation, regulate the nature of and amount of investments, and otherwise expand overall regulation of insurance products and the insurance industry.  The Company has established procedures and policies to facilitate compliance with laws and regulations, to foster prudent business operations, and to support financial reporting.  The Company routinely reviews its practices to validate compliance with laws and regulations and with internal procedures and policies.  As a result of these reviews, from time to time the Company may decide to modify some of its procedures and policies.  Such modifications, and the reviews that led to them, may be accompanied by payments being made and costs being incurred.  The ultimate changes and eventual effects of these actions on the Company’s business, if any, are uncertain.

 

The Company is currently being examined by certain states for compliance with unclaimed property laws.  It is possible that this examination may result in additional payments of abandoned funds to states and to changes in the Company’s practices and procedures for the identification of escheatable funds, which could impact benefit

 

97



 

payments and reserves, among other consequences; however, it is not likely to have a material effect on the consolidated financial statements of the Company.

 

13.  Income Taxes

 

ALIC and its subsidiaries (the “Allstate Life Group”) join with the Corporation (the “Allstate Group”) in the filing of a consolidated federal income tax return and are party to a federal income tax allocation agreement (the “Allstate Tax Sharing Agreement”).  Under the Allstate Tax Sharing Agreement, the Allstate Life Group pays to or receives from the Corporation the amount, if any, by which the Allstate Group’s federal income tax liability is affected by virtue of inclusion of the Allstate Life Group in the consolidated federal income tax return.  Effectively, this results in the Allstate Life Group’s annual income tax provision being computed, with adjustments, as if the Allstate Life Group filed a separate return.

 

The Internal Revenue Service (“IRS”) is currently examining the Allstate Group’s 2011 and 2012 federal income tax returns.  The IRS has completed its examination of the Allstate Group’s 2009 and 2010 federal income tax returns and issued a Revenue Agent’s Report on April 15, 2013.  The Allstate Group protested certain of the adjustments contained in the report and the case was forwarded to Appeals on June 13, 2013.  The IRS has also completed its examinations of the Allstate Group’s federal income tax returns for the years 2005-2008 and a final settlement for those years has been approved by the Joint Committee on Taxation.  The Allstate Group’s tax years prior to 2005 have been examined by the IRS and the statute of limitations has expired on those years.  Any adjustments that may result from IRS examinations of tax returns are not expected to have a material effect on the results of operations, cash flows or financial position of the Company.

 

The Company had no liability for unrecognized tax benefits as of December 31, 2013, 2012 or 2011, and believes it is reasonably possible that the liability balance will not significantly increase within the next twelve months.  No amounts have been accrued for interest or penalties.

 

The components of the deferred income tax assets and liabilities as of December 31 are as follows:

 

($ in millions)

 

2013

 

2012

Deferred assets

 

 

 

 

Sale of subsidiary

$

196 

$

27 

Difference in tax bases of investments

 

44 

 

53 

Other assets

 

 

    Total deferred assets

 

246 

 

81 

Deferred liabilities

 

 

 

 

Unrealized net capital gains

 

(501)

 

(883)

DAC

 

(470)

 

(444)

Life and annuity reserves

 

(273)

 

(193)

Other liabilities

 

(94)

 

(85)

    Total deferred liabilities

 

(1,338)

 

(1,605)

 

 

 

 

 

       Net deferred liability before classification as held for sale

 

(1,092)

 

(1,524)

 

 

 

 

 

       Deferred taxes classified as held for sale

 

(151)

 

-- 

 

 

 

 

 

       Net deferred liability

$

(941)

$

(1,524)

 

Although realization is not assured, management believes it is more likely than not that the deferred tax assets will be realized based on the Company’s assessment that the deductions ultimately recognized for tax purposes will be fully utilized.

 

The components of income tax expense for the years ended December 31 are as follows:

 

($ in millions)

 

2013

 

2012

 

2011

Current

$

71 

$

(82)

$

29

Deferred

 

(52)

 

261 

 

196

Total income tax expense

$

19 

$

179 

$

225

 

98



 

The Company received refunds of $11 million and $58 million in 2013 and 2012, respectively, and paid income taxes of $72 million in 2011.  The Company had current income tax payable of $5 million as of December 31, 2013 and current income tax receivable of $77 million as of December 31, 2012.

 

A reconciliation of the statutory federal income tax rate to the effective income tax rate on income from operations for the years ended December 31 is as follows:

 

 

 

2013

 

 

2012

 

 

2011

 

Statutory federal income tax rate - (benefit) expense

 

(35.0)

 %

 

35.0

 %

 

35.0

 %

Tax credits

 

(181.8)

 

 

(3.8)

 

 

(1.4)

 

Dividends received deduction

 

(46.1)

 

 

(1.4)

 

 

(1.2)

 

Adjustments to prior year tax liabilities

 

(14.1)

 

 

(0.3)

 

 

(0.2)

 

Sale of subsidiary

 

351.3

 

 

--

 

 

--

 

State income taxes

 

15.3

 

 

--

 

 

0.3

 

Non-deductible expenses

 

6.8

 

 

0.1

 

 

--

 

Other

 

0.1

 

 

--

 

 

--

 

Effective income tax rate - expense

 

96.5

 %

 

29.6

 %

 

32.5

 %

 

14.  Capital Structure

 

Debt outstanding

 

All of the Company’s outstanding debt as of December 31, 2013 and 2012 relates to intercompany obligations.  These obligations reflect notes due to related parties and are discussed in Note 5.  The Company paid $27 million, $48 million and $97 million of interest on debt in 2013, 2012 and 2011, respectively.

 

15.  Statutory Financial Information and Dividend Limitations

 

ALIC and its insurance subsidiaries prepare their statutory-basis financial statements in conformity with accounting practices prescribed or permitted by the insurance department of the applicable state of domicile.  Prescribed statutory accounting practices include a variety of publications of the NAIC, as well as state laws, regulations and general administrative rules.  Permitted statutory accounting practices encompass all accounting practices not so prescribed.

 

All states require domiciled insurance companies to prepare statutory-basis financial statements in conformity with the NAIC Accounting Practices and Procedures Manual, subject to any deviations prescribed or permitted by the applicable insurance commissioner and/or director.  Statutory accounting practices differ from GAAP primarily since they require charging policy acquisition and certain sales inducement costs to expense as incurred, establishing life insurance reserves based on different actuarial assumptions, and valuing certain investments and establishing deferred taxes on a different basis.

 

Statutory net income (loss) of ALIC and its insurance subsidiaries was $447 million, $382 million and $(83) million in 2013, 2012 and 2011, respectively.  Statutory capital and surplus was $2.88 billion and $3.38 billion as of December 31, 2013 and 2012, respectively.

 

Dividend Limitations

 

The ability of ALIC to pay dividends is dependent on business conditions, income, cash requirements and other relevant factors.  The payment of shareholder dividends by ALIC to AIC without the prior approval of the Illinois Department of Insurance (“IL DOI”) is limited to formula amounts based on net income and capital and surplus, determined in conformity with statutory accounting practices, as well as the timing and amount of dividends paid in the preceding twelve months.  Based on the formula and absent the limitation discussed as follows, the maximum amount of dividends ALIC would be able to pay without prior IL DOI approval at a given point in time during 2014 is $258 million.  However, any dividend must be paid out of unassigned surplus excluding unrealized appreciation from investments, which for ALIC totaled a deficit position of $504 million as of December 31, 2013.  Therefore, ALIC is not able to pay dividends without prior IL DOI approval as of December 31, 2013.  ALIC will be able to pay dividends without prior IL DOI approval when its unassigned surplus excluding unrealized appreciation from investments becomes positive.

 

Under state insurance laws, insurance companies are required to maintain paid up capital of not less than the minimum capital requirement applicable to the types of insurance they are authorized to write.  Insurance companies are also subject to risk-based capital (“RBC”) requirements adopted by state insurance regulators.  A company’s

 

99



 

“authorized control level RBC” is calculated using various factors applied to certain financial balances and activity.  Companies that do not maintain statutory capital and surplus at a level in excess of the company action level RBC, which is two times authorized control level RBC, are required to take specified actions.  Company action level RBC is significantly in excess of the minimum capital requirements.  Total statutory capital and surplus and authorized control level RBC of ALIC were $2.88 billion and $554 million, respectively, as of December 31, 2013.  ALIC’s insurance subsidiaries are included as a component of ALIC’s total statutory capital and surplus.

 

Intercompany transactions

 

Notification and approval of intercompany lending activities is also required by the IL DOI when ALIC does not have unassigned surplus and for transactions that exceed a level that is based on a formula using statutory admitted assets and statutory surplus.

 

16.  Benefit Plans

 

Pension and other postretirement plans

 

Defined benefit pension plans, sponsored by the Corporation, cover most full-time employees, certain part-time employees and employee-agents.  Benefits under the pension plans are based upon the employee’s length of service and eligible annual compensation.  The cost allocated to the Company for the pension plans was $51 million, $36 million and $22 million in 2013, 2012 and 2011, respectively.

 

The Corporation has reserved the right to modify or terminate its benefit plans at any time and for any reason.

 

Allstate 401(k) Savings Plan

 

Employees of AIC are eligible to become members of the Allstate 401(k) Savings Plan (“Allstate Plan”).  The Corporation’s contributions are based on the Corporation’s matching obligation and certain performance measures. The cost allocated to the Company for the Allstate Plan was $6 million, $6 million and $5 million in 2013, 2012 and 2011, respectively.

 

17.  Other Comprehensive Income

 

The components of other comprehensive (loss) income on a pre-tax and after-tax basis for the years ended December 31 are as follows:

 

($ in millions)

 

2013

 

2012

 

2011

 

 

Pre-
tax

 

Tax

 

After-
tax

 

Pre-
tax

 

Tax

 

After-
tax

 

Pre-
tax

 

Tax

 

After-
tax

Unrealized net holding gains and losses arising during the period, net of related offsets

(1,047

)

367

 

(680

)

1,180

 

(414

)

766

 

1,001

 

(350

)

651

 

Less: reclassification adjustment of realized capital gains and losses

 

42

 

 

(15

)

 

27

 

 

(84

)

 

29

 

 

(55

)

 

579

 

 

(203

)

 

376

 

Unrealized net capital gains and losses

 

(1,089

)

 

382

 

 

(707

)

 

1,264

 

 

(443

)

 

821

 

 

422

 

 

(147

)

 

275

 

Unrealized foreign currency translation adjustments

 

3

 

 

(1

)

 

2

 

 

--

 

 

--

 

 

--

 

 

(2

)

 

1

 

 

(1

)

Other comprehensive (loss) income

(1,086

)

381

 

(705

)

1,264

 

(443

)

821

 

420

 

(146

)

274

 

 

18.  Quarterly Results (unaudited)

 

($ in millions)

 

First Quarter

 

Second Quarter

 

Third Quarter

 

Fourth Quarter

 

 

 

2013

 

2012

 

2013

 

2012

 

2013

 

2012

 

2013

 

2012

 

Revenues

1,049

1,052

1,087

1,065

1,016

970

1,076

1,116

 

Net income (loss)

 

109

 

83

 

150

 

98

 

(394)

 

103

 

97

 

142

 

 

100



 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Shareholder of

Allstate Life Insurance Company

Northbrook, Illinois 60062

 

We have audited the accompanying Consolidated Statements of Financial Position of Allstate Life Insurance Company and subsidiaries (the “Company”), an affiliate of The Allstate Corporation, as of December 31, 2013 and 2012, and the related Consolidated Statements of Operations and Comprehensive Income, Shareholder’s Equity, and Cash Flows for each of the three years in the period ended December 31, 2013.  Our audits also included the consolidated financial statement schedules listed in the Index at Item 15.  These financial statements and financial statement schedules are the responsibility of the Company’s management.  Our responsibility is to express an opinion on these financial statements and financial statement schedules based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States).  Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement.  The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.  Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting.  Accordingly, we express no such opinion.  An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.  We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of Allstate Life Insurance Company and subsidiaries as of December 31, 2013 and 2012, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2013, in conformity with accounting principles generally accepted in the United States of America.  Also, in our opinion, such consolidated financial statement schedules, when considered in relation to the basic consolidated financial statements taken as a whole, present fairly in all material respects the information set forth therein.

 

/s/ Deloitte & Touche LLP

 

Chicago, Illinois

March 5, 2014

 

101



 

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

None.

 

Item 9A. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures.  We maintain disclosure controls and procedures as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934.  Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report.  Based upon this evaluation, the principal executive officer and the principal financial officer concluded that our disclosure controls and procedures are effective in providing reasonable assurance that material information required to be disclosed in our reports filed with or submitted to the Securities and Exchange Commission under the Securities Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities Exchange Act and made known to management, including the principal executive officer and the principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

 

Management’s Report on Internal Control over Financial Reporting.  Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934.

 

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2013 based on the criteria related to internal control over financial reporting described in “Internal Control – Integrated Framework (1992)” issued by the Committee of Sponsoring Organizations of the Treadway Commission.  Based on our evaluation, management concluded that our internal control over financial reporting was effective as of December 31, 2013.

 

Changes in Internal Control over Financial Reporting.  During the fiscal quarter ended December 31, 2013, there have been no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Item 9B. Other Information

 

None.

 

102



 

Part III

 

Item 14.  Principal Accounting Fees and Services

 

(1), (2), (3) and (4) Disclosure of fees -

 

The following fees have been, or are anticipated to be billed by Deloitte & Touche LLP, the member firms of Deloitte & Touche Tohmatsu, and their respective affiliates, for professional services rendered to us for the fiscal years ending December 31, 2013 and 2012.

 

 

 

2013

 

2012 (c)

Audit fees (a)

$

3,037,600

$

3,169,400

Audit related fees (b)

 

30,000

 

146,900

Total fees

$

3,067,600

$

3,316,300

 

 

______________________

 

 

(a)

Fees for audits of annual financial statements, reviews of quarterly financial statements, statutory audits, attest services, comfort letters, consents, and review of documents filed with the Securities and Exchange Commission. The amount disclosed does not reflect reimbursed audit fees received from non-Deloitte entities in the amounts of $304,000 and $253,400 for 2013 and 2012, respectively.

 

 

(b)

Audit related fees relate primarily to professional services such as accounting consultations relating to new accounting standards and are set forth below.

 

 

2013

 

2012

Adoption of new accounting standards

$

--

$

61,900

Audits and other attestation services

 

30,000

 

30,000

Other

 

--

 

55,000

Audit related fees

$

30,000

$

146,900

 

The amount disclosed does not reflect reimbursed audit fees received from non-Deloitte entities in the amount of $44,000 for 2012.

(c)       Total fees for 2012 have been increased by $227,000 primarily to reflect fees for non-recurring reviews related to Allstate Financial’s experience studies and separate accounts.

 

(5)(i) and (ii) Audit Committee’s pre-approval policies and procedures -

 

The Audit Committee of The Allstate Corporation has established pre-approval policies and procedures for itself and its consolidated subsidiaries, including Allstate Life.  Those policies and procedures are incorporated into this Item 14 (5) by reference to Exhibit 99 – The Allstate Corporation Policy Regarding Pre-Approval of Independent Registered Public Accountant’s Services (the “Pre-Approval Policy”).  In addition, in 2005 the Audit Committee of Allstate Life adopted the Pre-Approval Policy, as it may be amended from time to time by the Audit Committee or the Board of Directors of the Corporation, as its own policy, provided that the Designated Member referred to in such policy need not be independent because the New York Stock Exchange corporate governance standards do not apply to Allstate Life.  All of the services provided by Deloitte & Touche LLP to Allstate Life in 2013 and 2012 were approved by The Allstate Corporation and Allstate Life Audit Committees.

 

103



 

Part IV

 

Item 15. (a) (1) Exhibits and Financial Statement Schedules.

 

The following consolidated financial statements, notes thereto and related information of Allstate Life Insurance Company (the “Company”) are included in Item 8.

 

Consolidated Statements of Operations and Comprehensive Income
Consolidated Statements of Financial Position
Consolidated Statements of Shareholder’s Equity
Consolidated Statements of Cash Flows
Notes to the Consolidated Financial Statements

 

Report of Independent Registered Public Accounting Firm

 

Item 15. (a) (2)

 

The following additional financial statement schedules are furnished herewith pursuant to the requirements of Form 10-K.

 

Allstate Life Insurance Company

Page

 

 

 

 

 

Schedules required to be filed under the provisions of Regulation S-X Article 7:

 

 

 

 

 

Schedule I

Summary of Investments - Other than Investments in Related Parties

S-1

 

Schedule IV

Reinsurance

S-2

 

Schedule V

Valuation Allowances and Qualifying Accounts

S-3

 

 

All other schedules are omitted because they are not applicable, or not required, or because the required information is included in the Consolidated Financial Statements or in notes thereto.

 

Item 15.  (a) (3)

 

The following is a list of the exhibits filed as part of this Form 10-K.

 

 

Incorporated by Reference

 

Exhibit
Number

Exhibit Description

Form

File
Number

Exhibit

Filing Date

Filed or
Furnished
Herewith

3(i)

Articles of Amendment to the Articles of Incorporation of Allstate Life Insurance Company dated December 29, 1999.

10

000-31248

3.1

April 24, 2002

 

3(ii)

Amended and Restated By-Laws of Allstate Life Insurance Company effective March 15, 2007.

8-K

000-31248

3(ii)

March 20, 2007

 

4

See Exhibits 3 (i) and 3 (ii).

 

 

 

 

 

10.2

Credit Agreement dated April 27, 2012 among The Allstate Corporation, Allstate Insurance Company and Allstate Life Insurance Company, as Borrowers; the Lenders party thereto, Wells Fargo Bank, National Association, as Syndication Agent; Citibank, N.A. and Bank of America, N.A., as Documentation Agents; and JPMorgan Chase Bank, N.A., as Administrative Agent.

10-Q

1-11840

10.6

May 2, 2012

 

10.3

Surplus Note Purchase Agreement between Allstate Life Insurance Company and Kennett Capital, Inc. effective, August 1, 2005.

10-Q

000-31248

10.2

November 7, 2005

 

10.4

Pledge and Security Agreement between Allstate Life Insurance Company and Kennett Capital, Inc. effective August 1, 2005.

10-Q

000-31248

10.3

November 7, 2005

 

10.5

Intercompany Loan Agreement between The Allstate Corporation, Allstate Life Insurance Company, Lincoln Benefit Life Company and other certain subsidiaries of The Allstate Corporation effective February 1, 1996.

10-K

000-31248

10.24

March 13, 2007

 

10.6

Amended and Restated Intercompany Liquidity Agreement between Allstate Insurance Company, Allstate Life Insurance Company and The Allstate Corporation effective as of May 8, 2008.

10-Q

000-31248

10.2

May 14, 2008

 

10.7

Revolving Loan Credit Agreement, effective December 20, 2010 between American Heritage Life Insurance Company and Road Bay Investments, LLC.

8-K

000-31248

10.1

December 27, 2010

 

 

104



 

10.8

Pledge and Security Agreement, dated as of December 20, 2010, between Road Bay Investments, LLC and American Heritage Life Insurance Company securing obligations under the Revolving Loan Credit Agreement.

8-K

000-31248

10.2

December 27, 2010

 

10.9

Form of Asset Purchase Agreement between Allstate Insurance Company and Road Bay Investments, LLC dated as of March 24, 2011.

10-Q

000-31248

10.1

May 4, 2011

 

10.10

Form of Pledge and Security Agreement between Road Bay Investments, LLC and Allstate Insurance Company dated as of March 24, 2011.

10-Q

000-31248

10.2

May 4, 2011

 

10.11

Capital Support Agreement between Allstate Life Insurance Company and Allstate Insurance Company effective December 14, 2007.

8-K

000-31248

10.1

February 7, 2008

 

10.12

Form of Amended and Restated Service and Expense Agreement among Allstate Insurance Company, The Allstate Corporation and certain affiliates effective January 1, 2004.

10-K

000-31248

10.1

March 17, 2008

 

10.13

Form of Amendment No. 1 effective January 1, 2009 to Amended and Restated Service and Expense Agreement among Allstate Insurance Company, The Allstate Corporation and certain affiliates dated as of January 1, 2009.

8-K

000-31248

10.1

February 17, 2010

 

10.14

Letter Agreement among Allstate Insurance Company, The Allstate Corporation and certain affiliates, including Allstate Life Insurance Company, effective December 1, 2007.

8-K

000-31248

10.1

May 23, 2008

 

10.15

Addendum among Allstate Insurance Company and certain affiliates dated August 17, 2011 to Amended and Restated Service and Expense Agreement among Allstate Insurance Company, The Allstate Corporation and certain affiliates effective as of January 1, 2004, as amended by amendment No. 1 effective as of January 1, 2009.

10-K

000-31248

10.20

March 8, 2012

 

10.16

New York Insurer Supplement to Amended and Restated Service and Expense Agreement among Allstate Insurance Company, The Allstate Corporation, Allstate Life Insurance Company of New York and Intramerica Life Insurance Company, effective March 5, 2005.

10-Q

000-31248

10.2

August 8, 2005

 

10.17

Limited Servicing Agreement among Allstate Life Insurance Company, Allstate Distributors, L.L.C. and Allstate Financial Services, LLC effective October 1, 2002.

10-K

000-31248

10.40

March 17, 2008

 

10.18

Form of Investment Management Agreement among Allstate Investment Management Company, The Allstate Corporation and certain affiliates effective February 1, 2012.

8-K

000-31248

10.1

February 7, 2012

 

10.19

Form of Investment Management Agreement among Allstate Investments, LLC, Allstate Insurance Company, The Allstate Corporation and certain affiliates effective January 1, 2007.

10-K

000-31248

10.12

March 17, 2008

 

10.20

Investment Advisory Agreement and Amendment to Service Agreement as of January 1, 2002 between Allstate Insurance Company, Allstate Investments, LLC and Allstate Life Insurance Company of New York.

10

000-31248

10.31

April 24, 2002

 

10.21

Investment Management Agreement between Allstate Investments, LLC and ALIC Reinsurance Company, effective July 1, 2005.

10-Q

000-31248

10.1

November 7, 2005

 

10.22

Investment Management Agreement between Allstate Investments, LLC and ALIC Reinsurance Company effective as of March 31, 2008.

8-K

000-31248

10.1

December 23, 2008

 

10.23

Investment Advisory Agreement by and between Allstate Insurance Company and Intramerica Life Insurance Company effective July 1, 1999.

10

000-31248

10.29

April 24, 2002

 

10.24

Assignment and Assumption Agreement dated as of January 1, 2002 among Allstate Insurance Company, Allstate Investments, LLC and Intramerica Life Insurance Company.

10

000-31248

10.30

April 24, 2002

 

10.25

Assignment & Delegation of Administrative Services Agreements, Underwriting Agreements, and Selling Agreements entered into as of September 1, 2011 between ALFS, Inc., Allstate Life Insurance Company, Allstate Life Insurance Company of New York, Allstate Distributors, L.L.C., Charter National Life Insurance Company, Intramerica Life Insurance Company, Allstate Financial Services, LLC, and Lincoln Benefit Life Company.

8-K

000-31248

10.1

September 1, 2011

 

 

105



 

10.26

Selling Agreement by and among Allstate Life Insurance Company, Allstate Distributors, L.L.C. (ALFS, Inc., f/k/a Allstate Life Financial Services, Inc., merged with and into Allstate Distributors, L.L.C. effective September 1, 2011) and Allstate Financial Services, LLC (f/k/a LSA Securities, Inc.) effective July 26, 1999.

10-K

000-31248

10.6

March 26, 2004

 

10.27

Amendment effective August 1, 1999 to Selling Agreement between Allstate Life Insurance Company, Allstate Distributors, L.L.C. (ALFS, Inc. merged with and into Allstate Distributors, L.L.C. effective September 1, 2011) and Allstate Financial Services, LLC effective July 26, 1999.

10-Q

000-31248

10.1

November 10, 2004

 

10.28

Amendment effective September 28, 2001 to Selling Agreement between Allstate Life Insurance Company, Allstate Distributors, L.L.C. (ALFS, Inc. merged with and into Allstate Distributors, L.L.C. effective September 1, 2011) and Allstate Financial Services, LLC effective July 26, 1999.

10-Q

000-31248

10.2

November 10, 2004

 

10.29

Amendment effective February 15, 2002 to Selling Agreement between Allstate Life Insurance Company, Allstate Distributors, L.L.C. (ALFS, Inc. merged with and into Allstate Distributors, L.L.C. effective September 1, 2011) and Allstate Financial Services, LLC effective July 26, 1999.

10-Q

000-31248

10.3

November 10, 2004

 

10.30

Amendment effective April 21, 2003 to Selling Agreement between Allstate Life Insurance Company, Allstate Distributors, L.L.C. (ALFS, Inc. merged with and into Allstate Distributors, L.L.C. effective September 1, 2011) and Allstate Financial Services, LLC effective July 26, 1999.

10-Q

000-31248

10.4

November 10, 2004

 

10.31

Selling Agreement and Addenda to Agreement between Allstate Life Insurance Company as successor in interest to Glenbrook Life and Annuity Company, Allstate Distributors, L.L.C. (ALFS, Inc. merged with and into Allstate Distributors, L.L.C. effective September 1, 2011) and Allstate Financial Services, LLC effective May 17, 2001, December 31, 2001 and November 18, 2002, respectively.

10-K

000-31248

10.39

March 17, 2008

 

10.32

Selling Agreement by and among Allstate Life Insurance Company of New York, Allstate Distributors, L.L.C. (ALFS, Inc. merged with and into Allstate Distributors, L.L.C. effective September 1, 2011) and Allstate Financial Services, LLC effective May 1, 2005.

10-K

000-31248

10.7

March 26, 2004

 

10.33

Selling Agreement by and between Lincoln Benefit Life Company, Allstate Distributors, L.L.C. (ALFS, Inc. merged with and into Allstate Distributors, L.L.C. effective September 1, 2011) and Allstate Financial Services, LLC effective August 2, 1999.

10-K

000-31248

10.8

March 26, 2004

 

10.34

Marketing Coordination and Administrative Services Agreement among Allstate Insurance Company, Allstate Life Insurance Company and Allstate Financial Services, LLC effective January 1, 2003.

10-K

000-31248

10.9

March 26, 2004

 

10.35

First Amendment to Marketing Coordination and Administrative Services Agreement by and among Allstate Life Insurance Company, Allstate Financial Services, LLC and Allstate Insurance Company effective January 1, 2006.

10-Q

000-31248

10.1

August 8, 2006

 

10.36

Marketing Agreement by and among Allstate Life Insurance Company as successor in interest to Glenbrook Life and Annuity Company, Allstate Distributors, L.L.C. (ALFS, Inc. merged with and into Allstate Distributors, L.L.C. effective September 1, 2011) and Allstate Financial Services, LLC effective June 10, 2003.

10-K

000-31248

10.41

March 17, 2008

 

10.37

Reinsurance and Administrative Services Agreement by and between American Heritage Life Insurance Company and Columbia Universal Life Insurance Company effective February 1, 1998.

8-K

000-31248

10.3

January  30, 2008

 

10.38

Novation and Assignment Agreement by and among Allstate Life Insurance Company, American Heritage Life Insurance Company and Columbia Universal Life Insurance Company effective June 30, 2004.

8-K

000-31248

10.2

January  30, 2008

 

10.39

Amendment to Reinsurance Agreement effective December 1, 2007, by and between American Heritage Life Insurance Company and Allstate Life Insurance Company.

8-K

000-31248

10.1

January  30, 2008

 

 

106



 

10.40

Reinsurance Agreement between Allstate Life Insurance Company and American Heritage Life Insurance Company effective December 31, 2004.

8-K

000-31248

10.2

January 9, 2008

 

10.41

Amendment No. 1 dated as of January 1, 2008 to Reinsurance Agreement between Allstate Life Insurance Company and American Heritage Life Insurance Company effective December 31, 2004.

8-K

000-31248

10.1

January 9, 2008

 

10.42

Amendment No. 2 dated and effective as of April 1, 2011 to Reinsurance Agreement between Allstate Life Insurance Company and American Heritage Life Insurance Company effective December 31, 2004.

10-Q

000-31248

10.4

August 5, 2011

 

10.43

Retrocessional Reinsurance Agreement between Allstate Life Insurance Company and American Heritage Life Insurance Company effective December 31, 2004.

10-K

000-31248

10.23

March 16, 2005

 

10.44

Reinsurance Agreement effective October 1, 2008 between American Heritage Life Insurance Company and Allstate Life Insurance Company.

8-K

000-31248

10.1

October  28, 2008

 

10.45

Reinsurance Agreement effective July 1, 2010 between Allstate Life Insurance Company and American Heritage Life Insurance Company.

8-K

000-31248

10.1

July 15, 2010

 

10.46

Amendment No. 1 dated and effective as of July 18, 2011 to Reinsurance Agreement effective July 1, 2010 between Allstate Life Insurance Company and American Heritage Life Insurance Company.

10-Q

000-31248

10.3

August 5, 2011

 

10.47

Reinsurance Agreement effective September 30, 2012 between Lincoln Benefit Life Company and Lincoln Benefit Reinsurance Company.

8-K

000-31248

10.1

October 3, 2012

 

10.48

Form of Tax Sharing Agreement by and among The Allstate Corporation and certain affiliates dated as of November 12, 1996.

10-K

000-31248

10.24

March 17, 2008

 

10.49

Agreement for the Settlement of State and Local Tax Credits among Allstate Insurance Company and certain of its affiliates, including Allstate Life Insurance Company effective January 1, 2007.

8-K

000-31248

10.1

February  21, 2008

 

10.50

Stock Purchase Agreement, dated July 17, 2013, among the Registrant, Resolution Life Holdings, Inc., and Resolution Life L.P.

8-K

1-11840

10.1

July 22, 2013

 

23

Consent of Independent Registered Public Accounting Firm

 

 

 

 

X

31(i)

Rule 13a-14(a) Certification of Principal Executive Officer

 

 

 

 

X

31(i)

Rule 13a-14(a) Certification of Principal Financial Officer

 

 

 

 

X

32

Section 1350 Certifications

 

 

 

 

X

99

The Allstate Corporation Policy Regarding Pre-Approval of Independent Registered Public Accountant’s Services effective February 23, 2009.

10-K

000-31248

99

March 19, 2009

 

101.INS

XBRL Instance Document

 

 

 

 

X

101.SCH

XBRL Taxonomy Extension Schema

 

 

 

 

X

101.CAL

XBRL Taxonomy Extension Calculation Linkbase

 

 

 

 

X

101.DEF

XBRL Taxonomy Extension Definition Linkbase

 

 

 

 

X

101.LAB

XBRL Taxonomy Extension Label Linkbase

 

 

 

 

X

101.PRE

XBRL Taxonomy Extension Presentation Linkbase

 

 

 

 

X

 

Item 15. (b)

 

The exhibits are listed in Item 15. (a)(3) above.

 

Item 15. (c)

 

The financial statement schedules are listed in Item 15. (a)(2) above.

 

107



 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

ALLSTATE LIFE INSURANCE COMPANY

 

(Registrant)

 

 

 

/s/ Samuel H. Pilch

 

 

 

 

 

By: Samuel H. Pilch

 

(Senior Group Vice President and Controller)

 

March 5, 2014

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ Don Civgin

 

President, Chief Executive Officer

 

March 5, 2014

Don Civgin

 

and a Director (Principal Executive Officer)

 

 

 

 

 

 

 

/s/ Jesse E. Merten

 

Senior Vice President, Chief Financial

 

March 5, 2014

Jesse E. Merten

 

Officer and a Director (Principal Financial Officer)

 

 

 

 

 

 

 

/s/ Thomas J. Wilson

 

Chairman of the Board and a Director

 

March 5, 2014

Thomas J. Wilson

 

 

 

 

 

 

 

 

 

/s/ Angela K. Fontana

 

Director

 

March 5, 2014

Angela K. Fontana

 

 

 

 

 

 

 

 

 

/s/ Judith P. Greffin

 

Director

 

March 5, 2014

Judith P. Greffin

 

 

 

 

 

 

 

 

 

/s/ Gregory J. Guidos

 

Director

 

March 5, 2014

Gregory J. Guidos

 

 

 

 

 

 

 

 

 

/s/ Wilford J. Kavanaugh

 

Director

 

March 5, 2014

Wilford J. Kavanaugh

 

 

 

 

 

 

 

 

 

/s/ Samuel H. Pilch

 

Director

 

March 5, 2014

Samuel H. Pilch

 

 

 

 

 

 

 

 

 

/s/ John C. Pintozzi

 

Director

 

March 5, 2014

John C. Pintozzi

 

 

 

 

 

 

 

 

 

/s/ Steven E. Shebik

 

Director

 

March 5, 2014

Steven E. Shebik

 

 

 

 

 

 

 

 

 

/s/ Matthew E. Winter

 

Director

 

March 5, 2014

Matthew E. Winter

 

 

 

 

 

108



 

ALLSTATE LIFE INSURANCE COMPANY AND SUBSIDIARIES

SCHEDULE I - SUMMARY OF INVESTMENTS

OTHER THAN INVESTMENTS IN RELATED PARTIES

DECEMBER 31, 2013

 

($ in millions)

 

Cost/
amortized
cost

 

Fair
value

 

Amount at
which shown
in the
Balance Sheet

 

Type of investment

 

 

 

 

 

 

 

Fixed maturities:

 

 

 

 

 

 

 

Bonds:

 

 

 

 

 

 

 

United States government, government agencies and authorities

$

678

$

766

$

766

 

States, municipalities and political subdivisions

 

3,135

 

3,304

 

3,304

 

Foreign governments

 

715

 

792

 

792

 

Public utilities

 

4,810

 

5,143

 

5,143

 

Convertibles and bonds with warrants attached

 

139

 

106

 

106

 

All other corporate bonds

 

15,448

 

16,067

 

16,067

 

Asset-backed securities

 

1,011

 

1,007

 

1,007

 

Residential mortgage-backed securities

 

752

 

790

 

790

 

Commercial mortgage-backed securities

 

724

 

764

 

764

 

Redeemable preferred stocks

 

15

 

17

 

17

 

Total fixed maturities

 

27,427

$

28,756

 

28,756

 

 

 

 

 

 

 

 

 

Equity securities:

 

 

 

 

 

 

 

Common stocks:

 

 

 

 

 

 

 

Public utilities

 

34

$

34

 

34

 

Banks, trusts and insurance companies

 

19

 

20

 

20

 

Industrial, miscellaneous and all other

 

511

 

595

 

595

 

Nonredeemable preferred stocks

 

1

 

1

 

1

 

Total equity securities

 

565

$

650

 

650

 

 

 

 

 

 

 

 

 

Mortgage loans on real estate

 

4,173

$

4,300

 

4,173

 

Real estate (includes $19 acquired in satisfaction of debt)

 

46

 

 

 

46

 

Policy loans

 

623

 

 

 

623

 

Derivative instruments

 

265

$

266

 

266

 

Limited partnership interests

 

2,064

 

 

 

2,064

 

Other long-term investments

 

776

 

 

 

776

 

Short-term investments

 

590

$

590

 

590

 

Total investments

$

36,529

 

 

$

37,944

 

 

S-1



 

ALLSTATE LIFE INSURANCE COMPANY AND SUBSIDIARIES

SCHEDULE IV - REINSURANCE

 

($ in millions)

 

Gross
amount

 

Ceded to
other
companies 
(1)

 

Assumed
from other
companies

 

Net
amount

 

Percentage
of amount
assumed
to net

Year ended December 31, 2013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life insurance in force

$

512,105

$

195,414

$

28,060

$

344,751

 

8.1%

 

 

 

 

 

 

 

 

 

 

 

Premiums and contract charges:

 

 

 

 

 

 

 

 

 

 

Life insurance

$

1,969

$

532

$

125

$

1,562

 

8.0%

 

 

 

 

 

 

 

 

 

 

 

Accident and health insurance

 

124

 

86

 

67

 

105

 

63.8%

 

 

 

 

 

 

 

 

 

 

 

Total premiums and contract charges

$

2,093

$

618

$

192

$

1,667

 

11.5%

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2012

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life insurance in force

$

505,436

$

208,967

$

28,211

$

324,680

 

8.7%

 

 

 

 

 

 

 

 

 

 

 

Premiums and contract charges:

 

 

 

 

 

 

 

 

 

 

Life insurance

$

1,978

$

550

$

95

$

1,523

 

6.2%

 

 

 

 

 

 

 

 

 

 

 

Accident and health insurance

 

143

 

104

 

60

 

99

 

60.6%

 

 

 

 

 

 

 

 

 

 

 

Total premiums and contract charges

$

2,121

$

654

$

155

$

1,622

 

9.6%

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2011

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life insurance in force

$

504,176

$

221,372

$

22,108

$

304,912

 

7.3%

 

 

 

 

 

 

 

 

 

 

 

Premiums and contract charges:

 

 

 

 

 

 

 

 

 

 

Life insurance

$

2,072

$

610

$

72

$

1,534

 

4.7%

 

 

 

 

 

 

 

 

 

 

 

Accident and health insurance

 

157

 

120

 

61

 

98

 

62.2%

 

 

 

 

 

 

 

 

 

 

 

Total premiums and contract charges

$

2,229

$

730

$

133

$

1,632

 

8.1%

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) No reinsurance or coinsurance income was netted against premium ceded in 2013, 2012 or 2011.

 

S-2



 

ALLSTATE LIFE INSURANCE COMPANY AND SUBSIDIARIES

SCHEDULE V - VALUATION ALLOWANCES AND QUALIFYING ACCOUNTS

 

($ in millions) 

 

 

 

Additions

 

 

 

 

 

Description

 

Balance
as of
beginning
of period

 

Charged
to costs
and
expenses

 

Other
additions

 

Deductions

 

Balance
as of
end of
period

 

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for estimated losses on mortgage loans

$

42

$

(11)

$

--

$

10

$

21

 

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2012

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for estimated losses on mortgage loans

$

63

$

(5)

$

--

$

16

$

42

 

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2011

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Allowance for estimated losses on mortgage loans

$

84

$

33

$

--

$

54

$

63

 

 

S-3


Exhibit 23

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the following registration statements of our report dated March 5, 2014, relating to the financial statements and financial statement schedules of Allstate Life Insurance Company, appearing in this Annual Report on Form 10-K of Allstate Life Insurance Company for the year ended December 31, 2013, and to the reference to us under the heading “Experts” in the Prospectus, which is part of the registration statements.

 

Form S-3 Registration Statement Nos.

Form N-4 Registration Statement Nos.

333-150286

333-102934

333-150577

333-114560

333-150583

333-114561

333-177476

333-114562

333-177478

333-121687

333-177479

333-121691

333-177480

333-121692

333-177481

333-121693

333-177666

333-121695

333-177671

 

333-177672

 

333-177673

 

333-177675

 

333-178570

 

333-187073

 

 

 

 

/s/ Deloitte & Touche LLP

 

Chicago, Illinois

March 5, 2014

 


 

CERTIFICATIONS

EXHIBIT 31 (i)

 

I, Don Civgin, certify that:

 

1. I have reviewed this report on Form 10-K of Allstate Life Insurance Company;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 5, 2014

 

/s/ Don Civgin

 

 

 

Don Civgin

 

President and Chief Executive Officer

 



 

CERTIFICATIONS

EXHIBIT 31 (i)

 

I, Jesse E. Merten, certify that:

 

1. I have reviewed this report on Form 10-K of Allstate Life Insurance Company;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 5, 2014

 

/s/ Jesse E. Merten

 

 

 

Jesse E. Merten

 

Senior Vice President and

 

Chief Financial Officer

 


EXHIBIT 32

 

SECTION 1350 CERTIFICATIONS

 

Each of the undersigned hereby certifies that to his knowledge the report on Form 10-K for the fiscal year ended December 31, 2013 of Allstate Life Insurance Company filed with the Securities and Exchange Commission fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and result of operations of Allstate Life Insurance Company.

 

Date: March 5, 2014

 

 

/s/ Don Civgin

 

Don Civgin

 

President and Chief Executive Officer

 

 

 

 

 

/s/ Jesse E. Merten

 

Jesse E. Merten

 

Senior Vice President and Chief Financial Officer